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Abstract
Magnetic resonance spectroscopic imaging (MRSI) is a non-invasive tech-
nique able to provide the spatial distribution of relevant biochemical com-
pounds (metabolites) commonly used as biomarkers of disease. Information
provided by MRSI can be used as a valuable insight for the diagnosis, treat-
ment and follow-up of several diseases such as cancer or neurological disor-
ders. Obtaining accurate and reliable information from in vivo MRSI signals
is a crucial requirement for the clinical utility of this technique. Despite the
numerous publications on the topic, the interpretation of MRSI data is still
a challenging problem due to different factors such as the low signal-to-noise
ratio (SNR) of the signals, the overlap of spectral lines or the presence of
nuisance components. In this thesis, we propose novel signal processing al-
gorithms with the aim to alleviate these limitations. Our main goals are the
development of processing methods to improve the analysis of MRSI data,
and to exploit the potential of MRSI for the development of novel treatment
strategies in radiotherapy (RT). To address the SNR limitations of MRSI,
we first investigate a new algorithm for denoising MRSI data based on a hy-
brid spatio-spectral regularization scheme in the wavelet domain. We then
integrate this regularization scheme into two different novel methods to in-
terpret MRSI data. More specifically, a quantification and a tissue pattern
recognition algorithms are presented as complementary approaches for the
interpretation of MRSI data. The proposed methods rely on fast parallel
optimization algorithms dealing with convex but non-necessarily differen-
tiable criteria involving, for example, suitable sparsity promoting priors. All
the methods are evaluated and compared with other existing techniques us-
ing simulated and in vivo data. Results show the ability of these methods
to deal with the artifacts usually present in in vivo data, especially in the
context of lesions. In addition, in order to show the potential of MRSI to op-
timize the RT treatment planning, a supervised classification method for the
identification of regions at risk of relapse in brain tumor patients is proposed
and validated on real data.
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1.1 Motivation
Magnetic resonance spectroscopic imaging (MRSI) has demonstrated the
ability to localise and characterize tumour tissues and to detect abnormal
tissue beyond that seen on standard MRI. However, robust data analysis
methods are still needed. The aim of this thesis is to propose new algorithms
to overcome the current limitations and to address the open challenges in
the processing of MRSI data. MRSI is a non-invasive modality able to pro-
vide the spatial distribution of relevant biochemical compounds (metabolites)
commonly used as biomarkers of disease. Information provided by MRSI can
be used as a valuable insight for the diagnosis, treatment and follow-up of
several diseases such as cancer or neurological disorders. Obtaining accurate
and reliable information from in vivo MRSI signals is a crucial requirement
for the clinical utility of this technique. Despite the numerous publications
on the topic, the interpretation of MRSI data is still a challenging prob-
lem due to different factors such as the low signal-to-noise ratio (SNR) of
the signals, the overlap of spectral lines or the presence of nuisance compo-
nents. Most advanced methods to process MRSI data incorporate spectral
knowledge together with spatial smoothness assumptions on some spectral
parameters. This thesis addresses the problem of interpreting MRSI data
and characterizing tumor recurrence in brain tumor patients. Specifically,
four research questions are formulated in this thesis:
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• Extracting meaningful signals from noisy measured data
• Quantifying spatially coherent metabolites
• Decomposing MRSI signals in tissue-specific spectral patterns
• Identifying tumor relapse areas using multi-parametric MR data.
These objectives are addressed through a methodological approach based on
novel processing methods that incorporate prior knowledge on the MRSI data
using spatio-spectral regularization. As an application, the thesis addresses
the integration of MRSI into the radiotherapy treatment workflow within
the context of the European project SUMMER (Software for the Use of
Multi-Modality images in External Radiotherapy) founded by the European
Commission (FP7–PEOPLE–ITN framework).
Four main contributions are presented in this work:
• Spatio-spectral regularization to solve the ill-posed inverse problem of
MRSI denoising.
• Joint denoising-quantification of MRSI data based on a spatio-spectral
regularization and metabolite profiles.
• Spectral unmixing of MRSI spectra for brain tissue classification and
visualization of tumor spread (not visible from anatomical MRI modal-
ities).
• Classification of multi-parametric MR data using a supervised method,
and experimental correlation with clinical results for the identification
of areas with high probability of relapse.
1.2 Organization of the manuscript
The thesis is organized as follows:
- Chapter 2: Magnetic resonance spectroscopic imaging
This chapter describes the important role of imaging in the evaluation of can-
cer patients, focusing on brain tumor patients. While morphological imaging
is the most commonly used technique, the introduction of new functional
22
imaging modalities has improved the characterization of tumors. One of
such techniques is MRSI. This chapter summarizes the principles and basics
of this technique and its role into the radiotherapy context.
- Chapter 3: MRSI processing
This chapter summarizes the main conventional techniques to process and
interpret MRSI data. The concept of inverse problem is introduced, and it
is then exploited to express the processing methods proposed in this thesis.
Since the considered inverse problems are ill-posed, the technique of regular-
ization is also introduced. The regularization schemes proposed in this thesis
are based on objective functions that are convex but not necessarily differen-
tiable involving, for example, suitable sparsity promoting priors. This makes
impossible the use of standard gradient-based algorithms for optimization.
We therefore propose to perform the optimization by using the concept of
proximity operators which has been successfully used in a number of previous
works in convex optimization.
- Chapter 4: MRSI Denoising
In vivo MRSI suffers from poor signal-to-noise ratio (SNR) limiting its clin-
ical use for treatment purposes. This is due to the combination of a weak
magnetic resonance signal and low metabolite concentrations, in addition to
the acquisition noise. We propose a new method that handles this challenge
by efficiently denoising MRSI signals without constraining the spectral or
spatial profiles. The proposed denoising approach is based on wavelet trans-
forms and exploits the sparsity of the MRSI signals both in the spatial and
frequency domains. A fast proximal optimization algorithm is then used to
recover the optimal solution. Experiments on synthetic and real MRSI data
show that the proposed denoising method provides better noise suppression
(SNR increase up to 60%). In addition, this method is computationally effi-
cient and preserves data features better than other existing strategies.
- Chapter 5: MRSI Quantification
Obtaining accurate metabolite concentrations from in vivo MRSI signals is
a crucial requirement for clinical applications. Despite the numerous pub-
lications on the topic, accurate quantification is still a challenging problem
due to the low signal-to-noise ratio, the overlap of spectral lines and the
presence of nuisance components. We propose a novel quantification method
which alleviates these limitations by exploiting a spatial-spectral regulariza-
23
tion scheme. Spatial and spectral regularization terms are jointly incorpo-
rated into the quantification model with the aim of increasing the SNR of the
data and exploiting the neighboring information along the spatial and spec-
tral dimensions. Contrary to previous methods, the proposed technique is
not restricted to spatially smooth solutions and the regularization terms are
not expressed directly on the sought parameters, but on appropriate trans-
formed domains. In order to simultaneously quantify all signals in the MRSI
grid by using an appropriate prior information, a fast proximal optimization
algorithm is proposed. Experiments on synthetic MRSI data demonstrate
that the error in the estimated metabolite concentrations is reduced by a
mean of 41% with the proposed scheme. Results on in vivo brain MRSI
data show the benefit of the proposed approach which is able to correctly fit
overlapping peaks and to capture metabolites that are missed by single voxel
methods due to their low concentrations.
- Chapter 6: MRSI Classification
Despite post-operative radiotherapy (RT) of glioblastoma (GBM), local tu-
mor regrowth occur in irradiated areas and are responsible for poor outcome.
Identification of sites with high probability of recurrence is a promising way
to define new target volumes for dose escalation in RT treatments. We show
that a supervised learning system based on support vector machines can be
trained to generate probability maps of relapse for brain tumor patients. The
quantification method proposed in Chapter 4 is used as a feature extraction
technique. The estimated metabolite amplitudes in combination with differ-
ent modalities of anatomical MRI images are used as input features in the
classifier. This study outlines the ability of MRSI data, in combination with
other MRI modalities, to define new biologically tailored target volumes for
dose escalation in radiotherapy treatments.
- Chapter 7: MRSI Unmixing
This chapter presents a spectral unmixing algorithm as an alternative ap-
proach to interpret MRSI data. Spectral unmixing consists of extracting
from a hyperspectral data set (MRSI data set in our case), the spectral
patterns of the pure components (tissue types) present in the image and of
identifying their abundances. To this aim, we propose a blind source sep-
aration (BSS) algorithm for brain tissue classification and visualization of
tumor spread using MRSI data. The proposed BSS method jointly incor-
porates prior knowledge about the spatial and spectral dimensions of MRSI
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data. It aims at increasing the signal-to-noise ratio of the data and to favor
solutions with few irregularities in the spatial and the spectral dimensions.
Contrary to previous methods, it is able to extract more than two physically
meaningful tissue patterns and it is not restricted to non-negative sources.
In addition, the results do not depend on the initialization strategy since this
algorithm relies on the optimization of convex functions. Different experi-
ments with in-vivo MRSI data show that the method is robust to noise and
to the presence of low quality spectra.
- Chapter 8: Conclusions and perspectives
New algorithms combining spatial and spectral regularizations in the wavelet
domain to improve MRSI data processing have been presented. Contrary
to previous approaches, the suggested methods combine two regularization
terms to favour solutions with specific properties in both the spatial and
the spectral dimensions. Experiments on synthetic and in-vivo data show
the benefit of using this type of regularization in different applications: pre-
processing (denoising), quantification and spectral unmixing. The depen-
dency on only two hyperparameters and the use of fast proximal algorithms
that allow parallel computations facilitate the automation of the presented
methods, which is crucial for the acceptance of the MRSI technique into the
clinical routine.
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1.4 SUMMER Project
This PhD has be developed under the SUMMER project (Software for the
Use of Multi-Modality images in External Radiotherapy, PITN-GA-2011-
290148, a Initial Training Network (ITN) granted by Marie Curie Actions in
the 7th Framework Program (FP7–PEOPLE–ITN framework), http://summer-
project.eu/). The corner stone objective of this project is to develop a unique
tool that radiation oncologists, physicians, physicists and radiologists can
share to analyze images in the radiotherapy work-flow. ”SUMMER“ aims
to improve the precision of clinical target volume by the definition of a bi-
ological target volume, leading to define optimal radiotherapy planning and
to follow patient treatment response in order to perform on-line treatment
changes. The partners’ expertise ranged from oncology to computer engi-
neering, including ergonomics, signal processing and informatics, together in
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a consortium composed by five academic partners and two industrial part-
ners. As a fellow of this project, my work was focused on the development
of processing techniques for MRSI data to facilitate the integration of this
technique into the radiotherapy work-flow.
Software
This PhD work has led to the design of an MRSI processing plugin integrated
within the SUMMER project prototype. Note that this software is not freely
available online for confidentiality reasons.
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Magnetic resonance spectroscopic
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2.1 Introduction
Imaging in oncology has been traditionally based on morphological crite-
ria. Magnetic resonance imaging (MRI) is widely used for the diagnosis and
follow-up of brain tumors due to its high soft-tissue contrast. Advanced func-
tional MRI techniques can characterize physiological changes in tissues before
they become visible in conventional morphological images [Laprie et al., 2008;
Deviers et al., 2014]. The early assessment of biochemical and functional
properties of lesions can be used to guide and personalize oncological treat-
ments. The goal of this chapter is to provide an overview of MRI techniques
typically used in oncology. The development of new therapeutic strategies
based on advanced functional imaging techniques is discussed. More specifi-
cally, the integration magnetic resonance spectroscopy imaging (MRSI) into
the radiotherapy (RT) treatment planning is motivated.
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2.2 Imaging in oncology
2.2.1 Conventional morphological imaging
Non-invasive imaging plays a crucial role in cancer diagnosis and manage-
ment. Anatomical features are routinely assessed through morphological
imaging techniques. For example, tumour response to treatment is typi-
cally assessed from measurements of tumour size, using techniques such as
X-ray computed tomography (CT) and MRI [Organization, 1979; Therasse
et al., 2000; Eisenhauer et al., 2009]. However, morphological assessment is
not suitable for diffuse and/or multiple tumor lesions and changes in tumor
size do not always accurately reflect response to treatment [Wahl et al., 2009].
Indeed the limitations of morphological assessment are well documented, and
it has already been shown that changes in metabolism and perfusion occur
before morphological changes [Evelhoch, 1999; Tofts et al., 1999; Carmeliet
and Jain, 2000]. Conventional anatomical imaging often allows only vague
identification and localization of tumors, and biopsies are routinely required
to appropriately diagnose and treat tumors. Unfortunately, the location of
many brain tumors prevents biopsies from being performed, and detailed
knowledge of the nature of the tumor is missing in these cases.
Significant effort is put into the development and validation of new non-
invasive imaging techniques able to provide information about metabolic pro-
cesses as well as cellular and molecular interactions [Schober and Riemann,
2013]. Early and reliable assessment of functional properties of lesions has
become a necessity to correctly diagnose, differentiate, and guide therapy.
MRI has introduced many tools to improve morphological evaluation and
added capabilities for functional characterization of lesions. Implementing
different imaging sequences, MRI allows a considerable tissue characteriza-
tion regarding its proton/water or fatty tissue content. In addition, no health
risks are known to be caused by the main magnetic field of clinical MR sys-
tems. Whereas continuous improvements in image quality have been achieved
in MRI in the recent years, the major advance for oncologic applications is
the clinical implementation of functional assessment techniques that provide
additional information on top of morphology.
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2.2.2 Functional MRI techniques
Currently, MRI is well established in the clinical practice, even if it is in
continuous development [Hernando et al., 2010]. For more than 30 years
this method has presented significant progress in different fields of medicine,
particularly in cancer patients, including different steps of oncologic man-
agement, such as detection, characterization, staging, response evaluation
and post-therapeutic follow-up [Higgins and Pomper, 2011]. MRI has be-
come a powerful clinical tool for evaluation of brain anatomy able to pro-
vide morphological information, such as size, contours, number of lesions
and relationship with adjacent structures [Hernando et al., 2010]. However,
functional and metabolic alterations which normally precede morphological
alterations are not usually recognized by traditional imaging techniques. Ad-
vanced MRI techniques provide physiologic, metabolic and functional infor-
mation about tumor biology beyond standard MRI and CT evaluations [Hig-
gins and Pomper, 2011; Histed et al., 2012]. The development of new MRI
techniques has enabled the functional assessment of the structures in order
to obtain information on the different physiological processes of the tumor
micro-environment, such as oxygenation levels, cellularity and vascularity.
Functional MRI includes perfusion MRI, diffusion imaging, brain functional
MRI (fMRI) and magnetic resonance spectroscopy (MRS(I)). These func-
tional MRI modalities can provide unique pathological, physiological and
metabolic information that are not available in anatomic MR. MR perfu-
sion characterizes brain tumor biology through the underlaying pathological
and physiological changes that occur with tumor vasculature [Maeda et al.,
1993; Aronen et al., 1994; Gillard et al., 2009]. MR diffusion exploits the
translational mobility of water molecules to provide information on cellular
density and the nature of local edema [Tien et al., 1994; Krabbe et al., 1997].
Functional MRI (fMRI) is based on the changes in blood oxygenation and
flow that occur in response to neural activity [Ogawa et al., 1990; Logothetis
et al., 2001]. It is commonly performed using the Blood Oxygenation Level
Dependent signal (BOLD). The BOLD effect is based on the fact that when
neuronal activity is increased in one part of the brain, there is also an in-
creased amount of cerebral blood flow to that area. The ability to accurately
model the evoked hemodynamic response to a neural event also plays an im-
portant role in the analysis of fMRI data. Therefore, there is a significant
interest for estimating the hemodynamic response function (HRF) [Ciuciu
et al., 2003; Vincent et al., 2010] in order to better understand the mecha-
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nisms of cerebral activations. fMRI can be used to produce activation maps
showing which parts of the brain are involved in a particular mental process
or tasks. In addition, in recent years, there has been an increasing interest in
the application of the technique at rest, termed resting-state fMRI, in order
to investigate the functional architecture of the brain [Lee et al., 2013].
In this thesis we will focus on MRS (more specifically MRS imaging (MRSI))
which provides the metabolism characterization of the sampled tissue. The
next sections describe the principles and basics of this technique, and intro-
duce its role into the radiotherapy context.
The great flexibility of MRI systems allow the combined analysis of anatomi-
cal and functional findings allows a more comprehensive evaluation of the ex-
tension and activity of the lesions, including the phases of diagnosis, staging,
response evaluation and follow-up. This opens the possibility of developing
more individualized therapeutic strategies, with a favorable impact on the
quality of life and survival of the patients [Higgins and Pomper, 2011; Pad-
hani, 2011; Histed et al., 2012; Guimaraes et al., 2014]. In addition, unlike
other imaging modalities like Positron Emission Tomography (PET) or CT,
MR techniques do not involve exposure to ionizing radiation.
2.2.3 Quantitative MRI
Recently, there has been an increased interest in developing pulse sequences
which allow the estimation of quantitative MR parameters. In contrast to
conventional MRI, quantitative MRI (qMRI) is aimed at the direct mea-
surement of the physical tissue properties, such as the relaxation times, T1
and T2, as well as the proton density (PD). Quantitative MRI offers several
advantages including higher sensitivity, better accuracy and higher repro-
ducibility since these properties are, in theory, independent of acquisition
method. Whereas in conventional weighted MRI images the signal intensity
is in arbitrary units and cannot be compared across sites or even scanning
sessions, quantitative imaging can provide biomarkers that are absolute mea-
sures comparable across imaging sites and time points. However, qMRI is
not commonly used in the routine clinical practice due to the significant
longer acquisition times that are needed to obtain quantitative parameter
maps. Parameter mapping requires multiple MRI images acquired with dif-
ferent timings usually resulting in long acquisition times. As an alternative
to the acquisition of multiple images with varying parameters, model-based
approaches have also been proposed for both T1 and T2 mapping [Block
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et al., 2009; Velikina et al., 2010; Huang et al., 2012]. More recently, new
approaches allowing the simultaneous quantification of multiple physiological
parameters of interest in a reasonable scanning time have been proposed [Ma
et al., 2013; De Rochefort, 2010].
2.3 Magnetic resonance spectroscopic imaging
Whereas conventional MRI determines the spatial distribution of water (and
lipid) protons across a region of interest, MR spectroscopy measures the
chemical content of MR-visible nuclei which include the metabolically rele-
vant elements of proton (1H) , carbon (13C), and phosphorus (31P). In clinical
MRS, proton MRS, referred to as 1H MRS, is the most commonly used due
to its high natural abundance (hydrogen is the most abundant atom in the
body, representing about 63% of the total atoms), and high sensitivity over
the other nuclei (proton has the highest gyromagnetic ratio of non-radioactive
nuclei). Sensitivity is also enhanced compared to other nuclei due to favor-
able metabolite relaxation times, and also because several important (brain)
metabolites have resonances resulting from functional groups with multiple
protons. In addition, proton MRS relies on the same physical phenomenon
as MRI, the nuclear magnetic resonance. Proton MRS data can therefore
be acquired using the same scanner as conventional MRI. Nowadays most
clinical MRI scanners (1.5-3 Tesla) have routine sequences for 1H-MRS mea-
surements, providing a wide range of metabolic information integrated with
complementary anatomical or other functional MRI sequences.
MRS provides relevant information on tumour characteristics, progression
and response to treatment not available from conventional MRI [Laprie et al.,
2008; Deviers et al., 2014]. Historically, 1H MRS has been focused on study-
ing neurological disorders since the use of the technique in the brain imposes
fewer technical challenges that in other organs: motion artifacts are minor,
shimming (making magnetic field as homogeneous as possible) is easier to
perform, and lipids are generally absent in normal brain tissue [Oya et al.,
1999]. Nowadays MRS has become a valuable tool for the examination of
human brain tumours, neurological disorders and also prostate and breast
cancers [Kwock et al., 2006; Posse et al., 2013]. Spectroscopy of the prostate
can pinpoint the location of cancer. Breast MRS can dramatically reduce
the need for needle biopsy. Brain spectra can help to differentiate different
tissue types in heterogeneous brain tumors or to detect tumor infiltration
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onto healthy tissue.
Early MRS studies used single-voxel spectroscopy (SVS) (i.e., spectra recorded
from a single , typically 8cm3 cube of tissue), for several reasons: they are
widely available in clinical scanners, have short scan times (around 5 min-
utes), usually a good field homogeneity, and are relatively easy to process and
interpret. However, SVS lacks spatial resolution and cannot be used to map
regional metabolic variations. Since tumors are commonly heterogenous, the
MR signal may greatly vary depending on the region that is sampled by
SVS (see Figure 2.1) [Ricci et al., 2000]. Hence, the region-of-interest chosen
for analysis will have a large influence on the results. Multi-voxel methods
(known as chemical shift imaging (CSI) or magnetic resonance spectroscopic
imaging (MRSI)) allow the analysis of the metabolic heterogeneity of tumors
since they are able to map the spatial distribution of the lesion and the sur-
rounding areas. In this thesis we focus on proton MRSI data from brain
tumor patients.
Figure 2.1: MRSI (TR/TE=1200/135 ms) and conventional MRI in a 56-
year-old man who had chemotherapy after partial surgical resection of a
GBM in the left temporal and inferior parietal lobe. The enhancing rim
of the lesion is characterized by a high Choline signal (regions 2 and 4),
while the central necrotic core (region 3) has elevated lipids and reduced
levels of other metabolites. Region 1 shows the normal spectrum from the
right hemisphere. Arrows in the Creatine and Choline images point to field-
inhomogeneity artifacts due to surgical staples. Edited from [Horská and
Barker, 2010].
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2.3.1 Basics of magnetic resonance spectroscopy
2.3.1.1 Nuclear Magnetic Resonance
MR spectroscopy relies on the same physical phenomenon as conventional
MRI, the nuclear magnetic resonance (NMR), first described in 1946 simul-
taneously by the Nobel Prize winners Edward Purcell, from Harvard Univer-
sity, and Felix Bloch, from Standford University [Purcell et al., 1946; Bloch,
1946]. The use of NMR to study the the structure of biological molecules
was significantly improved in the late 1960s with the development of super-
conducting magnets and the implementation of Fourier transform NMR. It
was in the mid-1970s when NMR started to be used for the study of living
biological systems, after the use of magnetic field gradients to encode NMR
signals spatially was introduced [Lauterbur et al., 1973], and thus the concept
of magnetic resonance imaging (MRI) was born. When an NMR technique is
used in vivo and in particular in the clinic, the convention is to avoid the term
“nuclear” as it may erroneously lead to associations with nuclear medicine,
radioactive materials, and ionizing radiation. For this reason, in vivo NMR
spectroscopy is referred to as magnetic resonance spectroscopy (MRS).
Subatomic particles like electrons, protons and neutrons are associated with
“spin”, a fundamental property like charge or mass. In the case of atomic
nuclei with even number of protons and neutrons, individual spins are paired
and the overall spin becomes zero. However, any atomic nucleus that has an
odd number of protons and/or neutrons possess a net spin, called “nuclear
spin”. Spin can be visualised as a rotating motion of the nucleus about its
own axis. Each nucleus has a unique nuclear spin, which is described by
the spin quantum number I. Each nuclear spin also has a magnetic moment
µ. The nuclear spin and the magnetic moment are related by the following
equation:
µ = γI, [2.1]
where the constant γ is known as the gyromagnetic ratio and it is unique for
each NMR-active nucleus. The combination of spin and charge makes that
such nuclei behave like small magnets (Figure 2.2), and when a nucleus with
a nuclear spin I is placed in an external magnetic field, it may assume one
of 2I + 1 orientations relative to the direction of the external field.
Nuclei with this property can be observed by nuclear magnetic resonance
(NMR) spectroscopy. The main nuclei used in clinical MRS are proton (1H),
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Figure 2.2: A charged, spinning nucleus creates a magnetic moment which
acts like a bar magnet. Edited from http://www.voxelcube.com.
phosphorous-31 (31P), carbon-13 (13C) and fluorine-19 (19F), all of which
have nuclear spin I = 1/2. Due to its abundance in the human body, the
most common nucleus used in MR is 1H. The following description of the
NMR experiment will be limited to proton spectroscopy (analogous for any
other nuclei with I = 1/2).
An NMR experiment consists of embedding a sample into a static external
field B0 to align the angular momentum of the nuclei, applying a radio
frequency (RF) pulse with a bandwidth chosen to excite all the nuclei within
the required frequency range and acquiring the emitted response signal. In
the absence of an external magnetic field, each nucleus (magnet) is randomly
oriented. In the presence of an static external magnetic field, B0, the I =
1/2 nuclei adopt two possible orientations: either parallel (low energy) or
antiparallel (high energy) to the external magnetic field (Figure 2.3). The
difference in energy (∆E) between the two spin states is proportional to
the strength of the applied magnetic field (B0) according to the following
equation:
∆E =
hγB0
2pi
, [2.2]
where h is the Planck constant (6.626 ×10−34 Js).
The following diagram illustrates that the two spin states have the same
energy when the external field is zero, but diverge as the field increases.
Nuclei in the lower energy orientation (parallel to the field) can be excited to
the higher energy orientation (antiparallel to the field) by a radiofrequency
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Figure 2.3: NMR-active nucleus behaves like a small magnet when it is placed
in an external magnetic field.
Edited from http://chem.ch.huji.ac.il/nmr/whatisnmr/whatisnmr.html.
(RF) pulse of the correct frequency (ν) according to:
ν =
∆E
h
[2.3]
It follows from equations [2.2] and [2.3] that the frequency ν is related with
the strength of the external magnetic field B0 by the following equation
which is known as the Larmor equation:
ν =
γB0
2pi
[2.4]
The Larmor equation shows that the frequency required to excite the nucleus
is proportional to the strength of the external magnetic field and to the gy-
romagnetic ratio of the nucleus observed.
To induce transitions between both energy states, a RF pulse is applied by a
coil in a plane perpendicular to the direction of the static external field B0.
The frequency of the RF pulse has to correspond with the energy difference
between the two states and matches to the Larmor frequency (Equation [2.4]).
The RF pulse will excite simultaneously all the nuclei whose resonance fre-
quencies are close to the frequency of the pulse. When the RF pulse is turned
off, the excited nuclei quickly return to their original state (i.e., align with
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B0) generating the signal that is acquired by a detector coil. The MR signal
originates from the process of energy absorption by spins making a transition
from the lower energy state to the higher energy state, and energy emission
by spins making a transition from the higher energy state to the lower energy
state. The intensity of the signal emitted by the nuclei (amount of energy)
depends on the population difference between the two energy states. In ther-
mal equilibrium, the relative amount of nuclei in the highest n and the lowest
n+ energy state is given by:
n−
n+
= e−
∆E
kT , [2.5]
where k is the Boltzman constant (1.381 ×10−23 J/K) and T the temperature
in Kelvin.
The ratio n−
n+
is very close to unity because the number of spins in the low
energy level is slightly higher than the number of spins in the high energy
level, causing a weak net magnetic field. For example, at room temperature
in a 1.5 Tesla magnetic field, there will typically be a population ratio n−
n+
equal to 100.000:100.006. This explains the inherently low signal-to-noise
ratio (SNR) of the signal emitted when the spin system returns to equilib-
rium after excitation. The emitted signal is called a free induction decay
(FID) signal and corresponds to an exponentially decaying sinusoid in the
time domain. The FID is typically transformed to the frequency domain via
Fourier transform in order to obtain a frequency spectrum. The intensity
of the signal is proportional to the number of nuclei that contribute to it
(i.e., the area under each peak in the spectrum is proportional to the number
of nuclei generating that peak (Figure 2.4)). In order to increase the SNR,
several data acquisitions are performed consecutively and the final signal is
the average of all measured signals.
2.3.1.2 Chemical Shift
MRS is based on the chemical shift properties of the atoms. As described
above, the nuclei of a tissue exposed to an external magnetic field will res-
onate at a frequency (ν) given by the Larmor equation [2.4]. Since the
gyromagnetic ratio (γ) is a constant that is characteristic for each nuclear
species, the Larmor equation [2.4] shows that the resonance frequency of the
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Figure 2.4: The (low resolution) proton MRS spectrum of ethanol contains
three peaks. Distinct chemical groups emit signals at different frequencies.
The area under each peak in the spectrum is proportional to the number of
nuclei (protons) generating that peak. Edited from [Bushong, 2013].
nuclei (ν) depends on the external magnetic field strength and, that nuclei
of different elements have different resonance frequencies. The principle that
allows the discrimination of different chemical compounds using the same
isotope (1H for example) is the chemical shielding effect. The electronic in-
teractions of the nuclei with the surrounding molecules cause a change in the
local magnetic field leading to a change on the spin frequency of the atom.
This results in slightly different resonance frequencies for the same isotope
in different molecules and even for isotopes in the same molecule but at dif-
ferent positions. Since the chemical structure of molecules determines the
electronic environment, this shift in the frequency has been named chemical
shift.
In MRS, the chemical shift of a peak in the spectrum is often expressed in
terms of the dimensionless unit parts per million (ppm), which is indepen-
dent of the spectrometer frequency. A metabolite that resonates at a specific
ppm value for a spectrometer frequency of 63.8 MHz, also resonates at the
same ppm value for a spectrometer frequency of 500 MHz. The ppm value of
a resonance is the observed chemical shift in Hz from a reference frequency,
often set to the frequency resonance of the Tetramethylsilane (TMS), divided
by the spectrometer frequency in MHz:
ppm =
f − fref
fS
, [2.6]
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where f denotes the resonance frequency in Hz, fref the reference frequency
also in Hz and fS is the spectrometer frequency in MHz.
For example, at 1.5 T, NAA (methyl group) has a resonance shift of 129 Hz
from TMS and the Larmor frequency of protons is 63.8 MHz. Thus, the ppm
frequency for NAA is:
ppmNAA =
129
63.8
= 2.02. [2.7]
2.3.1.3 J-coupling
In addition to chemical shifts, MR spectra are also modulated by J-coupling
(or scalar coupling) [Govindaraju et al., 2000]. J-coupling is the result of an
internal indirect interaction of two spins via the intervening electron struc-
ture of the molecule. The coupling strength is measured in Hertz (Hz) and
is independent of the external field strength. J-coupling between the same
species of spins, e.g., proton and proton is termed homo-nuclear J-coupling
whereas J-coupling between different species of spins, e.g., proton and phos-
phorous is referred to as heteronuclear J-coupling. J-coupling results in a
modulation of the signal intensity depending on sequence type and acquisi-
tion parameters, particularly the echo time. The most prominent example in
proton spectroscopy is lactate where there is a 7 Hz strong coupling between
the two MR-detectable proton groups. Other molecules with more complex
J-coupling patterns are glutamate and glutamine with three J-coupled pro-
ton groups. A spectrum of N -acetylaspartate(NAA) is shown in Figure 2.5.
NAA has both uncoupled and J-coupled protons.
2.3.1.4 Water suppression
1H MRS spectra are dominated by the water signal. The water peak is
several orders of magnitude larger than the metabolite peaks of interest.
This greatly impedes the ability of the spectrometer to accurately record
the metabolite signals. To avoid this high peak from water to superimpose
on the signal of other metabolites, water suppression techniques are applied
during the acquisition of the data. The most commonly used technique is
chemical shift selective water suppression (CHESS) [Haase et al., 1985] (Fig-
ure 2.6) which uses frequency selective pulses to exclusively excite the water
molecules and then a magnetic gradient to destroy their phase coherence.
Other techniques sometimes used are Water suppression Enhanced Through
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Figure 2.5: The spectrum of the N -acetyl-aspartate (NAA) molecule is shown
(PRESS, echo time (TE) 35 ms, 1.5 Tesla). The NAA molecule has protons
at different positions. The three protons of the -CH3 group are equivalent and
their individual signals add-up and give the prominent peak at 2.0 ppm. The
other protons attached to carbons of NAAmolecule also provide a signal. The
protons of the –NH, –CH, and –CH2 are in close proximity in the molecule
and do interact via J-coupling (indicated by dashed arrows in above fi gure).
J-couplings split peaks and modulate the phase of a signal. The result is a
more complex pattern of multiple peaks, which can be asymmetric or point
downwards. The signal from proton next to the nitrogen atom (amide proton)
resonates at approx. 8 ppm. Due to rapid exchange with protons from
surrounding water molecules, the magnetization disappears quickly and the
signal from this proton is very weak. Edited from [Blüml, 2013].
T1 effects (WET) [Ogg et al., 1994] and VAriable Pulse power and Optimized
Relaxation Delays (VAPOR) [Tkáć and Gruetter, 2005].
2.3.1.5 Sequences and Spatial encoding
Spatial localization allows signals to be recorded from well-defined structures
or lesions within the body. It is worth noting that by recording signals from
smaller volumes, improved field homogeneity can be obtained [Bax and Free-
man, 1980].
Spatial localization techniques for proton brain spectroscopy fall into two gen-
eral categories: single-voxel techniques where a spectrum is recorded from a
single volume element (voxel), and multi-voxel techniques (also called MR
spectroscopic imaging (MRSI) or chemical shift imaging (CSI)) where spec-
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Figure 2.6: Water signal suppressing with CHESS. Brain MR spectrum be-
fore CHESS (A) and after CHESS (B). CHESS reduces the signal from
water allowing brain metabolites to be depicted on the spectrum. Edited
from [Bertholdo et al., 2013].
tra from multiple regions are acquired simultaneously.
The two most commonly used single voxel sequences are STEAM (stimu-
lated echo acquisition mode) [Frahm et al., 1987] and PRESS (point resolved
spectroscopy sequence) [Bottomley, 1987]. Both methods are based on three
slice selective RF pulses applied in orthogonal directions (Figure 2.7 A). The
STEAM sequence uses three 90° pulses and detects the resulting stimulated
echo from the volume intersected by all three pulses. All other signals should
be dephased by a large crusher gradient during the so-called “mixing time”
(TM) between the second and third pulses (Figure 2.7 B). The PRESS se-
quence uses one 90° pulse and two 180° pulses to detect a spin echo from
the localized volume. The second and third pulses are refocusing pulses, and
crusher gradients are applied around these pulses to select the desired spin
echo signal arising from all three RF pulses, and dephasing unwanted sig-
nals (Figure 2.7 C). A detailed comparison of both sequences can be found
in [Moonen et al., 1989].
While single-voxel MR spectroscopy provides a signal from a certain volume,
MRSI allows the simultaneous acquisition of spatially localized MR signals
from a two- or three-dimensional grid of voxels. The concept of MRSI was
first demonstrated on phantoms by Brown et al. in 1982 [Brown et al.,
1982]. The authors showed that an array of spatially localized spectra could
be reconstructed using phase encoding applied in that direction. For MRSI,
a variety of different spatial encoding approaches are used, but most com-
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Figure 2.7: Single-voxel localization techniques. Spatial localization is
achieved by collecting signals from the intersection of three slice-selective RF
pulses applied in orthogonal directions (A). The STEAM sequence, consisting
of three 90° slice selective pulses (B). The PRESS sequence, consisting of
a slice selective 90° excitation pulse and two 180° slice selective refocusing
pulses (C). For simplicity, only slice selection gradients are shown (except for
the mixing time (TM) crusher gradient in the STEAM sequence depicted in
B). Edited from [Barker and Lin, 2006].
monly the collection of spectroscopic data from multiple adjacent voxels is
accomplished by the introduction of phase encoding gradients (field gradi-
ents) in the spatial directions of the grid, resulting in phase encoded FIDs.
In addition to the main magnet to create a strong static magnetic field (B0),
after the RF excitation pulse, gradient coils are used to generate magnetic
field gradients in one, two or three dimensions. These field gradients are in
the range of 10–50 mT/m with a switching time on the order of a millisecond.
Spins are encoded as to position by the amount of phase encoding imparted
to them based on their distance form the isocenter in the encoding gradient
dimension.
In MRSI of the brain, it is is typically necessary to restrict the acquisition to
a fairly small region to avoid strong lipid signals from the scalp and to reduce
potential magnetic field inhomogeneities. In this case, it is typical to combine
a volume selective sequence (PRESS or STEAM) with linear phase encoding
along two or three directions [Brown et al., 1982] (Figure 2.8). The idea of
volume pre-selected MRSI sequences is to incorporate the volume selection
used in PRESS or STEAM single voxel spectroscopy into an MRSI sequence.
In contrast to SVS, the PRESS excitation in MRSI is additionally combined
with two- or three phase-encoding gradients. An example of reconstructed
MRSI grid and selected rectangular volume of interest (VOI) is shown in
Figure 2.9.
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Figure 2.8: 2D spectroscopic imaging with volume pre-selection. Only the
region in the rectangle is excited to eliminate spurious signals. Edited
from [Skoch et al., 2008].
Figure 2.9: 2D-PRESS-MRSI pulse sequence; a PRESS sequence is used
to excite a large volume of brain tissue while excluding signal from lipid in
the scalp and/or regions of poor field homogeneity, and then phase-encoding
gradients (gX and gY ) are used to localize spectra from regions within the
excited region. A CHESS pulse and crusher gradient is applied prior to the
PRESS sequence for water suppression. Crusher gradients applied around
the 180° refocusing pulses are also shown. Edited from [Barker and Lin,
2006].
More recently, fast MRSI techniques have been developed like the parallel
spectroscopic imaging techniques [Dydak et al., 2001] or the compressed sens-
44
ing accelerations [Hu et al., 2008; Geethanath et al., 2012; Askin et al., 2012;
Shankar et al., 2015; Worthington, 2015]. The use of prospective compressed
sensing approaches allows the improvement of the spatial resolution by at
least a two-fold factor in each dimension at high magnetic fields (e.g., 3T).
High spatial resolution MRSI and 3D MRSI techniques may especially ben-
efit from these accelerating methods [Van der Graaf, 2010].
The resolution of the MRSI data is limited due to the intrinsic low SNR of
the signals, requiring adequately large voxel volumes. The spatial resolution
of MRSI is lower than the one of conventional MRI (Figure 2.10).
Figure 2.10: T1-weighted MRI with a grid overlay indicating the spatial reso-
lution of the MRSI data. MRI has a spatial resolution of about 1 millimeter,
while MRSI is in the range of several millimeters to a centimeter.
2.3.1.6 Acquisition parameters in MRS
In addition to the actual concentration of the metabolites, the MR signal will
be influenced by many parameters, such as the strength of the magnetic field,
echo time, repetition time, localization technique, as well as the longitudinal
(T1) and transverse (T2) relaxation times of the metabolites. With the
exception of the relaxation times, these parameters can be controlled.
As previously described (Equation [2.5]), there are only few more protons
that adopt the parallel (low energy) position than in the antiparallel (high
energy) position. However, this is sufficient to generate a net magnetisation
(M ) aligning with the main magnetic field B0 (conventionally direction of
the z-axis) (Figure 2.11).
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Figure 2.11: The number of spins in the low energy level (parallel to B0)
is slightly higher than the number of spins in the high energy level (anti-
parallel to B0), causing a weak net magnetic field M . At equilibrium, the
net magnetization M is aligned with the external static magnetic field B0.
Edited from http://www.voxelcube.com.
The application of a RF pulse alters the population ratios, and creates a
transverse magnetic field component (Mxy). The greater the amount of en-
ergy applied by the RF pulse, the greater the angle that the net magnetisation
makes with the B0 field (the z axis). This depends on both the amplitude
and duration of the pulse. The RF pulse is switched off once the angle of the
RF pulse has reached a prescribed value. This is known as the flip angle of
the RF pulse (Figure 2.12).
When the RF pulse stops, the magnetization vector M recovers until it
reaches its equilibrium value M 0. The return of M to its equilibrium state
(the direction of the z-axis) is known as relaxation. This relaxation process
is characterized by two independent factors: the T1 relaxation, character-
izing the return of the original magnetization along the main magnetic field,
and the T2 relaxation, characterizing the exponential decay of magnetiza-
tion in a plane perpendicular to this field. T1 relaxation also referred to as
spin-lattice relaxation or longitudinal relaxation, describes the return of the
excited magnetization vector M to equilibrium in the direction of the mag-
netic field (conventionally shown along the z-axis) (Figure 2.13). Following
termination of an RF pulse, nuclei will dissipate their excess energy as heat
to the surrounding environment (or lattice) and revert to their equilibrium
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Figure 2.12: At equilibrium, the net magnetisation, M , is aligned along the
z axis (a). When an RF pulse is applied,M makes an angle with the z-axis,
known as the flip angle, and rotates around the axis (b). At any instant the
magnetisation can be split into two components,M z andMxy. The rotating
Mxy component generates the detectable MR signal. This pulse has a 90°
flip angle (c). A 180° RF refocusing pulse (d). A 180° inversion pulse (e).
Edited from [Ridgway, 2010].
position. The recovery ofM z is an exponential process with a time constant
T1:
M z = M 0(1− e−t/T1), [2.8]
where T1 is the time taken for approximately 63% of the longitudinal mag-
netisation to be restored following a 90° pulse.
T2 relaxation is also referred to as spin-spin relaxation or transverse relax-
ation and describes the decay of the excited magnetization vector perpen-
dicular to the applied magnetic field (conventionally in the xy plane). The
observed spectral line-width is related to the T2. T2 relaxation is affected by
magnetic inhomogeneity and the overall term for the observed loss of phase
coherence is called T2* relaxation. T2* relaxation accounts for the more
rapid decay of the FID signal due to the additional de-phasing caused by lo-
cal inhomogeneities in the magnetic field. Both T2 and T2* are exponential
processes with times constants T2 and T2*, respectively. This is the time at
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Figure 2.13: Process of T1 relaxation after a 90° RF pulse is applied at
equilibrium. The z component of the net magnetisation, M z is reduced to
zero, but then recovers gradually back to its equilibrium value if no further
RF pulses are applied. Edited from [Ridgway, 2010].
which the magnetization has decayed to 37% of its initial value immediately
after the 90° RF pulse.
Various tissues and substances have particular T1 and T2 values. The most
important determinant is the size and motion of the molecule on which the
hydrogen nucleus is embedded. Small and rapidly rotating molecules (like
water) have long T1 and T2 times. As molecular motion slows (as in pro-
teins), T2 shortens and T1 again increases.
By adjusting scanning parameters (e.g. repetition time and echo time de-
scribed below), differences in T1 and T2 relaxation characteristics among
tissues can be highlighted to emphasize certain MR image contrast proper-
ties. The relaxation properties and the acquisition parameters also affect the
appearance of MR spectra. Each metabolite in a MR spectrum has its own
longitudinal and transversal relaxation characteristics and the signal strength
of the spectral peaks vary depending on the acquisition parameters.
Echo time (TE) is the time from the application of an excitation RF pulse
48
Figure 2.14: Process of transverse (T2) relaxation after a 90° RF pulse is
applied at equilibrium. Initially the transverse magnetisation (red arrow) has
a maximum amplitude as the population of proton magnetic moments(spins)
rotate in phase. The amplitude of the net transverse magnetisation (and
therefore the detected signal) decays as the proton magnetic moments move
out of phase with one another (shown by the small black arrows). Edited
from [Ridgway, 2010].
to the measurement of the MR signal. During this time, the signal from
each metabolite relaxes with its own characteristic T2-relaxation time. TE
determines how much decay of the transverse magnetisation is allowed to
occur before the signal is measured. It therefore controls the amount of T2
relaxation.
Choosing long echo times simplifies spectra because the number of detectable
metabolites is reduced. Long TE (TE > 135 ms) is typically used in clini-
cal practice because of a flat baseline (no macromolecular contribution) and
because the three main metabolites detected at these echo times (NAA, Cre-
atine, Choline) can be easily identified. Short TE (TE ≤ 35 ms) allows the
detection of an increased number of metabolites and has an SNR advantage
over long TE. However, short TE spectra suffer from severe baseline (short
T2 signals of macromolecules) and lineshape (stronger gradients are required
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for shorter duration) distortions which makes spectra analysis more difficult
(Figure 2.15).
Figure 2.15: Three MR spectra of the same voxel acquired with echo times
of TE = 288 ms ( top ), TE = 144 ms (center), and TE = 35 ms (bottom).
Edited from [Blüml, 2013].
Repetition time (TR) is the time interval between two consecutive RF
pulse sequences measured in milliseconds. For a given type of nucleus in a
given environment, TR determines the amount of T1 relaxation. The longer
the TR, the more the longitudinal magnetisation is recovered. Tissues with
short T1 have greater signal intensity than tissues with a longer T1 at a
given TR. A long TR allows more magnetisation to recover and thus reduces
differences in the T1 contribution. Spectra acquired with repetition times
that are substantially longer than the T1-relaxation times are compromised
by lower signal-to-noise ratio. For that reason, repetition times are generally
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set to approximately 1–1.5 times the T1-relaxation times of metabolites. In
contrast to TE, the repetition time does not influence significatively the ap-
pearance of MR spectra. It only causes different scaling of the peaks [Blüml,
2013].
Mixing time (TM) The mixing time (TM) is the time delay between the
second and the third 90° RF pulse in a STEAM sequence.
2.3.2 1H MRSI-visible metabolites
Depending on the clinical question, many major metabolites can be measured
with MR spectroscopy. Spectra from human brain (TE 135ms) are shown in
Figure 2.16.
N-acetylaspartate (NAA), which resonates at 2.01 ppm, is the most abun-
dant metabolite visible on MRS (after the water) in healthy human brain.
NAA is considered a neuronal marker and is present only in neurons, axons,
and dendrites. It is found to be decreased in most brain tumors [Stadlbauer
et al., 2007]. A decrease in NAA level is usually associated with neuronal
loss or damage.
Choline (Cho) (3.22 ppm) represents the constituents of cell membranes.
Increased Cho is associated with increased concentration of cells and/or cell
membrane synthesis such as cancer.
Creatine (Cr) (3.02 and 3.8 ppm) is a marker for cell energy metabolism.
Decreased in Cr is associated with tissue death or necrosis.
Lactate (Lac) is not seen or is hardly visualized in the normal brain. The
doublet signal of lactate at 1.33 ppm appears in phase (short/long TE) or in
opposed phase (TE of 135-144 ms) to other signals. Lac is a product of anaer-
obic glycolysis so its concentration increases under anaerobic metabolism
such as cerebral hypoxia, ischemia, seizures and metabolic disorders (espe-
cially mitochondrial ones).
Mobil lipids (Lip) (1.3 and 0.9 ppm) Mobil lipids are absent in normal
brain, unless the volume of interest is placed too close to the skull (allowing
extracranial lipid signals to contaminate the spectrum). Increased lipids
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concentration is observed when there is cellular membrane breakdown, and
have been associated with the degree of malignancy, with metastases and
the presence of necrosis [Kuesel et al., 1994; Negendank et al., 1996; Murphy
et al., 2003].
Table 2.17 summarizes the main metabolites from in vivo 1H-MRS brain and
their biological significance.
Figure 2.16: Examples of normal spectrum (left) and abnormal spectra (mid-
dle and right). Compared to the normal spectrum, the abnormal spectra
show increased Choline, decreased levels of Creatine and NAA and the pres-
ence of Lactate (middle) and Lipids (right).
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Figure 2.17: Main metabolites from in vivo 1H-MRS brain and their biological
significance. Edited from [García-Figueiras et al., 2016].
2.4 Radiotherapy guided by MRSI
Radiotherapy (RT) is a local cancer treatment that uses ionizing radiation
to destroy tumor cells. It has become the standard post-surgical treatment
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modality for glioblastoma (GBM), the most common and deadliest of ma-
lignant primary brain tumors in adults [Stupp et al., 2005]. In fact, it has
demonstrated a dose-dependent antitumoral efficiency (up to 60 Gy) for this
type of tumor, and it has also allowed a significant increase of the patient me-
dian survival compared to surgery alone or followed by chemotherapy [Walker
et al., 1978; Kristiansen et al., 1981].
The field of radiation oncology relies heavily on imaging modalities. From
initial consultation to treatment completion, images are used to guide nearly
every step of the patient. The standards in radiotherapy of brain tumors are
currently based on anatomic imaging techniques, usually CT and MRI.
Despite the survival benefit associated with adjuvant radiation, more than
90% of the GBM patients develop local tumor recurrence within the irradi-
ated areas [Minniti et al., 2010; McDonald et al., 2011]. Therefore, there is
interest in increasing the dose to specific and more aggressive parts of the
tumor while sparing normal tissue, using new technologies such as intensity-
modulated radiation therapy (IMRT). Conventional imaging modalities may
not reliably identify regions of active tumor or tumor infiltration [Payne and
Leach, 2014], and they are insufficient to determine the potential target for a
dose escalation. Therefore, there is a need of incorporating other modalities
into the RT planning process, which may provide more specific information
about the lesions.
MRSI is an interesting modality in RT planning due to its ability to pro-
vide valuable information on tumor biology not available from conventional
imaging modalities [Laprie et al., 2008; Deviers et al., 2014]. The additional
biological information provided by this technique can be used for the devel-
opment of more targeted therapies, for example, to define new target volumes
for dose escalation in RT treatments. The ability of MRSI to detect areas of
high metabolic activity linked to tumor cell proliferation is particularly use-
ful for radiotherapy treatment planning because the most aggressive areas of
the tumor may be targeted with higher radiation dose, potentially improv-
ing local control without excessive irradiation to the normal adjacent tissues.
The potential of MRSI to define new biologically tailored target volumes for
dose escalation in radiotherapy treatments is shown in Chapter 6.
There are two main difficulties slowing the integration of MRSI into the
RT workflow. First, there is no standardized treatment of MRS(I) signal
analysis, and second, the metabolic maps obtained after post treatment are
not delivered in a DICOM standard format compatible with the treatment
planning system (TPS). A reliable and reproducible integration technique of
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MRSI metabolic maps is needed [Ken et al., 2013]. These limitations are
addressed throughout the different chapters of this thesis.
2.5 MRSI data
As described in Section 2.3.1.5, MRSI provides MR signals from a two- or
three dimensional grid of multiple adjacent volume elements, called voxels,
within a body volume. In this thesis we focus on the processing of MRSI
data. Synthetic and in vivo MRSI datasets are used in the different experi-
ments described throughout the manuscript.
2.5.1 Synthetic data
Simulated MRSI datasets used in this thesis were generated by combining
profiles from the principal metabolites observed in long echo time brain MR
spectroscopy: choline (Cho), creatine (Cr), N-acetyl-aspartate (NAA) and
lactate (Lac). Metabolite profiles were obtained from quantum mechanical
simulations of a spin-echo MR experiment using the jMRUI software pack-
age [Stefan et al., 2009] (Figure 2.18).
2.5.2 In vivo data
In vivo data were acquired from healthy volunteers as well as from patients
with diagnosed glioblastoma (GBM) included in a prospective clinical trial.
2.5.2.1 Healthy volunteers
In vivo MRSI data from healthy volunteers were acquired at Institut Claudius
Regaud using a 1.5T clinical MR scanner (Siemens Magnetom Avanto) using
a 3D CSI sequence with water suppression, TE=135 ms, TR =1500 ms, 512
FID data points, 4 averages, slice thickness: 15mm, matrix size: 16 × 16,
FOV: 160× 160 mm yielding a voxel size of 10 mm × 10 mm × 15 mm.
2.5.2.2 Patients
Data were acquired from patients with diagnosed GBM included in a phase
III prospective clinical trial named Spectro-Glio. The use of this data has
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Figure 2.18: Simulated metabolite profiles.
been approved by ethics committees. GBM is the most common and deadli-
est of malignant primary brain tumors in adults. Preliminary studies suggest
that the integration of MRSI into radiotherapy planning for these type of tu-
mor is feasible and safe[Laprie et al., 2008; Deviers et al., 2014].
Spectro-Glio is a French multi-institutional phase-III clinical trial promoted
and coordinated by the Institut Claudius Regaud. This ongoing trial, started
on March 2011, plans to include 220 patients with GBM. It has been de-
signed to compare two radiotherapy treatments for GBM: the “standard
treatment” for which patients are treated according to the protocol Stupp
(i.e., 60Gy to the planning target volume (PTV) with concomitant Temo-
zolomide) and the “experimental treatment” in which patients receive an
additional boost of 12 Gy into the gross tumor volume (GTV) and metabol-
ically abnormal CNR2 areas (Choline-over-NAA ratio higher than 2) with
intensity-modulated radiotherapy (Figure 2.19). Patients are stratified ac-
cording to the main prognostic factors recognized in this disease. More in-
formation about the trial and the participant centers can be found here:
https://clinicaltrials.gov/ct2/show/NCT01507506.
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Figure 2.19: Patients in the experimental arm receive a boost of 72 Gy
(instead of conventional 60 Gy) into the GTV and the CNR2 areas. Edited
from [Ken et al., 2013].
2.6 Conclusion
This chapter presented the important role of imaging in the evaluation of
brain tumor patients. While morphological imaging is the most commonly
used technique, the introduction of new functional MRI modalities has im-
proved the characterization of tumors. One of such techniques is MRSI,
which provides the metabolism characterization of the sampled tissue. This
chapter described the principles and basics of MRSI, and introduced its role
into the RT context. Due to its ability to provide information on tumor
biology, MRSI is an interesting modality in radiotherapeutic management
of brain tumors. Its integration into the RT treatment planning, allows the
development of more targeted therapies, for example, by the definition of
biologically tailored target volumes for dose escalation.
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MRSI processing
Contents
3.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58
3.2 Pre-processing . . . . . . . . . . . . . . . . . . . . . . . . . . . 58
3.3 Processing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63
3.4 Inverse problems and regularization . . . . . . . . . . . . . . . 68
3.5 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 74
3.1 Introduction
An MRSI acquisition is basically very similar to that of MRI. However, in
addition to an adequate spectral acquisition technique, advanced methods of
analysis are needed for obtaining a clinically useful spectrum with an optimal
signal-to-noise ratio (SNR) that allows the separation of the most significant
metabolites. MRS(I) data analysis is usually divided into two stages. Firstly,
preprocessing methods are applied in order to improve the quality of exper-
imental MRSI data. Preprocessing of the MRS(I) data is a crucial step due
to the low SNR of in vivo MRS(I) signals and the experimental conditions
decreasing the quality o the data. In a second step, methods to interpret
and/or to extract useful information from the data are performed.
3.2 Pre-processing
In vivo MRSI signals are affected by a number of limitations resulting in a
decreased quality of the data. Some of such limitations are the following:
- presence of residual water signal (proton MRS),
- low concentrations of the observed metabolites,
- restricted measurement time,
- inhomogeneity of magnetic fields,
- fast decaying signals from immobile components,
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- overlapping signals from relatively mobile components,
- physiologic motion.
Therefore, the quality of experimental MRSI data is often insufficient to ex-
tract reliable information directly after the acquisition. It is then necessary
to perform a preprocessing step to remove or reduce the irrelevant informa-
tion, while enhancing the key features of the data. There are a variety of
preprocessing methods that considerably improve the quality of the signals
by appropriate manipulation of the data. Due to the correspondence of FID
and spectrum, pre-processing steps are performed either in the time or fre-
quency domain. Typical preprocessing methods applied to MRSI data are
briefly described below.
3.2.1 Water suppression
In vivo 1H MRSI signals are dominated by the signal from water. Even using
frequency selective pulse sequences such as CHESS to reduce the strength
of the acquired water signal, it remains significantly larger than any of the
metabolites of interest. Such a large signal has a considerable overlap with
the metabolite peaks, and a corresponding negative impact on their quan-
tification. An effective technique used for residual water suppression is the
Hankel singular value decomposition (HSVD) algorithm [Laudadio et al.,
2002]. This method decomposes the MR signal into a set of exponential
decays, then identifies which ones belong to the water peak and selectively
subtracts those from the input signal (Figure 3.1).
3.2.2 Zero padding
Adding zeros to the acquired FID does not bring any additional information,
but it increases the digital resolution of the signal in the frequency domain.
A better digital spectral resolution helps with the characterization of the line
shapes in the spectrum when, for example, frequency domain quantification
methods are used.
3.2.3 Baseline correction
MR spectra are affected by the presence of residual water and/or strong
signals arising from lipids and macromolecules that is referred to as the
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Figure 3.1: Example of water suppression with HSVD. Top row: spectrum
from normal brain tissue. Small metabolite peaks are not visible in the
presence of a large water peak. On the top right and on the bottom row
the y-axis is scaled to show the metabolites more clearly. In the bottom left
we see the set of Lorentzians fitted by the HSVD algorithm, while on the
right the spectrum is shown after the subtraction of the water signal. Edited
from [Rowland et al., 2013].
baseline. The baseline usually overlap with the metabolite signals which
complicates the assessment of the intensity of the metabolites. The macro-
molecular contributions may provide relevant clinical information, if properly
evaluated [Hofmann et al., 2001]. However, in order to facilitate the quan-
tification of the metabolite signals, the baseline is usually removed. The
baseline can be suppressed during the acquisition using specific sequences
based on T1 relaxation such as the inversion-recovery [Knight-Scott, 1999]
or the saturation-recovery sequences [Hofmann et al., 2001]. Baseline re-
moval can also be based on T2 relaxation by increasing the echo time [Kreis
et al., 1993]. Alternatively, the baseline can be corrected in a preprocessing
step. A straightforward approach is the truncation of the initial points of
the FID [Ratiney et al., 2005]. The baseline signal decays very rapidly, thus
removing the initial part of the FID results in a suppression of the baseline
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components. However, this procedure may also suppress part of the metabo-
lite contributions and may lead to reduced accuracy of the estimates due to a
decreased SNR. Numerical methods based on polynomials and splines to fit
a smooth function below the actual spectrum are widely used [Güntert and
Wüthrich, 1992; Cobas et al., 2006; Xi and Rocke, 2008; De Sanctis et al.,
2011].
3.2.4 Frequency alignment
The chemical shifts of in vivo metabolites can vary due to variations in the
physiological and experimental conditions (tissue, temperature and pH). The
resonance frequency of the observable metabolites is known and can be used
for shifting the full spectra such that the recognizable peaks reach the desired
frequency locations.
3.2.5 Phase correction
The usual phase correction term consists of two components, one frequency-
dependent (first order phase) and one frequency-independent (zero order
phase). Normally, zero-order and first-order phase corrections are required
for NMR spectra in order to restore pure absorption and dispersion shapes.
The zero-order phase misadjustment arises from the phase difference between
the reference phase and the receiver detector phase. The first-order phase
mismatch can be a result of the time delay between excitation and detec-
tion, flip-angle variation across the spectrum, and phase shifts from the filter
employed to reduce noise outside the spectral bandwidth [Chen et al., 2002].
Phase correction can be performed manually or using automatic algorithms
like the Ernst’s method [Ernst, 1969], Dispa [Craig and Marshall, 1998] and
eDispa [Cobas and Sykora, 2007], Shanon’s entropy minimization [Chen et al.,
2002] and Automics [Wang et al., 2009].
3.2.6 Denoising
The SNR of MRSI data is intrinsically low due to the low concentration of
the metabolites of interest (around 3 orders of magnitude below that of wa-
ter [Van den Boogaart et al., 1994]). In addition, there are various sources
of noise affecting the quality of the data, such as the thermal motion of the
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charged particles in the sample, or the thermal motion of the electrons in
the coil and reception paths. Under normal circumstances the latter is the
major source of noise in the MR signal. The noise in an MRS(I) acquisition is
typically characterized as being additive Gaussian with zero mean and con-
stant standard deviation in time. The SNR can be improved by increasing
the signal using higher magnetic field strength. However, the implementa-
tion of MRSI at high fields (7 Tesla and beyond) is still challenging due to
technical limitations that may reduce the expected SNR, such as increased
field inhomogeneity [Boer et al., 2012]. In fact, currently, clinical manufac-
turers do not support field strength higher than 3 Tesla. Signal averaging
is a widely used technique to improve SNR at acquisition time. However,
this approach is not feasible because of the lengthening of the already long
acquisition times (around 20 minutes for a standard PRESS 3D-MRSI at 1.5
Tesla with a quadrature head coil and spatial resolution of 1cm3). Moreover,
physiological motion may lead to destructive averaging due to variations in
signal phase and frequency. Therefore, methods enabling the improvement
of the SNR after the acquisition are of great interest. The post acquisition
noise reduction by means of signal processing is called denoising. A pop-
ular method in MR spectroscopy is to apply apodizing filters. The FID is
multiplied pointwise by some appropriate function/filter in order to force
the signal to decay. This technique is tipically used for MR signals to avoid
the spurious peaks that are present in the spectrum when the FID has not
decayed completely by the end of the acquisition. Apodization techniques
often compromises the spectral resolution of the data [Bartha et al., 1999].
For a better trade-off between SNR and resolution, many advanced denoising
methods specifically designed for MRSI data have also been proposed [Diop
et al., 1994; Cancino-De-Greiff et al., 2002; Ahmed, 2005; Bao and Maudsley,
2007; Eslami and Jacob, 2009a; Nguyen et al., 2010]. These methods can be
categorized into two classes:
1. methods without exploiting spectral models and
2. methods explicitly using spectral models.
In the first case, a popular method to denoise MRS signals is to apply wavelet
shrinkage [Cancino-De-Greiff et al., 2002]. In [Ahmed, 2005], MRS signals are
consecutively projected and filtered in different domains using time-frequency
(SLTF) transforms. This method provides some improvement compared with
the single-voxel wavelet shrinkage, but at the cost of an increased computa-
tional time. These methods process each MR spectrum independently and
do not explore the spatial context of MRSI data.
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The methods in the second class make use of spectral models for denoising
MRSI data either prior to or during metabolite quantitation [Diop et al.,
1994; Bao and Maudsley, 2007; Eslami and Jacob, 2009a; Nguyen et al.,
2010]. Most of these methods incorporate constraints on the spectral pro-
file, either by using explicit parametric models or by assuming particular
line-shape characteristics. Consequently, they tend to bias the interpreta-
tion of the measured signal towards the prior assumptions. In addition,
these methods are often dependent of several parameters. For example, a
popular denoising method described in [Diop et al., 1994] makes strict use
of the Lorentzian lineshape of the spectral peaks and is very sensitive to
noise. In [Nguyen et al., 2010], an autoregressive spectral constraint is used
to describe the spectral structure. This approach imposes a weaker spectral
constraint than explicit parametric modeling methods. However, it incorpo-
rates a spatial smoothness constraint limiting its ability to capture the spatial
variations exhibited by in vivo scans, especially in the context of lesions. A
less-constrained approach was proposed in [Eslami and Jacob, 2009a], where
spatial piecewise smoothness is combined with a sparse spectral model. This
method makes use of a spatial total variation (TV) regularization that is
known to lead to an increase of the reconstruction noise under certain exper-
imental conditions [Liu et al., 2009].
In Chapter 4, a novel denoising method using an hybrid spatio-spectral reg-
ularization is proposed. Unlike previous denoising methods, the proposed
approach does not use constraints on the spectral profile, and it explores
both the spectral and the spatial dimensions of the data.
In Chapters 5 and 7, novel processing methods to interpret MRSI data inte-
grating this denoising scheme are proposed.
3.3 Processing
Two basic approaches for the evaluation of MRSI data can be distinguished:
quantification-based methods and pattern recognition (PR) techniques.
3.3.1 Quantification
The peaks in the MR spectra correspond to observable metabolites which
can be used as biomarkers of diseases. Quantification consists on the esti-
mation of spectral parameters from measured data. Signal amplitude (in the
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time-domain) is the main parameter of interest since it is proportional to the
metabolite concentration. Quantification is the most extended approach to
extract information from MRSI data and it is usually performed by fitting
mathematical models to the resonance signals. Quantification is typically
expressed as a nonlinear least squares (NLS) problem. In the presence of
artifacts and/or severe noise, the NLS problem can have many local optima
and the result becomes very sensitive to the choice of initial values. Prior
knowledge about the sought signal is used in some quantification methods to
alleviate these problems, but it can lead to an estimation bias in cases where
the employed prior knowledge is inadequate.
A brief description of the existing methods and a novel quantification tech-
nique are described in Chapter 5.
3.3.1.1 Absolute quantification
The area of a resonance peak in a phased MR spectrum is proportional to the
absolute concentration of the corresponding metabolite, but it also depends
on the relaxation times, T1 and T2 (which differ between different body re-
gions) and on instrumental factors. This makes absolute quantification of
metabolite concentrations difficult. A careful calibration is needed to con-
vert peak areas to metabolite concentrations to which the metabolite signals
are referenced. Absolute concentrations are expressed in biochemical units
such as molarity (number of moles of metabolite per liter of tissue water)
and molality (number of moles of metabolite per kilogram of tissue water).
There are different absolute quantification strategies:
External reference: A sample with a known reference solution and relax-
ation properties is positioned near or inside the RF coil. Immediately after
the acquisition of the in vivo spectrum, a reference spectrum from the cali-
bration sample is obtained.
Water signal reference: Tissue water is used as an internal standard. The
in vivo measurement is performed first. Then, from the same voxel, the signal
from unsuppressed tissue water is recorded, which serves as an endogenous
concentration reference. Alternatively, the water content can be derived from
proton-density–weighted images.
Replace-and-match: The basic principle of this strategy is to replace the
human subject with a phantom that simulates (human) tissue as closely as
possible and to match the coil load to the load obtained previously in vivo.
Then, a calibration measurement is performed, which is identical with respect
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to all image settings (eg, pulse sequence and size and position of the VOI).
The phantom usually contains a solution that mimics the electric conduc-
tivity of human tissue. A more detailed description of the existing absolute
quantification methods and references to the main publications can be found
in [Jansen et al., 2006].
3.3.1.2 Metabolite ratios
Because of the difficulties in calibrating in vivo spectra to obtain absolute
metabolite concentrations, quantification results are usually expressed as ra-
tios, e.g., the widely used Choline-over-NAA ratio in brain tumor analysis.
Metabolite levels are expressed relative to a "reference metabolite" from the
same spectrum. Metabolite ratios are expressed in arbitrary units. The use
of metabolite ratios has the great advantage that it is very easy to implement
because it does not require extra imaging time and time-consuming postpro-
cessing. Furthermore, a number of problems—for example, partial volume
effects arising from different amounts of cerebrospinal fluid in the selected
volumes—can be largely avoided. However, metabolite ratios have a signifi-
cant limitation: it is not possible to determine whether an abnormal ratio is
due to a change in the numerator, in the denominator or both. In addition,
ratios may not reflect a change in the concentrations of the metabolites in
the case of a comparable reduction (or increase) of both metabolites.
3.3.1.3 Metabolite ratio index
In 2001, McKnight et al. [McKnight et al., 2001] described a new and auto-
mated method to find abnormal voxels within an MRSI examination. This
method assumes a normally linear relationship between Cho and NAA and
that the ratio Cho/NAA is increased with malignancy. Choline is plotted
versus NAA for all spectra available in the MRSI dataset and a linear re-
gression line is calculated. The perpendicular distance of a data point to
the regression line is then used as a measure of abnormality. Assuming a
normal data distribution, 95% of the data points lie within two standard
deviations of all perpendicular distances either side of the regression line and
are considered to be normal, whereas data points outside two standard de-
viations are defined as abnormal. Abnormal points are excluded and a new
regression line is calculated through the remaining points. This process is
repeated until no abnormal points are detected. That is, when all of the re-
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maining points meet the criterion for normality (laying within two standard
deviations of all perpendicular distances either side of the regression line).
These normal points are used as the control population to estimate the nor-
mal ratios of Cho/NAA. A Choline-N-acetylaspartate index (CNI) value is
assigned to each spectra indicating the number of standard deviations of dif-
ference between the amount of Cho and NAA and the mean values of the
control spectra. In the preliminary studies [McKnight et al., 2001], a CNI
value of 2 was used as the threshold for distinguishing tumor from control tis-
sue. The choice of this threshold was based on results from previous studies
as well as on general statistical criteria that assume a Gaussian distribution
of variations in the CNI within normal tissue.
This approach can be extended to derive abnormality indices for the relative
levels of other metabolites, for example Cr to NAA, or Cho to Cr (CrNI, and
CCrI, respectively).
A clear advantage of the CNI method compared to the use of the Cho/NAA
ratio is to avoid considering necrotic spectra (whose Cho/NAA ratio can be
high because of the reduction of the NAA signal) as areas of cell proliferation
while the signal of Choline is not increased compared to a normal spectrum.
However, voxels with the same metabolite ratio, can be erroneously identified
by this method as belonging to different regions (voxel with higher absolute
NAA and Cho intensities is regarded as abnormal, whereas the voxel with
lower intensities is regarded as a non-tumour region) (Figure 3.2).
This limitation may reduce the sensitivity in the CNI method. To avoid
this behaviour, a novel method called radial CNI (rCNI) has been recently
proposed in [Raschke et al., 2014]. This method works in a similar manner
to the original CNI method, but instead of using the perpendicular distance
from a regression line, the Cho-to-NAA ratio is used as the abnormality
measure. Cho-to-NAA distribution is not used directly for tissue character-
isation, but the arctan(Cho/NAA) transformation is performed in order to
avoid problems in voxels with very low NAA.
3.3.2 Pattern Recognition
As mentioned above (Section 3.3.1), quantification is very sensitive to the
presence of artifacts in the data and heavily relies on the choice of prior
knowledge. Therefore, statistical analysis relying on quantification results
inherits all problems associated with the quantification technique consid-
ered. In addition, as it has been shown in [Mosconi et al., 2014a], different
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Figure 3.2: The two data points highlighted in green have approximately
the same Cho-to-NAA ratio, yet the point with higher metabolite intensi-
ties (1) is considered to be abnormal, whereas the other (2) is not. Edited
from [Raschke et al., 2014].
quantification algorithms may lead to different results. Therefore, the choice
of the quantification method can influence the final result and thus its sta-
tistical significance.
Alternatively, pattern recognition (PR) techniques can be used to analyze
and simplify the interpretation of MRSI data. PR methods can be differ-
entiated into supervised and unsupervised. Supervised PR methods learn
patterns from labelled training data. Unsupervised PR methods discover
previously unknown patterns/structures in the data. From the PR point of
view, quantification can be used as a feature extraction and dimension reduc-
tion technique. However, it is worth mentioning that recent studies [Kelm
et al., 2006] show that pattern recognition methods which do not rely on
an explicit quantification step can be superior for a given diagnostic prob-
lem. In this thesis we explore two different pattern recognition approaches
to interpret in vivo MRSI data. Chapter 6 introduces a supervised learning
system based on support vector machines (SVM) identify tumor relapse areas
using multi-parametric MR data. On the other hand, in Chapter 7, a novel
blind source separation method to decompose MRSI signals in tissue-specific
spectral patterns is proposed.
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3.4 Inverse problems and regularization
In this thesis we propose to express different MRSI preprocessing and pro-
cessing methods as inverse problems and to solve them using regularization
techniques.
3.4.1 Inverse problems
As in many other real world problems, the MRSI signal is not directly avail-
able, but only measured through some physical laws relating the sought signal
to the measurements. Let S and Y be the target and observed MRSI signals,
respectively. We can express the denoising of MRSI data as the following in-
verse problem:
Y = S +N , [3.1]
where Y ∈ RM×R is the data matrix in which each column is a measurement
involving M spectral points and R spatial positions, S is the target solution,
and N is an additive complex-valued Gaussian noise of covariance matrix Ψ
which has to be estimated.
The inverse problem [3.1] can be solved using conventional estimators by
minimizing some distance D between the solution and the observation. In
this case, the estimation procedure relies on the optimization of the following
criterion:
Sˆ = arg min
S
D(S,Y ). [3.2]
In the case of Gaussian noise, the considered distance is quadratic and the
Weighted Least Squares (WLS) estimator is often used in signal/image re-
covery literature. However, the WLS estimation lacks stability with respect
to imprecise or noisy measurements. To alleviate this problem and to find a
suitable solution, methods incorporating prior knowledge about the sought
solution have been proposed [Eslami and Jacob, 2009a; Nguyen et al., 2010].
In this thesis we propose to exploit prior knowledge about MRSI data using
regularization techniques. The additional information is modelled by regu-
larization terms added to the criterion measuring the closeness of the solution
to the data [3.2].
In Chapter 4, the inverse problem [3.1] is solved in order to estimate S from
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the noisy measurement Y , keeping specific features of the data which might
be distorted by noise or other experimental conditions.
In Chapter 5, the target solution S is expressed as S = BA, where B ∈
RM×K is a matrix in which each column is a metabolite profile, and A ∈
RK×R is the unknown mixing matrix which defines the contribution (abun-
dance) of each metabolite in each spatial position (voxel). Assuming that the
matrix B is known, we can estimate A by solving the inverse problem [3.1].
This approach allows us to integrate the denoising strategy proposed in Chap-
ter 4 into a novel quantification procedure.
If both matrices, B and A, are assumed to be unknown, the inverse prob-
lem [3.1] becomes a blind source separation (BSS) problem. Using this ap-
proach, a novel tissue pattern recognition method is proposed in Chapter 7.
3.4.2 Regularization in MRI
Different regularization techniques have been proposed in the MRI literature.
Prior information about the expected characteristics of the imaged object is
introduced in order to preserve the spatial resolution and improve the signal-
to-noise ratio of the reconstructed image. Many commonly-used algorithms
make use of a quadratic regularization term like the standard Tikhonov reg-
ularization [Liang et al., 2002; Ying et al., 2004a; Lin et al., 2004]. This
kind of quadratic regularizations improve the reconstructed image quality
when the experimental conditions are not too degraded (high magnetic field
intensity such as 3T, low noise level,...). However, when it is not the case,
these methods can suffer from noise propagation, blurring, ringing or alias-
ing errors. The research focus during the last years has shifted towards the
use of non-quadratic regularization terms in order to maintain edge sharp-
ness such as the total variation (TV) [Liu et al., 2007; Block et al., 2007;
Liu et al., 2009]. TV regularization has shown to be well adapted to piece-
wise smooth images [Liu et al., 2007], but this is not necessarily the case in
most of the real MRI images. In addition, it has been shown that use of the
TV norm may result in images exhibiting staircase-like artifacts, which are
physically implausible in the case of MRI [Chambolle and Pock, 2011]. The
connection between `1 regularization and sparsity has been found to outper-
form traditional algorithms and it is recently attracting a lot of attention in
MRI [Lustig et al., 2007; Gamper et al., 2008]. However, the great majority
of reconstruction algorithms consider a finite-difference sparsifying transform
which is formally equivalent to TV regularization and, therefore suffer from
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the same limitations. Since 2008, `1 wavelet-based regularizations have been
introduced in the MRI literature to alleviate this problem [Chaari et al.,
2008b; Liu et al., 2008; Guerquin-Kern et al., 2009a].
3.4.3 Regularization in MRSI
The role of regularization is to incorporate prior knowledge about the target
solution into the problem to be solved. The aim is to constrain the space
of possible solutions to stabilize the problem. This is done by prioritizing
certain features in the sought solution.
The incorporation of prior knowledge has been exploited by several MRS(I)
methods in order to simplify the computational procedure and derive more
reliable results. The prior knowledge typically considered is the definition
of bounds for some spectral parameters [Vanhamme et al., 1997], the use
of parametric spectral models [Diop et al., 1994; Bao and Maudsley, 2007;
Nguyen et al., 2010] or the introduction of experimentally measured or simu-
lated spectral profiles [Provencher, 2001; Ratiney et al., 2005; Poullet et al.,
2006]. These methods process the signals separately and ignore the spatial
context of the MRSI data. More advanced methods exploit not only the
spectral but also the spatial context of MRSI signals by incorporating spa-
tial priors [Sava et al., 2011; Kelm et al., 2012].
Regularization techniques promoting spatial smoothness have been used in
previous approaches. Spatial smoothness priors are used in [Sava et al., 2011;
Kelm et al., 2012] to improve the fitting of MRSI spectra. Both methods en-
courage spatially smooth variations for some selected spectral parameters.
Methods incorporating more than one regularization term to combine both,
spatial and spectral priors, are less common. In [Nguyen et al., 2010], a
method to denoise MRSI data assuming a particular spectral line-shape and
weighted spatial-smoothness is proposed. All these methods incorporating
spatial priors rely on spatial smoothness constraints limiting their ability to
capture the spatial variations exhibited by in vivo scans, especially in the
context of lesions. A less-constrained approach was proposed in [Eslami and
Jacob, 2009a], where spatial piecewise smoothness imposed by the spatial to-
tal variation (TV) norm is combined with a sparse spectral model. In Kasten
et al. [2013], a reconstruction method for MRSI data based on an extension
of the TV norm is proposed. Instead of the conventional form of the TV, a
method considering higher-order derivatives [Knoll et al., 2011] is considered
in order to alleviate the eventual staircase-like artifacts related to the TV.
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However, the use of TV-based approaches typically leads to high computa-
tional cost due mainly to the estimation of the gradient. Moreover, other
limitations of the TV norm in the context of proximal optimization will be
described in the next chapter of this manuscript.
In this thesis we propose the use a hybrid regularization scheme to introduce
prior knowledge about the different dimension of the MRSI data. Contrary
to previous regularization proposed in the context of MRSI, the proposed
regularization scheme is based on less restricted assumptions and relies on
efficient optimization algorithms.
3.4.3.1 Hybrid regularization
The different processing methods proposed in this thesis are formulated as
optimization problems which explore the different dimensions of the data.
The prior knowledge on each dimension is expressed as a regularization term
introduced in the objective function:
J (S) = D(S) +
N∑
n=1
λnRn(Sn), [3.3]
where J is the objective function to be minimized, D(S) is the data fidelity
term which measures the closeness of the target solution S to the measured
data, Rn (n = 1, ..., N) are the regularization terms describing the prior
knowledge of each of the dimensions Sn of the data, respectively, and λn are
the regularization parameters which balance the sought solution between the
data fidelity term and the constraints imposed by the regularization terms.
3.4.3.2 Regularization in transformed domains
Prior knowledge that might be used to constraint or regularize the sought
solution of the problem [3.3] is sometimes better expressed in a transformed
domain. For example, it may be desirable to use a data representation where
the artifacts decreasing the quality of the signal can be easily detected and
hence attenuated. In this respect, the wavelet transform has been shown as
a powerful tool that enables a good representation of useful information [Ser-
rai et al., 1997, 2000; Cancino-De-Greiff et al., 2002; Mahmoodabadi et al.,
2008].
In this thesis, we propose to express the regularization terms in the wavelet
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domain by employing spatial (2D or 3D) and spectral (1D) wavelet decom-
positions. The optimization problem to be solved can be then be formulated
as follows:
J (S) = D(S) +
N∑
n=1
λnRn(Wn(Sn)), [3.4]
where Wn is a wavelet operator.
3.4.4 Convex Optimization
The regularization schemes proposed in this thesis are based on objective
functions that are convex but not necessarily differentiable, which makes im-
possible the use of standard gradient-based algorithms for minimization. We
therefore propose to perform the optimization by using the concept of prox-
imity operators [Moreau, 1962] which was found to be fruitful in a number of
recent works in convex optimization [Combettes and Pesquet, 2008; Chaari
et al., 2011].
The concept of proximity operator was introduced by Moreau in 1962 [Moreau,
1962] as a generalization of a convex projection operator. In what follows,
we recall the definition of a proximity operator.
Definition 3.4.1. [Moreau, 1962] Let Γ0(χ) be the class of proper lower
semicontinous convex functions from a separable real Hilbert space χ to ] −
∞,+∞] and let ϕ ∈ Γ0(χ). For every x ∈ χ, the function ϕ + ‖ · −x‖2/2
achieves its infimum at a unique point denoted by proxϕx. The operator
proxϕ : χ→ χ is the proximity operator of ϕ.
Example 3.4.1. When ϕ is the indicator function of a closed convex set C,
i.e., ∀x ∈ R,
iC(x) =
{
0, if x ∈ C
+∞, otherwise
proxϕ is the orthogonal projector onto the set.
Example 3.4.2. Another example of proximity operator that is extensively
used in the signal processing literature is the one associated with the abso-
lute value function ϕ = 1
λ
|.|p, where p = 1 and λ > 0. In this case, the
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proximity operator is the well-known soft thresholding operator with 1
λ
as
threshold [Donoho and Johnstone, 1994]:
prox 1
λ
|.|x = sign(x)max
(|x| − 1
λ
, 0
)
. [3.5]
In the case p > 1, the proximity operator of ϕ = 1
λ
|.|p is given by prox 1
λ
|.|px =
sign(x)η, where η = ηRe + ı ηIm is the unique solution in [0,+∞[ to η +
pηp−1 1
λ
= |x|.
Fig. 3.3 illustrates the curve of the function ϕ = 1
λ
|.|p for different values of
λ and p. Fig. 3.4 shows the corresponding proximity operators for the same
values of λ and p.
Figure 3.3: Curves of the convex function 1
λ
|.|p for different values of λ and
p.
Proximity operators have very attractive properties that make them par-
ticularly well suited for iterative minimization algorithms [Combettes and
Pesquet, 2008]. For instance, proxϕ is firmly non-expansive, i.e.,
∀x,y ∈ RN , ‖proxϕx−proxϕy‖2+‖(x−proxϕx)−(y−proxϕy)‖2 ≤ ‖x−y‖,
[3.6]
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Figure 3.4: Curves of the proximity operators (Eq. [3.5]) associated with the
functions shown in Fig. 3.3 for different values of λ and p.
and its fixed point set is precisely the set of minimizers of ϕ. Another in-
teresting property of proximity operators is the separability [Moreau, 1965;
Starck et al., 2010]: Let {Fi}1≤i≤n a family of functions in Γ0(χ) and F de-
fined on χn with F (x) =
∑N
f=1 Fi(xi). Then proxF =
{
proxFi
}
1≤i≤n . This
property implies that the proximal operator of 1
λ
‖x‖1, x ∈ RN , is the soft
thresholding operator applied coordinate-wise to each coefficient xi, i.e.,
prox 1
λ
‖.‖1x =
[
prox 1
λ
|.|x1, prox 1
λ
|.|x2, ..., prox 1
λ
|.|xN
]t
. [3.7]
The separability of the terms gives us the ability to evaluate the proximal op-
erator in parallel. The interested reader can find many other useful properties
and closed-form expressions of the proximity operators of various functions
in [Combettes and Pesquet, 2008].
3.5 Conclusion
This chapter described the main techniques to process MRSI data. The con-
cept of inverse problem is introduced and exploited to express different MRSI
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processing methods. Since the proposed inverse problems are ill-posed, we
propose to exploit prior knowledge about the sought solutions using regular-
ization techniques. The regularization schemes used are based on objective
functions that are convex but not necessarily differentiable, which makes im-
possible the use of standard gradient-based algorithms for optimization. The
concept of proximity operators is therefore introduced to solve the inherent
optimization problem.
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MRSI denoising
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4.1 Introduction
Single Voxel Spectroscopy (SVS) techniques identifying abnormal levels of
various metabolites have been used for diagnosis purposes for many years
and in a variety of illnesses. More recently, much more interest has been
developed to acquire multi-voxel spectroscopic images (MRSI) which allow
the generation of “metabolic maps” showing the variation in metabolite con-
centrations over a body volume [Kounelakis et al., 2009]. Unfortunately, this
spatial information comes at the cost of a reduced SNR, due to a reduced
scan time for each voxel. For typical MRSI acquisition conditions, the noise
level is often similar in magnitude to some metabolite signal levels as shown
in Fig. 4.1. Noise is thereby a limiting factor in determining metabolite signal
amplitude and makes accurate quantification of metabolite signals extremely
challenging. Therefore, improving the SNR is a key factor in achieving clin-
ical utility for the MRSI technique.
The SNR can be increased using higher magnetic field strengths. However,
the implementation of MRSI at high fields (7 Tesla and beyond) is still chal-
lenging due to technical limitations that may reduce the expected SNR, such
as increased field inhomogeneity [Boer et al., 2012]. In fact, currently, clini-
cal manufacturers do not support field strength higher than 3 Tesla. Signal
averaging is a widely used technique to improve SNR at acquisition time.
However, this approach is not feasible because of long acquisition times.
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Figure 4.1: Water-suppressed MRSI spectra acquired in a 2D MRSI acqui-
sition from the brain of a healthy human. Edited from [Eslami and Jacob,
2009b]
Moreover, physiological motion may lead to destructive averaging due to
variations in signal phase and frequency.
Methods to increase the SNR at the processing level (after acquisition) have
also been proposed. A popular method to improve SNR by noise suppression
is to apply apodizing filters, but this approach always compromises the spec-
tral resolution of the data [Kim et al., 2012]. Another popular method to
denoise MRS signals is to apply wavelet shrinkage [Cancino-De-Greiff et al.,
2002]. In another work proposed in [Ahmed, 2005], MRS signals are denoised
by consecutive projection onto different domains, represented by a set of lin-
ear time-frequency transforms. However, none of these methods explore the
spatial properties of the MRSI signals that are processed separately (voxel-
wise).
Methods incorporating constraints on the spectral profile, either by using
explicit parametric models or by assuming particular line-shape character-
istics have also been used for denoising MRSI data [Diop et al., 1994; Bao
and Maudsley, 2007; Nguyen et al., 2010]. These approaches tend to bias
the interpretation of the measured signal towards the prior assumptions. For
example, the method described in [Diop et al., 1994] makes strict use of the
Lorentzian lineshape of the spectral peaks which might be too limited to
describe the disturbed lineshapes, often presented by in vivo MRSI signals,
due to magnetic field inhomogeneities or tissue heterogeneities. In addition,
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most of these methods rely heavily on spatial smoothness constraints limit-
ing their ability to capture the spatial variations exhibited by in vivo scans,
especially in the context of lesions. As a consequence, they are often ineffec-
tive in practical applications [Laruelo et al., 2013a].
A less-constrained approach was proposed in [Eslami and Jacob, 2009a],
where spatial piecewise smoothness imposed by the spatial TV norm is com-
bined with a sparse spectral model. In order to alleviate the staircase effect
related to the conventional TV, a reconstruction method for MRSI data
based on an extension of the TV norm is proposed in Kasten et al. [2013].
In this work, a method considering higher-order derivatives, referred to as
the total generalized variation of second order [Knoll et al., 2011] is adopted.
However, the use of TV-based methods leads to high computational cost due
to the estimation of the gradient. Moreover, it prevents the use of the ef-
ficient proximal optimization algorithms, due to the lack of a closed form
for the proximity operator of the TV (except if TV is combined with some
suitable linear operator to decompose it [Chaari, 2010; Combettes and Pes-
quet, 2011]). In such context, the TV norm would need an additional inner
optimization step to evaluate its proximal operator [Boyer et al., 2012]. A de-
tailed review of regularized reconstruction approaches for MRSI is provided
in [Kasten et al., 2015].
It is then desirable to have a method able to suppress noise in MRSI sig-
nals in a non-constrained way while preserving the spectral and the spatial
features. Since there might be applications where prior information can be
reliably incorporated, such a method should also allow natural extensions
that preserve this possibility.
In this chapter, we investigate a spatio-spectral sparse regularization to ad-
dress the limitations mentioned above. We propose a novel method for MRSI
denoising, which accounts for signal regularity across the spectral dimension
without altering the spectral resolution, but also across the spatial dimension.
The proposed approach relies on sparsity promoting priors using wavelet
transforms, a key tool that has been successfully used in a wide spectrum
of image processing applications, especially in the biomedical field [Pizurica
et al., 2006; Chaari et al., 2011]. MRSI data might not be strictly sparse
with respect to the `0 pseudo-norm due to the typically low spatial resolu-
tion of these type of data. In fact, most commonly encountered signals are
not strictly sparse in any domain, so that the notion of real sparsity is hard
to find in practice. However, we aim to exploit the fact that MRSI data
can be represented using only a few dominating coefficients in the wavelet
78
domain leading to a low `1 norm. This is true for both, the spectral and the
spatial dimensions of the data. Indeed, the spatio-spectral sparsity of MRSI
data have already been successfully used in compressed sensing imaging ap-
proaches [Hu et al., 2008; Geethanath et al., 2012].
We use a fast optimization algorithm to deal with the convex optimality cri-
terion which is not differentiable. For doing so, proximal algorithms have
been investigated, a family of fast convex optimization algorithms that have
also been widely used in signal/image processing [Combettes and Pesquet,
2008; Chaari et al., 2011].
4.2 Problem statement
As in many other real world problems, the MRSI signal is not directly avail-
able, but only measured through some physical laws relating the sought signal
to the measurements. Let S and Y be the target and observed MRSI signals,
respectively. We can express the denoising problem as the following inverse
problem:
Y = S +N , [4.1]
where N is an additive complex-valued Gaussian noise of covariance matrix
Ψ which has to be estimated.
The goal is to compute S from the inverse problem [4.1] keeping specific
features of the data which might be distorted by the noise.
4.3 Spatio-spectral denoising
4.3.1 Motivation
Existing methods recover S from the inverse problem [4.1] either by using
general schemes where the inherent spectro-spatial dimensions of the MRSI
data are not explored, or by assuming restrictive models that are not able to
deal with the variability of in vivo data. These are some of the drawbacks
of the current methods, like the widely used linear-shift invariant filters, the
standard wavelet shrinkage or the method presented in [Nguyen et al., 2010].
We propose to estimate S from Eq. [4.1] by adopting a sparse spatio-spectral
regularization scheme that is less constrained than the previous approaches.
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The proposed scheme is able to capture the spatio-spectral nature of MRSI
data and keeps opened the feasibility of incorporating prior knowledge into
the model. The presented method overcomes the limitations of the previous
methods by removing the spurious spatio-spectral irregularities while pre-
serving the spatial and spectral resolutions. In addition, unlike the existing
regularization schemes, this method relies on an efficient fast optimization
algorithm and it is not subject to local optima. The proposed algorithm also
presents interesting parallelization properties that could be exploited for big
data processing problems.
4.3.2 Regularization
4.3.2.1 Spatio-spectral representation of an MRSI dataset
A 3D MRSI dataset (see Fig. 4.2) can be represented as a multidimensional
matrix of size Nr×Nc×Ns×M , where Nr, Nc and Ns are the spatial dimen-
sions and M is the number of spectral points (typically 512 or 1024). Let
S be the MRSI signals corresponding to a 2D slice involving R = Nr × Nc
spatial positions and M spectral points. Denoting the 2D spatial position by
r, S can be written as S = (sr)r=1,...,R = (sf )1≤f≤M , where the M × 1 vector
sr denotes the spectrum at voxel r, and sf the 2D image of size Nr × Nc
related to frequency f .
At a given spectral frequency f , the 2D complex-valued image sf of size
Nr × Nc can be seen as an element of the Euclidean space CK with K =
Nr ×Nc endowed with the standard inner product 〈 · | · 〉 and norm ‖ · ‖. On
the other hand, the spectrum sr of size M at spatial position r can be seen
as an element of the Euclidean space CM endowed with the standard inner
product and norm.
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Figure 4.2: Schematic representation of an MRSI dataset. Edited
from [Siemens, 2005].
4.3.2.2 Spatio-spectral representation of an MRSI dataset in the
wavelet domain
We employ a dyadic 2D orthonormal wavelet decomposition operator T over
j1max resolution levels. The coefficient field resulting from the wavelet de-
composition of an image sf is defined as ζf =
(
ζfa, (ζ
f
o,j)o∈O,1≤j≤j1max
)
with
o ∈ O = {0, 1}2\{(0, 0)}, ζfa = (ζfa,k)1≤k≤Kjmax and ζfo,j = (ζfo,j,k)1≤k≤Kj where
Kj = K2
−2j is the number of wavelet coefficients in a given subband at reso-
lution j (by assuming that Nr and Nc are multiples of 2jmax). Adopting such
a notation, the wavelet coefficients have been reindexed so that ζfa denotes
the approximation coefficient vector at the resolution level jmax, while ζfo,j
denotes the detail coefficient vector at the orientation o and resolution level
j.
Let be F a dyadic 1D orthonormal wavelet decomposition operator over j2max
resolution levels. The coefficient field corresponding to the spectrum sr is
then denoted by ζr =
(
ζra, (ζ
r
d,j)1≤j≤j2max
)
, where the subscripts a and d de-
note approximation and detail subbands, respectively.
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4.3.2.3 Regularization terms
In order to reduce the search space of S to solutions having fewer irreg-
ularities both in the spatial and spectral dimensions, we propose here to
introduce two regularization terms. The first one describes the 2D spatial
prior knowledge about the wavelet coefficients of the target solution. This
first regularization term is defined as:
Rspat(S) =
M∑
f=1
[Kj1max∑
k=1
Φpµa,αa
(
(Tsf )a,k
)
+
∑
o∈O
j1max∑
j=1
Kj∑
k=1
Φp
µjo,α
j
o
(
(Tsf )o,j,k
)]
, [4.2]
where ∀ξ ∈ C, Φpµ,α(ξ) = α|ξ − µ|pp, µjo ∈ C, αjo ∈ R+ and p ≥ 1 (similarly
µa and αa). Due to the shape parameter p, this regularization term keeps a
compromise between sparsity (p ∼ 1) and smoothness (p ∼ 2) of the wavelet
coefficients.
The spectral regularization term allows us to reduce high spectral disconti-
nuities (especially close to the metabolite peaks) between adjacent frequency
bands at a voxel r. This regularization is made through the penalization of
the wavelet coefficients of the 1D spectra sr:
Rspect(S) =
∑
r∈R
[Kj2max∑
k=1
Φβηa,λa
(
(Fsr)a,k
)
+
j2max∑
j=1
Kj∑
k=1
Φβ
ηjd,λ
j
d
(
(Fsr)d,j,k
)]
, [4.3]
where ηjd ∈ C, λjd ∈ R+ and β ≥ 1 (similarly for ηa and λa).
Note that this kind of `β with β ≥ 1 regularization has already been success-
fully used in sparse MRI reconstruction [Chaari et al., 2008a].
4.3.3 Optimization procedure
Based on the formulation above, the criterion to be minimized can be written
as follows:
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J (S) = D(S) +Rspat(S) +Rspect(S), [4.4]
where D(S) = ‖Y −S‖2
Ψ−1 represents the data fidelity term. Since J is con-
vex, the convergency to a global optimum is guaranteed. However, J is not
necessarily differentiable, which makes impossible the use of gradient-based
algorithms for minimization. We therefore propose to perform the minimiza-
tion of Eq. [4.4] by using the concept of proximity operators [Moreau, 1962]
introduced in Chapter 3 (see Definition 3.4.1) which has been used in a num-
ber of recent works in convex optimization [Combettes and Pesquet, 2008;
Chaari et al., 2011].
In this work, as the observed data are complex-valued, the definition of prox-
imity operator is extended to a class of convex functions defined for complex-
valued variables. For the function
Φ : CR →]−∞,+∞]
x 7→ φRe[Re(x)] + φIm[Im(x)], [4.5]
where φRe and φIm are functions in Γ0(RR) and Re(x) (respectively Im(x)) is
the vector of the real parts (respectively imaginary parts) of the component
of x ∈ CR, the proximity operator is defined as
proxΦ : CR → CR
x 7→ proxΦRe [Re(x)] + proxΦIm [Im(x)]. [4.6]
An example of proximity operator for a function of a complex-valued variable
is given below.
Example 4.3.1. As shown in Chapter 3 (see Example 3.4.2), the proximity
operator of the absolute value function Φ = 1
λ
|x|, where x, λ ∈ R and λ > 0 is
the well-known soft thresholding operator with 1
λ
as threshold [Donoho and
Johnstone, 1994]:
prox 1
λ
|.|x = sign(x)max
(|x| − 1
λ
, 0
)
. [4.7]
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In the case of convex functions defined for complex-valued variables, x, λ ∈ C,
the proximity operator is expressed as follows:
prox 1
λ
|.|x = sign(Re
(
x)
)
max{|Re(x)| − Re(λ), 0}
+ ı sign
(
Im(x)
)
max{|Im(x)| − Im(λ), 0}. [4.8]
Since the cost function in Eq. [4.4] is made up of more than two non-
necessarily differentiable terms, an appropriate solution for its minimization
is the Parallel Proximal Algorithm [Combettes and Pesquet, 2008] which is
designed to minimize the sum of a finite number of convex functions. This
algorithm requires the knowledge of the proximity operators of the functions
involved in the optimization criterion. In our case, we have a sum of three
convex functions: the data fidelity term, D, and the two penalizations, Rspat
and Rspect. The expressions of the proximity operators of these functions and
the details of the minimization algorithm are described below.
4.3.3.1 Proximity operator of the data fidelity term
According to standard rules about the calculation of proximity operators
[Combettes and Pesquet, 2008, Table 1.1], the proximity operator of the
data fidelity term D is given by:
proxDS =
(
Id + 2Ψ
−1)−1(S + 2Ψ−1Y ), [4.9]
where Id is the identity operator.
4.3.3.2 Proximity operator for the regularization terms
Using the same rules as in Section 4.3.3.1, the proximity operator of Φpµ,α
for every ξ ∈ C is given by proxΦpµ,αξ = sign(ξ)η, where η = ηRe + ı ηIm is
the unique solution in C+ to η + pηp−1α = |ξ − µ|. If p = 1, this proximity
operator simplifies as follows:
proxΦpµ,αξ = sign(Re
(
ξ − µ)
)
max{|Re(ξ − µ)| − Re(α), 0}
+ ı sign
(
Im(ξ − µ)
)
max{|Im(ξ − µ)| − Im(α), 0}. [4.10]
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However, due to the presence of the wavelet operators in both the spatial
and the spectral regularization terms (Eqs. [4.2] and [4.3]), we need to calcu-
late the proximity operators of Φpµ,α◦T and Φβη,λ◦F , respectively. Since T and
F are both orthonormal wavelet decomposition operators, we have TT ∗ = Id
and FF ∗ = Id, where T ∗ and F ∗ are the adjoint wavelet operators of T and
F , respectively, and Id is the identity operator. Therefore the proximity oper-
ators of the regularization terms can be calculated based on [Combettes and
Pesquet, 2008, Lemma 2.4], leading to proxΦpµ,α◦T = Id+T
∗◦(proxΦpµ,α−Id)◦T
(similarly for proxΦβη,λ◦F ).
4.3.3.3 Optimization algorithm
A minimizer of the criterion [4.4] can be iteratively computed according to
Algorithm 1. This algorithm is based on the extension to the complex case
of the Parallel Proximal Algorithm (PPXA) [Combettes and Pesquet, 2008]
which is designed to minimize the sum of a finite number of convex func-
tions f1, ..., fm. At each iteration n, this algorithm requires the knowledge
of (prox γ
ωi
fi
)i=1,...,m, where γ corresponds to a step-size parameter and the
weights ωi measure the contribution of each function in the criterion [4.4].
The fact that the algorithm involves several parameters (γ, (ωi)1≤i≤m, and
relaxation parameter λ) should not be viewed as a weakness since the con-
vergence is guaranteed for any choice of these parameters under some as-
sumptions [Combettes and Pesquet, 2008]. In fact, these parameters bring
flexibility to PPXA in the sense that an appropriate choice of them may be
beneficial to the convergence speed [Pustelnik et al., 2011]. Typical values
for these parameters are indicated in [Pustelnik et al., 2011] in Section 5.2.
In our case, Algorithm 1 is implemented by setting γ = 10, ωi = 1/3 (equal
contributions to the three functions in [4.4]) and λ = 1.6. A key advantage of
PPXA is its parallel structure which makes it easily implementable on mul-
ticore architecture while preserving the convergence to the global minimum.
The resulting algorithm for the minimization of the optimality criterion in
Eq. [4.4] is described below.
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Algorithm 1 Hybrid MRSI denoising
Set γ > 0, λ ∈]0, 2[, n = 0, (ωi)1≤i≤3 ∈ [0, 1]3 s. t.∑3
i=0 ωi = 1, S
(n) =
∑3
i=1 ωiU
(n)
i , U
(n)
i = (s
r)r∈R = (sf )1≤f≤M ∈
(CK×M)3.
1: repeat
2: Calculate p(n)1 = prox γ
ω1
DS
(n).
3: Calculate p(n)2 = prox γ
ω2
RspatS
(n).
4: Calculate p(n)3 = prox γ
ω3
RspectS
(n).
5: Set P (n) =
∑3
i=1 ωip
(n)
i .
6: for i = 1 to 3 do
7: U (n)i = U
(n)
i + λ(2P
(n) − S(n) − p(n)i ) .
8: end for
9: S(n+1) = S(n) + λ(P (n) − S(n)).
10: Set n← n+ 1.
11: until Convergence.
12: return Sˆ = S(n).
4.4 Results
In order to validate the performance of the proposed algorithm, we carried
out a set of experiments on both synthetic and real data. The main goal of
this validation is to show the ability of the algorithm to increase the SNR of
MRSI data while preserving spatial and spectral features. Another important
objective is to demonstrate the flexibility of the algorithm to deal with the
variations exhibited by in vivo data.
4.4.1 Synthetic Data
To show the performance of the proposed method, we carried out a set of
experiments on synthetic data. We simulate 1H MRSI data based on values
commonly reported in the literature [Govindaraju et al., 2000] and experi-
mental data. We consider four MR-observable metabolites in human brain:
N-acetylaspartate (NAA), creatine (Cr), choline (Cho) and lactate (Lac). For
each metabolite, a spectral profile was obtained from quantum mechanical
simulations of a spin-echo MR experiment using the jMRUI software pack-
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age [Stefan et al., 2009]. Different levels of additive white Gaussian noise
were added to the ground truth signal Figure 4.3). The standard deviation
(σ) of the different levels of noise were selected in accordance to values from
in vivo scans.
Figure 4.3: Simulation of synthetic MRSI spectra from simulated metabolite
profiles.
Two synthetic MRSI datasets presenting different geometries were generated:
a dataset with a sharp edge separating tumor-like and normal appearing re-
gions, and another dataset with a smooth edge between both regions (Fig-
ure 4.4). The objective is to measure the gain in SNR and to test if the
proposed method is able to preserve both the spectral and the spatial fea-
tures.
In addition, we compare the proposed spatio-spectral regularization (SSR)
with conventional apodization (Apod), with spatial 2D wavelet shrinkage
(2D-WS) and with the method incorporating spatial-smoothness and au-
toregressive spectral constraints (SSAC) proposed in [Nguyen et al., 2010].
Apodization refers to the processing technique by which the FID is multi-
plied pointwise by some appropriate function/filter in order to improve the
SNR of the signal. This technique is typically used for MR signals to avoid
the spurious peaks that are present in the spectrum when the FID has not
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Figure 4.4: Spatial distributions of the synthetic MRSI datasets presenting
different geometries: a sharp edge separating different regions (left), and a
smooth edge between both regions (right).
decayed completely by the end of the acquisition. In order to avoid this
artifact, the signal can be forced to decay more rapidly using an apodiza-
tion filter. Here we have considered the Hanning function (centered in 0 ms,
width 256 ms), one of the most popular apodization filters for MRS signals.
For the 2D wavelet shrinkage we have used a Matlab implementation using
the the Donoho-Johnstone universal threshold approach [Donoho and John-
stone, 1994]. In SSAC, the spatial and spectral regularization parameters
have been chosen so as to optimize the output SNR, while preserving at best
the spectral features, especially lineshapes. The SNR in dB of each signal, Y ,
was computed in the frequency domain as SNR = 20 log10
‖Sref‖2
‖Sref−Y ‖2 , where
Sref denotes the noiseless signal. SSAC is very sensitive to the prediction
coefficients and the order of the Autoregressive (AR) model that defines the
spectral regularization term. We have chosen here an order L = 5 to capture
the mean peaks present in the simulated spectra. Linear prediction coeffi-
cients were estimated using a least squares method. The same compromise
has been applied to tune the regularization parameters in our method (SSR)
(see Section 4.3.2.3) for p = 1 in Equation [4.2] and β = 1 in Equation [4.3].
It is worth noticing that fully autocalibrated approaches may be used to au-
tomatically estimate these parameters directly from the data [Chaari et al.,
2010]. Note that only wavelet detail coefficients were processed. This is
equivalent to setting the regularization parameters to zero for the approxi-
mation coefficients (i.e., αa = 0 in Eq. [4.2] and λa = 0 in Eq. [4.3]). The
parameters µo and ηd (in Equations [4.2] and [4.3]) were also set to zero. In
order to show an example on how the regularization parameters are selected
for the proposed method, Figure 4.5 shows the variation of the SNR as a
function of the spectral and spatial parameters for a given MRSI dataset.
As it can be seen in the figure, the highest SNR is reached when the spa-
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tial regularization parameter is around 0.05 and the spectral regularization
parameter takes any of the following values: 0.01, 0.05 or 0.1. In case that
different combinations of regularization parameters provide the same (or very
similar) SNR, as in this example, we select the smallest parameter value in
order to preserve the spatial and spectral features. Therefore, in the example
provided we would set the spatial regularization parameter to 0.05 and the
spectral parameter to 0.01.
Figure 4.5: SNR of a given MRSI dataset as a function of the spatial and
spectral parameters (αo in Eq. [4.2] and λd in Eq. [4.3]).
As regards the wavelet transforms (operators T and F in Equations [4.2]
and [4.3], respectively), we used a Daubechies basis over one resolution level.
The use of Daubechies wavelets is supported by the fact that this wavelet
family has already shown to be well suited for MRS(I) data in previous
works [Ahmed, 2005; Hu et al., 2008; Geethanath et al., 2012]. The prop-
erty that distinguishes Daubechies wavelets is that they have minimum local
support for any given number of vanishing moments. This trade-off between
length of the support and vanishing moments makes the Daubechies family
well suited to represent (compress) signals that have few singularities and
that are smooth between singularities (as it is normally the case for clinical
long/medium TE MRSI data). Indeed, the shorter the wavelet support the
less wavelets interacting with each singularity (i. e., fewer wavelet coefficients
are needed to describe a spectral peak). Generally speaking, a smaller sup-
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port implies less computation and more vanishing moments implies better
compression (better representation) of the signal.
In addition, we have explored various wavelet families, including Daubechies,
Symlets and Coiflets using synthetic MRSI data. The synthetic dataset with
a smoother border between lesion and normal regions was considered for this
analysis since it seems to be more realistic than the extreme case represented
by the sharp dataset(Figure 4.4). Synthetic datasets at three different levels
of noise were generated (Figure 4.3) in order to compare the performance
of the different wavelet families. The accuracy of the three wavelets turned
out to be very similar, with Daubechies having slightly better SNR results
(Table 4.1). Since the efficiency of noise reduction seemed to decrease as
the number of Daubechies filter coefficients increased we decided to use db2
(4 filter coefficients). This behaviour has already been reflected in previous
works like [Kim et al., 2000].
The reason to use one resolution level is mainly the low spatial resolution
of the data. On the other hand, increasing the number of resolution levels
increases the number of regularization parameters to be set leading to a more
difficult configuration and automation of the algorithm. However, high spa-
tial resolution MRSI images, where the low signal-to-noise ratio is a major
limitation, may benefit from the use of different resolution levels.
SNRafter
SNRbefore db2 db4 db2 sym2 coi2
SNR=2 6.5 6.42 6.39 6.21 6.07
SNR=6 11.84 11.72 11.64 11.75 11.6
SNR=12 16.71 16.61 16.57 16.71 16.60
Table 4.1: Performance of the proposed denoising method for each of the
analyzed wavelet families and for different levels of noise.
We processed the two different synthetic datasets with the different methods
at three different levels of noise. The method SSAC could not suppress
noise correctly in the metabolite regions (Figure 4.6 (b.1,b.2) and Figure 4.7
(b.1,b.2)). Even if it provides better SNR than the proposed method in some
cases (Tables 4.2 and 4.3), the signals in regions close to the metabolite peaks
are underestimated as shown in Figures 4.8 and 4.9. Apodization filters
provide good SNR but they are known to broaden resonances and distort
90
spectral lineshapes [Kotyk et al., 1995]. Therefore, this method tend to blur
the spatial distribution of the data as shown in Figures 4.8 and 4.9. 2D-WS
provides the best SNR values but at the expense of spatial artifacts as it can
be seen in the spatial distributions shown in Figure 4.8 and Figure 4.9. The
proposed method provides the best trade-off between SNR gain and features
preservation.
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Figure 4.6: Normal appearing spectrum from a particular voxel: (a.1) noisy
spectrum; (b.1) spectrum obtained from SSAC; (c.1) spectrum obtained from
Hanning apodization; (d.1) spectrum obtained from 2D wavelet shrinkage;
(e.1) spectrum obtained from the proposed denoising; (a.2), (b.2), (c.2), (d.2)
and (e.2) are the absolute residuals of (a.1), (b.1), (c.1), (d.1) and (e.2),
respectively. Ground truth spectrum is shown in blue.
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Figure 4.7: Tumor-like spectrum from a particular voxel: (a.1) noisy spec-
trum; (b.1) spectrum obtained from SSAC; (c.1) spectrum obtained from
Hanning apodization; (d.1) spectrum obtained from 2D wavelet shrinkage;
(e.1) spectrum obtained from the proposed denoising; (a.2), (b.2), (c.2), (d.2)
and (e.2) are the absolute residuals of (a.1), (b.1), (c.1), (d.1) and (e.2), re-
spectively. Ground truth spectrum is shown in blue.
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Figure 4.8: Spatial distributions at 2.01 ppm (close to NAA peak) and 1.33
ppm (close to Lac peak) corresponding to the sharp edges dataset of size
8× 8.
SNRafter
SNRbefore SSAC Apod 2D-WS SSR
SNR=2 5.34 6.02 7.39 6.15
SNR=6 9.78 12.84 12.74 10.34
SNR=12 14.31 17.31 16.79 13.1
Table 4.2: Performance of the compared methods in terms of SNR for the
sharp edges dataset.
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Figure 4.9: Spatial distributions at 2.01 ppm (close to NAA peak) and 1.33
ppm (close to Lac peak) corresponding to the smooth edges dataset of size
8× 8.
SNRafter
SNRbefore SSAC Apod 2D-WS SSR
SNR=2 6.3 7.02 7.39 6.5
SNR=6 11.78 12.68 12.74 11.84
SNR=12 17.78 17.31 16.79 16.71
Table 4.3: Performance of the compared methods in terms of SNR for the
smooth edges dataset.
4.4.2 In vivo Data
To further analyse the robustness of our method, we have tested the results
on in vivo MRSI data from human brain. These data were acquired with
a Siemens Avanto 1.5 T using a 3D CSI sequence with water suppression,
95
TE=135 ms, TR =1500 ms, 512 FID data points and 4 averages. Improve-
ments with SSR, compared to conventional signal apodization, were found
on experimental data. By using SSR, the SNR is increased without decreas-
ing spectral resolution, thus maintaining the spectral features. We have also
compared the performance of SSAC and SSR on in vivo MRSI signals. SSR
has shown to be more robust to noise than SSAC since it is less sensitive
to spectral lineshapes. Fig. 4.10 shows a real spectrum (related to abnormal
tissue) that has been denoised using both methods. We can easily notice
that our approach allows preserving the spectral lineshapes which are under-
estimated with SSAC. Fig. 4.11 shows how apodization (Hanning filter) dis-
torts spectral lines while they are well preserved after SSR denoising.
Figure 4.10: Raw in vivo spectrum (blue), spectrum after SSAC denoising
(red) and spectrum after SSR denoising (black).
NAA peak Cr and Cho peaks
Figure 4.11: Comparison of standard apodization and SSR: raw spectrum
(blue), apodized spectrum (red) and spectrum after SSR denoising (black).
In vivo spectra from healthy-appearing tissue were quantified using the method
described in [Poullet et al., 2006]. These same spectra were quantified again
after being processed using the denoising method described in this chap-
ter. Fig. 4.12 shows boxplots of the distribution of the estimated metabolite
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amplitudes ratios in both cases. Values estimated without previous denois-
ing show higher variances than for the other case where previous denoising
was applied. This may indicate poorer quantitation accuracy due to the
presence of noise. Indeed, according to values commonly reported in the
literature [Safriel et al., 2005], the ratios NAA/Cr and Cho/Cr tend to be
overestimated in noisy spectra. This behaviour is significantly corrected for
all metabolites by reducing the noise in the data before quantification.
Regarding the computational cost, the proposed algorithm is slower than con-
ventional denoising methods (like spectral wavelet shrinkage or apodization
filters). This is due to the fact that the proposed spatio-spectral regular-
ization takes into account an additional dimension of the data. Compared
to SSAC, the more recent method described in [Nguyen et al., 2010], our
method is significantly much faster: less than 50 seconds against few min-
utes for most of the experiments presented in this chapter. More specifically,
the computation times of the proposed algorithm were between 30 and 50
seconds (depending on the size of the MRSI data set and the level of noise),
while the computation times for the method in [Nguyen et al., 2010] were al-
ways higher than 60 seconds. The experiments were done on a 64-bit 1.8GHz
i7-4500U architecture with a Matlab implementation (R2013a).
Figure 4.12: Boxplots of the distribution of the relative metabolite ampli-
tudes. Without previous denoising (left), with previous denoising (right).
These results are in accordance with the results presented in our preliminary
work [Laruelo et al., 2013b].
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4.5 Conclusion
We presented a new denoising method for MRSI which overcomes the draw-
backs of previous approaches without any lineshape constraint. This prop-
erty makes our method suitable for handling in vivo data. It explores both
spectral and spatial dimensions of MRSI data. The inherent optimization
problem is solved using a fast proximal algorithm that allows parallel com-
putations while guaranteeing the convergence to the global minimum. Fur-
thermore, the proposed approach can be easily extended to incorporate more
sophisticated priors, such as tissue distributions and anatomical configura-
tion extracted from companion MRI images.
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5.1 Introduction
Despite the numerous publications on the subject [Vanhamme et al., 1997;
Soher et al., 1998; Provencher, 2001; Ratiney et al., 2005; Poullet et al., 2006;
Sava et al., 2011; Kelm et al., 2012], the quantification of MRSI data is still a
challenging problem due to the due to the acquisition artifacts (instrumental
noise, magnetic field inhomogeneities, body motion) that lead to low signal-
to-noise ratio (SNR) of the MRSI signals and overlap of spectral lines. SNR
and chemical shift separation of metabolite peaks increase approximately
linearly with the increase of the magnetic field. However, considering the
relatively weak magnetic fields used in clinical practice, a limited chemical
shift dispersion often causes spectral overlap and complicates the separation
of metabolites. The difficulty is higher when there are lesions that produce
non-characteristic spectra and when nuisance signals, such as poorly sup-
pressed water or lipid signals in 1H-MRSI, distort the spectra and desirable
metabolite signals are almost indistinguishable from noise due to their low
concentration. As shown in Chapter 4, improving the SNR is a key factor
in achieving robust and accurate quantification of MRSI data. Many quan-
tification methods incorporate techniques to face the low quality of MRSI
signals. A common approach to improve the robustness of the quantification
of MRSI spectra is the incorporation of prior knowledge for some spectral
parameters. For example, AMARES [Vanhamme et al., 1997] allows specify-
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ing upper and lower bounds for frequency, damping and phase. It also allows
imposing relations (such as differences or ratios) between individual spectral
parameters. Simulations as well as in vivo experiments confirm the decrease
of the Cramér-Rao lower bounds (CRLB) [Cavassila et al., 2001] when in-
corporating prior knowledge in the quantification process [Mierisová et al.,
1998]. Prior knowledge on the spectral parameters can also be incorporated
by making use of experimentally measured (in vitro) or simulated metabolite
profiles [Graveron-Demilly et al., 1993; Smith et al., 1994], as implemented
in [Provencher, 2001; Ratiney et al., 2005; Poullet et al., 2006]. More re-
cently, some quantification methods have proposed to exploit not only the
spectral but also the spatial context of MRSI signals by incorporating spatial
priors into the quantification model. An early approach using a priori spa-
tial information was introduced by Soher et al. [Soher et al., 1998]. In their
iterative method, selected parameter estimates are updated at each itera-
tion assuming smoothness of these parameter distributions. The well-known
LCModel [Provencher, 2001] also provides a spatial fitting mode for MRSI
data. It first analyzes a central voxel and then proceeds in the neighborhood
using previously fitted voxels for initialization and soft constraints for new
fits.
More recent quantification methods incorporate a penalty term encouraging
spatially smooth solutions. In [Kelm et al., 2012], a Bayesian smoothness
prior improving the fitting of MRSI data is proposed. This method en-
courages spatially smooth variations for some selected spectral parameters
(frequency, damping and phase). In [Sava et al., 2011], an iterative ap-
proach combining the spatial prior proposed in [Kelm et al., 2012] with other
methods incorporating spatial information is presented. Spatial smoothing
is desirable because it is reasonable to expect that neighbouring pixels will
contain similar information. However, it is well known that spatial smooth-
ing tends to blur the images since the edges between different regions may
be smoothed out.
In this chapter, we propose a novel quantification technique which benefits
from the combination of two strategies, the use of metabolite profiles and the
regularization scheme presented in Chapter 4 [Laruelo et al., 2016b]. Spatial
and spectral regularization terms are jointly incorporated with the aim of
increasing the SNR and exploiting the neighbouring information along the
spatial and spectral dimensions for a given MRSI voxel. Contrary to pre-
vious quantification methods, the prior knowledge is not imposed directly
on selected spectral parameters, but on the representation of the data in
100
the wavelet domain. The method exploits the fact that the wavelet trans-
form maps white noise in the signal domain to white noise in the transform
domain. Thus, while signal energy becomes more concentrated into fewer
coefficients in the wavelet domain, noise energy does not. This property en-
ables the efficient separation of signal from noise. A number of wavelet-based
techniques, including quantification and denoising, have been previously ap-
plied to MR spectroscopy [Serrai et al., 1997, 2000; Cancino-De-Greiff et al.,
2002; Zarei et al., 2008]. Fast MR spectroscopic imaging has also been ac-
complished by the use of wavelets to enable compression in the spectral and
spatial domains [Hu et al., 2008; Fu and Serrai, 2011]. To our knowledge,
this is the first time that the use of the wavelet properties together with a
hybrid regularization able to catch the different nature of the spectral and
the spatial dimensions of MRSI data is integrated into the quantification
algorithm. This method can be applied in addition to other types of prior
knowledge (as upper and lower bounds or smooth spatial variations for some
selected spectral parameters). A quantification solution is formulated for the
whole MRSI grid. However, in contrast to previous approaches, the presented
method is more flexible and less restrictive allowing the preservation of sharp
spatial features. In order to simultaneously fit all signals in the MRSI grid
while introducing spectral-spatial information, a fast proximal optimization
algorithm is proposed to recover the optimal solution.
5.2 Regularized quantification
5.2.1 Signal model
In vivo magnetic resonance spectroscopy (MRS) signals are measured in the
time domain and consist of responses from metabolites (including macro-
molecules), water and noise. Theoretically, a measured MRS signal at spa-
tial position r ∈ {1, . . . , R} can be modelled by a sum of K exponentially
damped complex sinusoids [Vanhamme et al., 2001] of M time-domain data
samples:
yr(m) =
K∑
k=1
ark exp(iφk) exp(−dkm+ 2piifkm) + lr(m) +wr(m) + nr(m),
[5.1]
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where m = 1, . . . ,M . In [5.1],the amplitude ark is proportional to the number
of nuclei contributing to the spectral component of frequency fk. The damp-
ing factor dk provides information about the mobility and macromolecular
environment of the nucleus, φk is the phase, l(m) is the baseline, i.e., the
contribution from the macromolecules, w(m) denotes the water signal and
the noise term n(m) is assumed to be a circular complex white Gaussian
noise.
Recent quantification algorithms impose spectral prior knowledge using metabo-
lite templates [Provencher, 2001; Ratiney et al., 2005; Poullet et al., 2006].
The MRS signal can therefore be described as a linear combination of basis
functions leading to:
yr(m) =
K∑
k=1
arkbk(m) + l
r(m) +wr(m) + nr(m), [5.2]
where bk denotes a basis function (in the time or frequency domain) and
the amplitudes ark are proportional to the concentration of the respective
metabolites. Note that m can refer to either a temporal or spectral index in
[5.2]. Section 5.2.2 introduces the new quantification model investigated in
this study.
5.2.2 Quantification Model
In MRS, quantification is the estimation of spectral parameters from mea-
sured data. Signal amplitude (in the time-domain) is the main parame-
ter of interest since it is proportional to the metabolite concentration. Let
Y ∈ CM×R be the observed MRSI signal corresponding to a 2D slice in-
volving M spectral points and R spatial positions. Let also A ∈ CK×R be
the matrix containing the contribution of the K metabolites to the observed
signal at each spatial position r = 1, . . . , R. According to [5.2], and assuming
that the water signal and the macromolecular contribution have been pre-
viously filtered, we propose to estimate the metabolite amplitudes from the
following inverse problem
Y = BA+N , [5.3]
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where
B
4
=
 b1(1) . . . bK(1)... ... ...
b1(M) . . . bK(M)
 , A 4=
 a
1(1) . . . aR(1)
...
...
...
a1(K) . . . aR(K)

Y
4
=
 y
1(1) . . . yR(1)
...
...
...
y1(M) . . . yR(M)
 , and N 4=
 n
1(1) . . . nR(1)
...
...
...
n1(M) . . . nR(M)
 .
[5.4]
For each k = 1, . . . , K, bk = [bk(1), . . . , bk(M)]
T denotes a vector of the
metabolite basis (spectral profile). For a fixed spatial position r, ur =
[ar(1), . . . , ar(K)]T is a column vector containing the contributions of the dif-
ferent metabolites to the observed MRS signal, and nr = [nr(1), . . . , nr(M)]T
is an additive complex-valued Gaussian noise of unknown covariance matrix
Ψ. Note here that the spatial positions have been vectorized so that a 2D
slice is represented by an R-dimensional vector.
5.2.3 Classic resolution scheme
Our goal here is to solve the inverse problem [5.3] in order to obtain an
estimate Â based on the observation Y , the knowledge of the basis B and
the noise covariance matrix Ψ. A basic solution to this problem is based on
the minimization of the weighted least squares criterion:
AˆWLS = arg min
A
JWLS(A) = arg min
A
‖ BA− Y ‖2Ψ−1 . [5.5]
which leads to
AˆWLS = (B
HΨ−1B)]BHΨ−1Y , [5.6]
where (·)H stands for transposed complex conjugate, (·)] stands for pseudo-
inverse and,
‖ · ‖Ψ−1 =
√
(·)HΨ−1(·) defines a norm on CK .
Due to the instability of the covariance matrix or the ill-conditioning of the
metabolite basis B, the inverse problem [5.3] is generally ill-posed. In this
case, the solution AˆWLS can be unstable and of poor quality. For this reason,
one must generally resort to regularization [Tikhonov, 1963]. As detailed in
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the previous chapter, regularization simply consists of introducing some prior
knowledge on the target solution. This issue has been widely investigated in
the MRI literature during the last decade [Ying et al., 2004b; Guerquin-Kern
et al., 2009b; Chaari et al., 2011, 2014]. Different priors have therefore been
investigated promoting smoothness or sparsity of the target solutions, either
in the original space or in a transform domain.
5.2.4 Spatio-spectral regularization
To the best of our knowledge, all existing methods for regularized MRSI
quantitation incorporate spatial smoothness assumptions on some spectral
parameters such as phase or line width [Sava et al., 2011; Kelm et al., 2012].
While promoting spatial smoothness for such specific parameters, no con-
straint is used for the signal amplitudes. In this paper, we propose to in-
corporate prior knowledge on the MRSI data using a different regularization
approach. On one hand, we exploit the sparsity of MR spectra by constrain-
ing the `1 norm of the wavelet transform. On the other hand, we favor
solutions (fits) with few irregularities in the spatial dimension by penalizing
the wavelet coefficients of the MRSI grid at each frequency band (Fig. 5.1).
The term “irregularities” mostly refers to noise and nuisance components
typically present in MRSI data. In fact, in MRSI-acquisition conditions, the
noise level is often similar in magnitude to some metabolite signal levels (like
Lactate) and noise interferes with signal identification and determination of
the metabolite amplitudes.
MRSI data might not be strictly sparse with respect to the `0 pseudo-norm
due to the typically low spatial resolution of these type of data. In fact, most
commonly encountered signals are not strictly sparse in any domain, so that
the notion of real sparsity is hard to find in practice. However, we aim to
exploit the fact that MRSI data can be represented using only a few dominat-
ing coefficients in the wavelet domain leading to a low `1 norm. This is true
for both, the spectral and the spatial dimensions of the data. Indeed, the
spatio-spectral sparsity of MRSI data have already been successfully used in
compressed sensing imaging approaches [Hu et al., 2008; Geethanath et al.,
2012].
Note that the proposed approach can be easily adapted to any convex penal-
ization in both, the spectral and the spatial dimensions. This prior knowledge
is included in the inversion scheme by using two regularization terms in the
optimality criterion JWLS in [5.5].
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Figure 5.1: MRSI data have a few dominating coefficients in the wavelet do-
main in the spectral and the spatial dimensions. Top left: real part of a MR
spectrum. Top right: MRSI dataset at a specific frequency position (MRSI
grid) and its corresponding 2D wavelet transform. Bottom left: Normalized
histograms showing the values of a MR spectrum (`1) and its corresponding
1D wavelet coefficients. Bottom right: Normalized histograms showing the
values of an MRSI grid (at a specific frequency position) and its correspond-
ing 2D wavelet coefficients. Only the detail wavelet coefficients are shown in
both cases.
5.2.4.1 Spatio-spectral representation of the data
At a given spectral frequency m, let us denote by ym ∈ CR the 2D complex-
valued image of size R = Nr × Nc which results from reshaping the R-
dimensional vector (BA)m. On the other hand, the spectrum yr = (BA)r
of size M at spatial position r can be seen as an element of the Euclidean
space CM .
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5.2.4.2 Spatio-spectral representation of the data in the wavelet
domain
Using the same notation as in Section 4.3.2.2 in Chapter 4, we employ a
dyadic 1D and 2D orthonormal wavelet decomposition operators, F and T ,
over j1max and j2max resolution levels, respectively.
5.2.4.3 Regularization terms
In order to constrain the solution Â to have few irregularities both in the
spatial and spectral dimensions, we propose to introduce two regularization
terms. The first one describes the 2D spatial prior knowledge about the
wavelet coefficients of the target solution. This first regularization term is
defined as
g1(A) =
M∑
m=1

LJ1∑
l=1
Φpµa,αa
[(
T (ym)
)
a,l
]
+
∑
o∈O
J1∑
j=1
Lj∑
l=1
Φp
µjo,α
j
o
[(
T (ym)
)
o,j,l
] ,
[5.7]
where Φpµ,α(ξ) = α|ξ − µ|pp, ∀ξ ∈ C, µjo ∈ C, αjo ∈ R+ and p ≥ 1 (and
similarly for µa and αa). Due to the shape parameter p, this regularization
term makes a compromise between sparsity (p ∼ 1) and smoothness (p ∼ 2)
of the wavelet coefficients of the 2D image ym. The second regularization
term allows us to reduce high spectral discontinuities (especially close to
the metabolite peaks) between adjacent frequency bands at a voxel r. This
regularization is made through the penalization of the wavelet coefficients of
the 1D spectra yr:
g2(A) =
R∑
r=1

LJ2∑
l=1
Φβηa,λa
[(
F (yr)
)
a,l
]
+
J2∑
j=1
Lj∑
l=1
Φβ
ηjd,λ
j
d
[(
F (yr)
)
d,j,k
] ,
[5.8]
where ηjd ∈ C, λjd ∈ R+ and β ≥ 1 (similarly for ηa and λa).
Note that this kind of `p regularization has already been successfully used in
sparse MRI reconstruction [Chaari et al., 2011, 2014].
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5.2.4.4 Optimization procedure
Based on the spatial and spectral regularization terms defined in [5.7] and
[5.8] (resp. g1(A) and g2(A)), and accounting for the quadratic data fidelity
term JWLS, the new criterion to be optimized can be written as:
J (A) = JWLS(A) + g1(A) + g2(A). [5.9]
Note here that if for instance one wants to perform only spatial regulariza-
tion, the spectral regularization term can be removed by setting λjd = λa = 0
in [5.8]. However, using both regularizations allows high spectral and spatial
discontinuities to be eliminated.
Since J is strictly convex, the uniqueness of the target solution is guaran-
teed. However, J is not necessarily differentiable, which makes impossible
the use of standard gradient-based algorithms for minimization. As proposed
in Chapter 4, the minimization of J in [5.9] can be performed by using the
concept of proximity operators [Moreau, 1962]. The minimization problem
that we need to solve here can not be tackled using PPXA, the proximal algo-
rithm considered in Chapter 4. The denoising problem described in Chapter 4
can be expressed as the sum of a finite number of convex functions as follows:
arg min
x
m∑
i=1
fi(x), [5.10]
where x are complex-valued variables. However,the problem that we need to
solve now is slightly different:
arg min
x
m∑
i=1
fi(Bx), [5.11]
where B denotes the matrix in which each column is a metabolite profile.
An appropriate method to solve this optimization problem is the simulta-
neous direction method of multipliers algorithm (SDMM) firstly introduced
in [Setzer et al., 2010] and detailed in [Combettes and Pesquet, 2008]. This
methods requires that the matrixBTB is invertible and the estimation of the
proximity operator of the three terms of the criterion to be minimized [5.9],
i.e., the data fidelity term and the spatio-spectral regularization terms. The
expressions of the proximity operators of these functions and the details of
the minimization algorithm are described below.
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5.2.4.5 Proximity operator of the data fidelity term
Based on the above definitions, and according to standard rules about the
calculation of proximity operators [Combettes and Pesquet, 2011, Table 1],
the proximity operator of the data fidelity term JWLS is given by:
proxJWLSA =
(
Id + 2Ψ
−1)−1(BA+ 2Ψ−1Y ). [5.12]
5.2.4.6 Proximity operators of the regularization terms
Regarding the regularization terms, the proximity operator of Φpµ,α for every
ξ ∈ C is given by
proxΦpµ,αξ = sign(ξ)η, [5.13]
where η = ηRe + iηIm is the unique solution in C+ to η + pηp−1α = |ξ − µ|.
If p = 1, this proximity operator simplifies as follows:
proxΦ1µ,αξ = sign
[
Re(ξ − µ)
]
max{|Re(ξ − µ)| − Re(α), 0}
+ i sign
[
Im(ξ − µ)
]
max{|Im(ξ − µ)| − Im(α), 0}. [5.14]
By referring to the spatial and spectral regularization terms g1 and g2 in [5.7]
and [5.8], it turns out that the proximity operator of the regularization term
can be obtained by calculating the proximity operator of Φpµ,α ◦ T and Φβη,λ ◦
F . These operators can be calculated based on [Combettes and Pesquet,
2008, Lemma 2.4], leading to proxΦpµ,α◦T = T
−1 ◦ proxΦpµ,α ◦ T (similarly for
proxΦβη,λ◦F ).
Based on the calculated proximity operators, the resulting algorithm for the
minimization of the optimality criterion in [5.9] is described below in Algo-
rithm 2.
It is important to note that the computations in this algorithm can be per-
formed in a parallel manner (steps 4 to 6 can be computed in parallel for
each i). In addition, the global convergence of the algorithm to an optimal
solution to the minimization problem is guaranteed. The parameter γ is
related to the convergence speed of the algorithm and has been chosen by
cross validation for each case [Combettes and Pesquet, 2008]. The stopping
parameter  has been set to 10−6 and the algorithm normally converges in
less than 50 iterations.
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Algorithm 2 Simultaneous Direction Method of Multipliers
Set γ > 0,  ∈]0, 1[, Z1i,0 ∈ CM×R, Z2i,0 ∈ CM×R, i ∈ {1, ..., N}, Q =
∑N
n=1B
∗B
(N = 3 in our case). Set n = 1.
1: repeat
2: Set An = Q−1
N∑
i=1
B∗(Z1i,n −Z2i,n)
3: for i = 1 to N do
4: Set Y i,n = BAn.
5: Calculate Z1i,n+1 = proxγgi(Y i,n +Z
2
i,n).
6: Set Z2i,n+1 = Z2i,n + Y i,n −Z1i,n+1.
7: end for
8: n← n+ 1.
9: until |J (An)− J (An−1)| < 
10: return Aˆ = An.
5.3 Results
5.3.1 Synthetic Data
In order to evaluate the performance of the proposed method, different ex-
periments on synthetic data were designed. Simulated MRSI datasets were
constructed by combining profiles from the principal metabolites observed in
long echo time brain MRS: choline (Cho), creatine (Cr), N-acetyl-aspartate
(NAA) and lactate (Lac). Metabolite profiles were obtained from quantum
mechanical simulations of a spin-echo MR experiment using the jMRUI soft-
ware package [Stefan et al., 2009]. First, N = 50 Monte Carlo simulations
of MRSI data sets of size 10 × 10 were performed to measure the accuracy
of the proposed method as a function of SNR. To this aim, five different
levels of white Gaussian noise were added to a noiseless simulated data set.
The SNR in dB of each signal, Y , was computed in the frequency domain
as SNR = 20 log10
‖Sref‖2
‖Sref−Y ‖2 , where Sref denotes the noiseless signal. Fig. 5.2
shows examples of spectra for different noise levels considered in this exper-
iment.
The root-mean-squared error (RMSE) of the estimated amplitudes for each
metabolite k was calculated for each voxel r as:
RMSEk,r =
√√√√ 1
N
N∑
n=1
(arefk,r,n − aˆk,r,n)2
(arefk,r,n)
2
, [5.15]
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Figure 5.2: Synthetic MRSI spectra for different noise levels [SNR = -0.5, 2,
4.5, 7, 10] and noiseless ground truth.
where arefk,r,n, aˆk,r,n are the true and estimated amplitudes of the kth metabo-
lite respectively at voxel r for the nth simulation.
Fig. 5.3 compares the estimation error of the proposed method referred to
as Spatial-Spectral Regularization (SSR), with the voxel-wise quantification
method AQSES [Poullet et al., 2006] and AQSES-MRSI [Sava et al., 2011].
The estimation error is measured as the RMSEk,r averaged over all the
metabolites and over all the voxels. The increase in accuracy due to the in-
corporation of the spatial-spectral prior (in the proposed method) is clearly
observed. The errors of the proposed method when only one of the regu-
larization terms is considered, referred to as SSR-Spatial (only the spatial
regularization term is used) and SSR-Spectro (only the spectral regulariza-
tion term is used), are also displayed. In the same figure (Fig. 5.3), the errors
in the metabolite amplitudes estimated with each method are also compared
with the CRLB obtained from the individual voxel approach. SSR provides
the best results for all noise levels reducing the error by a mean of 41%, from
24% to 54% depending on the noise level. This difference of accuracy can be
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clearly observed and is even below the CRLB in some cases.
A similar analysis is shown in Fig. 5.4, where the mean RMSEk,r averaged
over all the voxels is shown for each individual metabolite.
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Figure 5.3: RMSEk,r of the estimated metabolite amplitudes averaged over
all the metabolites and over all the voxels computed for 50 synthetic MRSI
data sets of size 10 × 10 for 5 different noise levels (SNR values are: -0.5,
2, 4.5, 7, 10). The proposed method (SSR) is compared with a voxel-wise
quantification method (AQSES) and with a quantification method dedicated
to MRSI data (AQSES-MRSI). The averaged RMSE of the proposed method
when only the spectral term (SSR-Spectro) or only the spatial term (SSR-
Spatial) are considered are also displayed. The CRLBs shown were computed
from AQSES.
Fig. 5.5 shows the quality of the fit (measured by the SNR) for each method
for different noise levels. The curves show the SNR of the fits, i.e, how close
is each fitted model to the ground truth signal. The error bars represent the
mean RMSEk,r of the estimated metabolite amplitudes averaged over all the
metabolites and all the voxels at each noise level.
Fig. 5.6 shows the scatter plots of the RMSEk,r of the metabolite amplitudes
at each voxel. Each point corresponds to a given voxel. In most of the voxels,
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Figure 5.4: Mean RMSEk,r of the estimated metabolite amplitudes averaged
over all the voxels computed for 50 synthetic MRSI data sets of size 10× 10
for 5 different noise levels (SNR values are: -0.5, 2, 4.5, 7, 10). The proposed
method (SSR) is compared with a voxel-wise quantification method (AQSES)
and with a quantification method dedicated to MRSI data (AQSES-MRSI).
The averaged RMSEk,n of the proposed method when only the spectral term
(SSR-Spectro) or only the spatial term (SSR-Spatial) are considered are also
displayed.
the proposed method yields lower errors for the metabolite amplitudes when
compared to the AQSES-MRSI method.
A second experiment was considered in order to check that the proposed
method preserves spatial features. Two MRSI data sets of size 10 × 10 rep-
resenting different spatial features were generated. Both data sets contain a
region with healthy appearing signals and a region with tumor-like signals.
In the first case there is a sharp transition between the two regions, while a
smoother change is applied for the second dataset. The Structural SIMilar-
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Figure 5.5: Mean SNR values computed for 50 synthetic MRSI data sets
of size 10 × 10 for 5 different noise levels (SNR values are: -0.5, 2, 4.5, 7,
10). The error bars indicate the mean RMSEk,r of the estimated metabolite
amplitudes averaged over all the metabolites and all the voxels.
ity (SSIMk) index [Wang et al., 2004] was estimated for the amplitude map
of each metabolite. This index provides a valuable measure of performance
over the whole grid for each metabolite. Fig. 5.7 presents results obtained
for a synthetic data set where the border between the regions of healthy and
abnormal spectra is a sharp edge. The first row shows the ground truth for
the amplitudes of NAA, Cr, Cho and Lac. The following rows show the so-
lutions obtained from three different approaches and their differences from
the ground truth. More precisely, the second row shows the results using the
single-voxel approach, the third row shows the results using AQSES-MRSI,
the fourth row shows the proposed spectral-spatial prior (SSR), whereas the
last three rows show differences between the estimated concentrations and
the ground truth. The differences are measured as the percentage respect
to the maximum ground truth value for each metabolite. Table 5.1 and ta-
ble 5.2 show the SSIM values for he metabolite maps in Fig. 5.8 and Fig. 5.8,
respectively. This values offer an objective and quantitative measure of the
accuracy of the metabolic maps obtained with the different methods.
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Figure 5.6: RMSEk,r of the estimated metabolite amplitudes obtained with
the proposed method (SSR) and with AQSES-MRSI for 50 synthetic MRSI
data sets of size 10 × 10 at SNR=4.5. Each point corresponds to one voxel
of the MRSI grid.
The same experiment was performed for a simulated data set where the
border between healthy and abnormal tissues is represented by a smoother
edge. Results are shown in Fig. 5.8.
For all the experiments (for both synthetic and in vivo data), a Daubechies
basis with 2 vanishing moments over one resolution level (J1 = 1 and J2 = 1
in [5.7] and [5.8], respectively) was considered. Different types of wavelet
families were tested and Daubechies showed to be the best suited for this
type of data. The reason to use one resolution level is twofold. On one hand,
no significant improvements were noticed using resolution levels greater than
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Figure 5.7: Synthetic MRSI data set containing two regions associated with
healthy and tumor-like signals separated by a sharp edge. From top to bot-
tom: true metabolite concentrations, estimated metabolite concentrations
using AQSES, AQSES-MRSI and SSR, difference (error) between the true
metabolite concentrations and the concentrations estimated using AQSES,
AQSES-MRSI and SSR.
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Figure 5.8: Synthetic MRSI data set containing a region with healthy appear-
ing signals and a region with tumor-like signals separated by a smooth edge.
From top to bottom: true metabolite concentrations, estimated metabolite
concentrations using AQSES, AQSES-MRSI and SSR, difference (error) be-
tween the true metabolite concentrations and the concentrations estimated
using AQSES, AQSES-MRSI and SSR.
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one [Laruelo et al., 2013a]. In the spatial dimension, this is mainly due to
the typically low spatial resolution of the MRSI images used in the clinical
routine (no bigger than 32× 32). On the other hand, increasing the number
of resolution levels increases the number of regularization parameters to be
set, which could lead to less preciseness in the prior information used for
regularization. In order to promote sparse solutions in the wavelet domain,
the values of p and β in equations [5.7] and [5.8], respectively, are set to
p = β = 1 for all the experiments. Note that only detail coefficients were
processed. This is equivalent to setting the regularization parameter to zero
for the approximation coefficients. Regularization parameters were selected
manually by testing a number of values for each MRSI dataset. The combi-
nation of parameters providing the best trade-off between spectral SNR and
spatial features preservation were selected. It is worth noticing that fully
autocalibrated approaches may be used to automatically estimate these pa-
rameters directly from the data [Belge et al., 2002; Chaari et al., 2010].
SSIM AQSES AQSES-MRSI SSR
NAA 0.69 0.87 0.91
Cr 0.59 0.68 0.78
Cho 0.78 0.91 0.94
Lac 0.20 0.27 0.36
Table 5.1: SSIM values for each metabolite amplitude map in Fig. 5.7.
SSIM AQSES AQSES-MRSI SSR
NAA 0.83 0.94 0.98
Cr 0.61 0.87 0.90
Cho 0.78 0.92 0.95
Lac 0.41 0.55 0.69
Table 5.2: SSIM values for each metabolite amplitude map in Fig. 5.8.
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5.3.2 In vivo data
We further analyze the performance of our method for in vivo MRSI data.
In vivo MRSI data were acquired at Institut Claudius Regaud using a 1.5T
clinical MR scanner (Siemens Magnetom Avanto) using a 3D CSI sequence
with water suppression, TE=135 ms, TR =1500 ms, 512 FID data points, 4
averages, slice thickness: 15mm, matrix size: 16 × 16, FOV: 160 × 160 mm
yielding a voxel size of 10 mm × 10 mm × 15 mm. Data were acquired from
a healthy volunteer and from two patients with diagnosed Glioblastoma mul-
tiforme included in a prospective clinical trial. Note that an estimation of
the noise covariance matrix Ψ has been obtained from a signal(and artifact)-
free part of the MRSI spectra for in vivo data. Preprocessing applied to
in vivo MRSI signals includes: residual water suppression (using the Han-
kel singular value decomposition (HSVD) algorithm [Laudadio et al., 2002])
and standard polynomial baseline correction. For the quantification of in
vivo data, a metabolite basis set containing Cho, Cr, NAA and Lactate was
considered. The choice of this basis set was based on the fact that these
metabolites are the most visible in long echo time spectra. Due to the ex-
perimental conditions suffered by in vivo signals during the acquisition, it
is typically necessary to apply phase, frequency and damping corrections to
the simulated metabolite profiles. We have used AQSES to estimate these
corrections for each MRSI signal. The estimated corrections were then aver-
aged over the MRSI grid and applied to the metabolite profiles in the basis
set B [5.3].
The robustness of the proposed method was tested on in vivo data to check
if the results are consistent with real conditions. Metabolite maps obtained
using the proposed method were compared with the maps obtained us-
ing voxel-wise quantification methods (AQSES [Poullet et al., 2006] and
QUEST [Ratiney et al., 2005]) and the spatially-constrained approach AQSES-
MRSI [Sava et al., 2011]). Regularization parameters were selected manually
using a grid-search strategy as described in Section 5.3.1. The SNR for in vivo
spectra was computed in frequency domain as SNR = I
σ
, where I denotes the
height of the NAA peak in the real spectrum and σ the standard deviation
of the noise (measured in a signal-free region of the spectrum) [Kreis, 2004].
On Fig. 5.9, the metabolite maps depict the presence of NAA, Cho and Cr
as expected in healthy tissue. For the operated GBM patient (Fig. 5.10),
the Lac map presents a spatial distribution which matches with the surgical
cavity. The presence of Lac is often observed after surgery and can be linked
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to the post-operative reorganization of the tissue. The Cho map presents
higher concentrations in correspondence with the contrast-enhancing bud
of the anterior part of the lesion, suggesting higher cellular proliferation in
this area. For the non-operated GBM patient (Fig. 5.11), the NAA map
presents lower concentrations spatially matching the center of the contrast-
enhancement area and the necrosis that can be seen on the T1-weighted
post-gadolinium injected MR image. The Cho map shows high concentra-
tions corresponding to the anterior left part of the contrast-enhancing lesion.
The elevated presence of Cho together with the collapsing of NAA suggests a
metabolically active tumor region. The Lac map shows higher concentration
at the anterior left part of the tumor, suggesting the presence of anaerobic
metabolism in this area and emphasizing the heterogeneous aspect of the
tumor. Fig. 5.12 shows nine adjacent voxels from a patient with brain tumor
and the corresponding fits from AQSES, AQSES-MRSI and SSR.
Regarding the computational cost, SSR is quite efficient. The computation
time depends on the size of the MRSI grid, the samples of the spectra and on
the level of noise. For the in vivo cases presented in this study, the computa-
tion times for processing the whole image were between 50 and 90 seconds.
The experiments were done on a 64-bit 1.8GHz i7-4500U architecture with
a Matlab implementation (R2013a). The convexity of the objective function
guarantees the convergence to a global minimum.
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Figure 5.9: In vivo 3D MRSI acquisition on a healthy volunteer located in the
central hemispheric right part of the brain. Metabolite maps of NAA, Cr and
Cho are presented, respectively from top to bottom, using QUEST, AQSES,
AQSES-MRSI and SSR. For comparison purposes metabolite estimations
have been normalized between 0 and 1.
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Figure 5.10: In vivo 3D MRSI acquisition on a resected Glioblastoma mul-
tiforme patient with a left parietal lesion associated to a thin peripheral
contrast-enhancement. Metabolite maps of NAA, Cr, Cho and Lac are pre-
sented, respectively from top to bottom, using QUEST, AQSES, AQSES-
MRSI and SSR. For comparison purposes metabolite estimations have been
normalized between 0 and 1.
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Figure 5.11: In vivo 3D MRSI acquisition on a biopsied Glioblastoma multi-
forme patient presenting a central hemispheric right lesion with a mass effect
on the right lateral ventricle and a deviation of the structures thorugh the left
of the median line. Metabolite maps of NAA, Cr, Cho and Lac are presented,
respectively from top to bottom, using QUEST, AQSES, AQSES-MRSI and
SSR. For comparison purposes metabolite estimations have been normalized
between 0 and 1.
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Figure 5.12: Nine adjacent voxels from a patient with a brain tumor (Gliobas-
toma Multiforme) and the corresponding AQSES, AQSES-MRSI and SSR
fits. Cr and Lac peaks are erroneously fitted by the voxel-wise approach
(AQSES) in many voxels. AQSES-MRSI clearly improves the quality of the
fits but still Cr and Lac are not well captured. SSR is able to correctly fit
all the spectra.
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5.4 Discussion
In order to apply the MRSI technique to routine clinical practice, it is im-
portant to maximize the accuracy and the robustness of the quantification.
Additionally, both processing time and technique subjectivity should be min-
imized by, for example, automation. The use of regularization techniques
has been proved to be a powerful approach to achieve these objectives. We
have presented here a quantification method based on a combined spatial-
spectral regularization scheme. Contrary to previous methods, the regular-
ization terms are expressed in the wavelet domain. This allows the method
to explore other types of prior knowledge and going beyond the conventional
assumption of spatial smoothness . The benefits of imposing appropriate
constraints for both spectral and spatial dimensions of MRSI data have been
presented in this chapter. Experiments with synthetic data show that the
proposed method increases the accuracy and the robustness against noise of
the quantification (Fig. 5.3). The presented spectral-spatial prior prevents
the quantification algorithm from moving away from the true solution by
narrowing down the search space. As a result, the method becomes, not only
more accurate, but also more robust being able to cope with signals contain-
ing high noise levels. The better accuracy provided by SSR can be explained
by a more accurate fitting of the data as shown in Fig. 5.5. The proposed
method outperforms other quantification methods even in the presence of
sharp spatial features as it is shown in 5.7 and in Table 5.1. The higher
SSIM values provided by SSR confirm objectively that the metabolic maps
obtained by SSR are closer to the ground truth than the maps from AQSES
and AQSES-MRSI. Experiments with in vivo data show that the proposed
method provides less noisy spatial metabolite distributions. This leads to
better contoured metabolite maps. In addition, overlapping peaks (e.g., Cho
and Cr with respective resonance frequency at 3.2 and 3.0 ppm) and metabo-
lites present at relatively low concentrations (e.g., lactate) can be better es-
timated (Fig. 5.12). The good performance of the method can be explained
by the `1-norm regularization which leads to soft-thresholding of the wavelet
coefficients. The wavelet thresholding acts a non-linear low-pass filter in the
wavelet domain where most image information is contained in a few largest
wavelet coefficients, while the noise is uniformly spread out across all coef-
ficients. Thus thresholding mostly affects the noise rather than the signal.
The risk of missing spatial features of the smoothing filters is alleviated by
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wavelets, which preserve the sharpness of images. Another interesting prop-
erty is that, even if we focus in the use of the `1-norm in this manuscript, the
presented method in not restricted to this case. Other `p-norm (for 1 ≥ p)
could be considered since the method can cope with any convex penalty.
Therefore, the regularization imposed on the spectral and spatial dimensions
can be different. For example, it might be interesting to exploit the sparsity
of the spectral dimension in combination with a spatial smoothness prior to
quantify MRSI data from a homogeneous region. It is interesting to note
that the use of an averaged metabolite basis set could limit the performance
of the method in case of high variances between voxels. However, this limi-
tation is true for any method assuming smooth spatial variations. Methods
able to handle different metabolite basis for each voxel will be analyzed in
future studies. Interestingly, the proposed method requires tuning only two
parameters which give weights to the two regularization terms and can be au-
tomatically estimated from the data [Chaari et al., 2010]. This facilitates the
necessary automation of the quantification process in order to make MRSI,
not only appealing but, feasible into the clinical setting. The method pre-
sented here can be extended to incorporate 3D spatial information by using
a 3D wavelet operator. This makes it especially attractive in view of the
increasing interest in high resolution 3D MRSI data where the low SNR is a
main limiting factor.
5.5 Conclusion
A new method combining spatial and spectral regularizations in the wavelet
domain to improve MRSI data quantification has been presented. It benefits
from the combination of using a basis of metabolite profiles and incorpo-
rating simultaneously spectral and spatial constraints. Contrary to previous
approaches, the suggested method combines two regularization terms to fa-
vor solutions with specific properties in both the spatial and the spectral
dimensions. Note that the spectral parameters are not restricted to have
spatially smooth variations. The method allows the use of other priors pro-
moting properties such as the sparsity of the MRSI spectra in the wavelet
domain. Experiments on synthetic data clearly demonstrated some signifi-
cant improvements in quantification accuracy and robustness by using the
proposed spatial-spectral regularization. Experiments on in vivo data showed
well contoured metabolite maps that can be used to define more targeted and
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more individualized treatments [Laprie et al., 2008; Ken et al., 2013; Deviers
et al., 2014]. In addition, the presented method was able to correctly quantify
metabolites that are missed by other methods due to the presence of noise
or nuisance components as it has been shown for the case of the lactate.
This is especially relevant for the quantification of metabolites present in
low concentrations. The dependency on only two hyperparameters and the
use of a fast proximal algorithm that allows parallel computations facilitate
the automation of the presented method, which is crucial for the acceptance
of any quantification method to the routine clinical implementation. Future
work includes the extension of the proposed method to incorporate 3D spatial
information available from 3D MRSI data and validation with high spatial
resolution MRSI images where the low signal-to-noise ratio is a major limita-
tion. The integration of an automatic hyperparameter estimation method is
also an interesting prospect. Furthermore, the proposed method can be ex-
tended to incorporate more sophisticated priors, such as tissue distributions
and anatomical structures extracted from companion MRI images.
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Tumor relapse prediction based on
multi-parametric MR data classi-
fication
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6.1 Introduction
In the previous chapter (Chapter 5), a novel quantification method for MRSI
data is proposed. The estimated metabolite amplitudes can be used as in-
put features in a classifier to discriminate different tissue types based on
metabolic information. From this point of view, quantification can be con-
sidered as a feature extraction and dimension reduction technique. In this
chapter, we propose an automated decision support system based on a super-
vised classification method for the identification of regions at risk of relapse
in brain tumor patients. The ultimate goal is to show the potential of com-
bining metabolic information with other MRI imaging modalities to define
new biologically tailored target volumes for dose escalation in radiotherapy
treatments.
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6.2 Motivation
GBM is the most common and deadliest of malignant primary brain tumors in
adults [Stupp et al., 2005]. The current standard of care is surgical resection
(if feasible) followed by radiotherapy (RT) and concomitant and adjuvant
temozolomide (TMZ) chemotherapy [Stupp et al., 2005]. Although RT has
played a key role in the treatment of this tumor since several decades ago,
local tumor regrowth occurs in irradiated areas in 93% of the patients [Mc-
Donald et al., 2011]. Recent RT technologies, such as the intensity-modulated
radiation therapy (IMRT) [Amelio et al., 2010; Monjazeb et al., 2012], allow
the delivery of high doses to specific regions of the tumor while sparing nor-
mal tissue. These technical advances enable to consider innovative strategies
to optimize the treatment of GBM. One of these strategies is based on the
assumption that the local tumor control may be improved if the tumor ar-
eas with high probability of recurrence received a higher dose [Laprie et al.,
2008; Deviers et al., 2014]. Therefore, the identification of sites with high
probability of recurrence appears as a promising way to define new target
volumes for dose escalation in RT treatments.
MRI is used for diagnosis, characterization, and radiotherapeutic treatment
planning of brain tumors. However, conventional MRI has a limited speci-
ficity in describing the tumor extent and functional regions within the hetero-
geneous GBM tumors. The use of more advanced MR techniques, like MRSI,
is a promising tool for the analysis of brain tumours as it is able to charac-
terize biochemical, metabolic, and pathologic changes of brain tissues [Alger
et al., 1990; Dowling et al., 2001; Astrakas et al., 2004; Tzika, 2008]. Previous
studies have shown that certain metabolically abnormal regions detected by
MRSI are predictive of the location of tumor relapse [Nelson, 2001; Laprie
et al., 2008; Deviers et al., 2014]. MRSI data interpretation has been mainly
based on single-variable classifiers, i.e., MRSI voxels with a value greater than
or equal to a threshold would receive a positive prediction, and those below
the threshold would receive a negative prediction [McKnight et al., 2001;
Laprie et al., 2008; Raschke et al., 2014; Deviers et al., 2014]. A multipara-
metric imaging assessment of tumors, combining anatomical and metabolic
information, represents an attractive approach for mapping the heterogene-
ity of brain tumors. In fact, the automated classification of multivariate MR
data from brain tumor patients is a growing field of research and develop-
ment. Classification methods based on machine learning tools such as linear
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discriminant analysis [McLachlan, 2004], artificial neural networks [Bishop,
1995], and support vector machines [Cortes and Vapnik, 1995; Cristianini
and Shawe-Taylor, 2000], have been reported to provide results in agreement
with histopathology based on biopsy [McKnight et al., 2002; Alonso et al.,
1998]. On the other hand, classification methods based on the combination
of imaging and spectroscopy data have shown to be superior to using images
or spectroscopy independently [Devos et al., 2005; Simonetti et al., 2005].
Therefore, combining different imaging modalities is an interesting approach
to find a multi-parametric fingerprint (pattern) of relapse that does not seem
possible using a single modality (Figure 6.1).
The objective of the approach detailed in this chapter is to find a map be-
tween the multiparametric MR data acquired before the RT treatment and
the site of relapse of the brain tumour. The proposed method relies on the
assumption that pre-radiotherapy images contain information that can be
used to predict the formation of new contrast-enhancing (CE) regions (indi-
cating potential relapse) after radiotherapy. To this aim, we used a support
vectors machine (SVM) [Cortes and Vapnik, 1995; Cristianini and Shawe-
Taylor, 2000] classification algorithm to identify regions at risk of relapse
in newly diagnosed glioblastoma patients. Our feature space included fea-
tures from MRI and MRSI. The ground truth used for training the algorithm
was defined by images acquired at relapse contoured by experienced medical
staff. The results of the proposed classifier were compared with the CNI
index [McKnight et al., 2001] (described in Chapter 3, section 3.3.1.3) with
an optimal threshold estimated for the cohort of patients.
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Figure 6.1: Radar charts showing the mean values of different parameters
(imaging intensities (FLAIR, T1-weighted before (T1) and after gadolinium
injection (T1gado) and perfusion (Perf)) and metabolite ratios) before RT
treatment for 4 patients. Data acquired before starting the RT treatment may
contain information able to discriminate the site of relapse. Mean values for
the voxels lying out of the site of the posterior relapse (green), margin around
the normal values (dashed green) (σ is the standard deviation of the normal
values for each parameter), mean values for voxels lying within the region of
relapse (red). For each patient, a different combination of parameters is able
to discriminate voxels within the site of relapse from normal tissue.
6.3 Used data
6.3.1 Patients
The patient database consisted of 10 newly diagnosed GBM patients included
in the Spectro-Glio clinical trial described in Chapter 2 (Section 2.5.2.2).
All the patients were treated with the reference treatment of 60 Gy, and
underwent magnetic resonance imaging (MRI) and MR spectroscopy (MRSI)
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before the RT treatment and every 2 months until relapse.
6.3.2 Data acquisition
For all patients, MR data acquisition was performed on a 1.5 T Magnetom
Avanto Siemens scanner (Erlangen,Germany), with the standard head coil.
MRI modalities considered for this study were: fluid attenuated inversion
recovery (FLAIR) T2-weighted (TR = 8000 ms, TI = 2400 ms, TE = 105
ms), as well as a T1-weighted (TR= 532 ms, TE= 17 ms) obtained before
and after the injection of a standard dose of gadolinium contrast agent (at
the rate of 5mL/s).
In vivo MRSI data were acquired using a 3D CSI sequence with water sup-
pression (TE=135 ms, TR =1500 ms, 512 FID data points, 4 averages, slice
thickness: 15mm, matrix size: 16×16, FOV: 160×160 mm2 yielding a voxel
size of 10 × 10 × 15 mm3). The 3D-MRSI box was positioned to cover the
majority of abnormalities and normal appearing tissue, while avoiding re-
gions that could corrupt the spectra (such as bone and subcutaneous lipids).
Saturation bands were also positioned around the volume of interest (VOI)
to suppress signals from excited regions outside the VOI, and to provide good
fat suppression.
6.4 Relapse prediction
6.4.1 Preprocessing
6.4.1.1 Image registration
All the images were registered to the pre-radiotherapy T1-weighted after
gadolinium injection (T1-Gd) dataset. The registration was performed us-
ing an automatic 3D intensity-based registration algorithm [Gholipour et al.,
2007]. The basic principle of intensity-based techniques is to search, in a
certain space of transformations, the one that maximizes (or minimizes) a
criterion or cost function (metric) measuring the intensity similarity of cor-
responding voxels [Khunt and Makwana, 2012]. The intensity-based regis-
tration algorithm determines iteratively the transformation that is applied
to the misaligned volume (moving volume) according to a specified trans-
formation type. The metrics considered in this work were mean squared
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difference [Thevenaz et al., 1998; Kybic and Unser, 2003] for monomodal
registration, and mutual information [Viola and Wells, 1997; Pluim et al.,
2003] for multimodal registration. The geometric transformation applied to
the moving volume at each iteration was an affine transformation (consisting
of translation, rotation, scale, and shear). The registration algorithm was
developed using the functions imregconfig and imregister from the Image
Processing Toolbox of Matlab (R2013a). The MRSI spectroscopic grid was
assumed to be registered with the T1-Gd images, since they were acquired
consecutively. Only voxels within the volume of interest (VOI) of the MRSI
box were considered.
The site of relapse was considered as the new appearing CE areas on T1-Gd
images, excluding CE before RT (Figure 6.2) or resection cavity for patients
without initial CE (Figure 6.3). The regions of CE were manually contoured
on both the pre- and post-radiotherapy T1-Gd images by experienced medical
staff using the SUMMER prototype.
Figure 6.2: Registered T1-weighted images after gadolinium injection of a
non-resected patient: pre-RT (left), relapse (middle), site of relapse defined
(white arrow) as CE at relapse (red contour) excluding excluding excluding
CE before RT (light blue contour) (right).
Preprocessing applied to in vivo MRSI spectra included residual water sup-
pression (using the Hankel singular value decomposition (HSVD)
algorithm [Laudadio et al., 2002]), frequency alignment and standard poly-
nomial baseline correction.
132
Figure 6.3: Registered T1-weighted images after gadolinium injection of a
resected patient: pre-RT (left), relapse (middle), site of relapse (white arrow)
defined as CE at relapse (red contour) excluding resection cavity (light blue
contour) (right).
6.4.2 Feature extraction
Any classification method uses a set of features or parameters to characterize
each object to be classified. In our study, the objects are brain regions (vox-
els) characterized by features derived from the combination of MR imaging
and spectroscopic data. Transforming the input data into a set of features
is called feature extraction. The set of features used has a big influence in
the classification performance, computational efficiency, and results inter-
pretability of the classifier [Nguyen and De la Torre, 2010]. Based on data
availability and on previous works combining MRI and MRS(I) data to build
classifiers for brain tumor diagnosis [Devos et al., 2005; Luts et al., 2007;
Lee and Nelson, 2008], the feature space used in the present study com-
bines intensity values from different MR imaging modalities and metabolic
information extracted from MRSI data.
6.4.2.1 MRI features
The intensities from two MRI modalities were considered in this study: T1-
Gd and FLAIR. This selection was based in data availability. In order to
combine information from MRI and MRSI, the resolution of the MRI images
was lowered to the one of the MRSI. This was performed by averaging MRI
pixel intensities within each MRSI voxel as proposed in [Simonetti et al.,
2003; Luts et al., 2009] (Figure 6.4).
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Figure 6.4: The resolution of the MRI images was lowered to the one of the
MRSI by averaging MRI pixel intensities within each MRSI voxels. Only
voxels within the VOI of the MRSI box (red) were considered.
6.4.2.2 MRSI features
Regarding the spectroscopic data, the full MR spectra can be used as in-
put for the classification method. In that case, all the spectral points are
considered as features. Results from previous works on brain tumor diagno-
sis [Lukas et al., 2004; Menze et al., 2006] suggest that using the full spectrum
provides a better performance of the classification algorithms. However, re-
duction of these features to a smaller number can minimize redundancy and
exclude noise and artifacts often present in the spectrum. In addition, the re-
duction of features can help to improve the performance, decrease the amount
of complexity, and simplify the calculation. In this context, quantification
can be considered as a feature extraction and dimensionality reduction tech-
nique. Additionally, quantification provides a biological interpretation of MR
spectra that can be useful to interpret the results. Therefore, MRSI spectra
were quantified using the method described in Chapter 5. The spatial and
spectral regularization parameters of this method (Equations [5.7] and [5.8])
were both set to 0.05 for all the MRSI datasets. Spectra showing large quan-
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tification errors were discarded. The R-square value of the quantification fit
was used as criterion [Carpenter, 1960; Draper et al., 1966]:
R-square = 1−
∑N
i=1(si − fi)2∑N
i=1(si − s¯)2
, [6.1]
where s = [s1, ..., sN ] is the spectrum, f = [f1, ..., fN ] is the quantification
fit and s¯ is the mean of the spectrum. R-square can take any value between
0 and 1, with a value closer to 1 indicating a better fitting. Spectra with
R-square lower than 0.6 were automatically rejected (Figure 6.5).
R-square = 0.96 R-square = 0.46
R-square = 0.39 R-square = 0.47
Figure 6.5: Spectrum suitable for quantification (top left); spectra discarded
for further analysis due to lipid contamination (top right), water contamina-
tion (bottom left) and overlapping Cho and Cr peaks (bottom right).
The peak areas of N-acetyl-aspartate (NAA), creatine (Cr), choline (Cho),
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lactate (Lac) and lipids (Lip) were estimated. Metabolite ratios describing
the relative levels of Cho to NAA, Cho to Cr and Lac to NAA were also
estimated.
6.4.2.3 Spatial correlation
It is well known that MR sequences cause a certain point spread leading
to MR signals that are spatially correlated. In the context of MRSI, the
slow decay of the point spread function results in cross talk between spectra
from adjacent spatial regions. In addition, the information of a MRSI voxel
is highly statistically dependent on the values of its neighbors (surround-
ing voxels) since regional tissue patterns (histopathological classes) normally
cover neighbouring voxels. Most classification methods do not incorporate
spatial neighborhood information and treat the data as independent obser-
vations. Such methods label a voxel based on its feature properties and do
not consider spatial correlations between neighboring voxels. In the presence
of experimental artifacts, those classifiers can label single voxels with a dif-
ferent class from the neighborhood. Spatial information can help to avoid
undesired isolated voxels and to make the edges between different classes
more clearly defined. In addition, it may disambiguate the classification
problem in case of significant overlap among tissue classes. In fact, it has
been shown that properly fusing spectral information with spatial-context
information results in an increased robustness to noisy training sets in the
learning phase of the classifier [Bruzzone et al., 2007]. In this work, in order
to take into account the spatial correlation between neighbouring voxels, the
feature set characterizing each MRSI voxel included the values of the features
in the surrounding 3× 3 neighborhood (Figure 6.6). The selection of a 3× 3
neighbourhood is based in the fact that the point spread function is usually
narrow (the effective voxel size is normally less than 1.5 times the nominal
voxel size) [Siemens, 2005].
6.4.2.4 Data normalization
Because SVM algorithms assume that each feature contributes equally to
the classification results, all values were normalized between −1 and 1. The
summary of the all the extracted features is shown in Table 6.1.
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Figure 6.6: Neighbourhood regions (blue) that are taken into account for
each voxel (red) in the MRSI grid.
Image intensities Metabolite peak areas Metabolite ratios
T1-wg Gado Cho Cho/NAA
FLAIR Cr Cho/Cr
NAA Lac/NAA
Lac
Lip
MRI pixel intensities
averaged within each MRSI voxel 3× 3 Neighbourhood
Table 6.1: Set of features used for the classification.
6.4.3 Support Vectors Machine
Using as input the set of features extracted from pre-treatment multi-parametric
MR data as described above, a supervised learning system based on support
vector machines (SVM) was trained to generate a probability map of relapse
for GBM patients. SVM [Cortes and Vapnik, 1995; Cristianini and Shawe-
Taylor, 2000] is among the most popular machine learning techniques because
it is easy to understand and to interpret. SVM-based classifiers have shown
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to provide good performances in previous works in the context of multipara-
metric MR data [Devos et al., 2005; Luts et al., 2007]. The basic idea behind
support vector machines is illustrated with the example shown in Figure 6.7.
Given a training set with points (samples) that belong to two classes, it finds
the best hyperplane to differentiate between the two types of points (classes)
(i.e. the distance between the hyperplane and the closest training points is
maximized). In this example the data is assumed to be linearly separable.
Therefore, there exists a linear hyperplane (or decision surface) that sepa-
rates the points into two different classes. In the two-dimensional case, the
hyperplane is simply a straight line. The minimal distance from the separat-
ing hyperplane to the closest training point is called margin. The training
samples that lie on the margin define the border between the two classes and
are referred to as support vectors.
Figure 6.7: Given a linearly separable training set, SVM finds the best hy-
perplane (straight line in the two-dimensional case) that differentiate the two
classes (left). The minimal distance from the separating hyperplane to the
closest training point is called margin. The training samples that lie on the
margin are referred as support vectors (right).
If training data are not linearly separable in the original space, they can be
mapped to a higher dimensional space by using what is called a kernel func-
tion. By employing kernel transformations to map the samples from their
original space into a higher-dimensional feature space, SVM can separate ob-
jects which are not linearly separable (Figure 6.8). Kernel-based techniques
are less sensitive to the amount of data and the input dimension than other
methods (like K-Nearest Neighbour [Samadzadegan et al., 2010] or Linear
Discriminant Analysis [Devos et al., 2005]) and are able to detect automat-
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ically important characteristics independently of the input pattern [Devos
et al., 2005].
Figure 6.8: The kernel function transforms the data into a higher dimensional
space to make it possible to perform the separation. Edited from [Statnikov
et al., 2011].
6.4.3.1 Kernel selection and parameters tuning
Several kernels can be used to map the input features into a higher-dimensional
space, according to the nature of the data. The performance of the SVM
algorithms closely depends on the kernel function and its corresponding pa-
rameters. The most widely used kernels includes linear, polynomial and
radial basis (RBF) functions. In this study, we used the RBF kernel because
non-linear techniques may improve the classification performance [Suykens
and Vandewalle, 1999], and they have shown to provide better classification
accuracy than other kernel functions in previous works [Devos et al., 2005;
Luts et al., 2007]. In addition, it is worth noticing that the linear kernel is
a special case of RBF kernel. A second reason to use this kernel is the num-
ber of hyperparameters which influences the complexity of model selection,
which is lower than with other non-linear kernels, such as the polynomial
kernel.
There are two parameters that can be tuned in the RBF kernel and which
depend on the input data: a parameter which determines the trade-off be-
tween minimizing the training errors and minimizing the model complexity
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(C) (a small value for C means the margin is calculated using many or all
of the observations around the separating line (more regularization); a large
value for C means that the margin is calculated on observations close to the
separating line (less regularization)), and the radius (or width) of the kernel
(γ). The performance of the SVM classifier strongly depends on the choice of
these parameters. Different techniques have been proposed to estimate the
optimal parameters for an RBF kernel [Chapelle et al., 2002; Ayat et al., 2002;
Ahn, 2010]. In this study we have considered two well-known approaches: a
grid-search strategy [Hsu et al., 2003] and the Jaakkola’s heuristic [Jaakkola
et al., 1999]. More details about these methods and their application to our
data can be found in the next Section 6.5.
6.5 Results
In order to build an optimal classifier for our data, a grid-search strategy was
employed to find the optimal parameters (C and γ) of the RBF kernel. To
this aim, we performed a two-dimensional grid search over the possible val-
ues of the parameters C and γ. A coarse grid search was initially conducted
(Figure 6.9). After identifying the best region on the grid, a finer grid search
on that region was performed. For each combination of the parameters,
the SVM method was trained and tested using leave-one-out-cross-validation
(LOOCV). LOOCV is a simple cross-validation in which each training set is
created by taking all the samples except one, and the test set is the sample
left out. Thus, for n samples, we have n different training sets and n differ-
ent test sets. The optimal parameters were selected based on the accuracy
(area under the curve), sensitivity and specificity. For patients in the conven-
tional arm of the trial, the optimal values empirically estimated for C and γ
were 1 and 0.025, respectively. The publicly available library libsvm [Chang
and Lin, 2011] was used to perform the SVM-based classification. More pre-
cisely, the two-class C-support vector classification (C-SVC) formulation was
used [Boser et al., 1992; Cortes and Vapnik, 1995]. This formulation has an
extension to provide probability estimates [Platt, 2000; Wu et al., 2004; Lin
and Weng, 2004] (to generate the probability maps). The output of the clas-
sifier are then class probabilities. This means that instead of binary output
scores (0 for “no relapse” and 1 for “relapse”) we get probability values for
each class.
We compared the results from the SVM method (using the estimated optimal
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Figure 6.9: Optimal parameter selection. A coarse (top) and fine (bottom)
grid search is performed to find the optimal hyperparameters C and γ for
the RBF kernel. A balance between accuracy, sensitivity and specificity is
employed for the decision of the parameters.
parameters) with the standard CNI index described in Section 3.3.1.3 [McK-
night et al., 2001]. For comparison purposes, the probability maps generated
with the SVM approach were thresholded with a value of 0.5. Thus, only
voxels with values higher than 0.5 on the probability map were considered
to predict the site of relapse. As the classes might be unbalanced (there are
much less voxels that relapse than voxels that do not relapse), it is more
appropriate to use the sensitivity (the ratio of true positives and the sum
of true positives and false negatives) and the specificity (the ratio of true
negatives and the sum of false positives and true negatives) as performance
measures [Luts et al., 2007] (see Figure 6.10).
The sensitivity and specificity of the proposed method were 0.80 (±0.19)
and 0.87 (±0.09), respectively. The optimal threshold for the CNI index
was estimated (for all the cohort of patients) from the receiver operating
characteristic (ROC) curve [Swets, 1988] (Figure 6.11). A ROC curve is a
plot of the sensitivity or true positive rate (TPR) (on the y-axis) versus (1
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Figure 6.10: One of the most important tasks of ROC analysis is the de-
termination of the optimal cutoff value. If the position of the threshold is
varied, sensitivity and specificity are also changed. Edited from [Vranova
et al., 2009].
- specificity) or false positive rate (FPR) (on the x-axis) for different cut-off
points of a parameter (CNI in this case) (Figure 6.11).
As it can be seen in Figure 6.11, the optimal CNI threshold was estimated us-
ing three different methods. The conventional “minimum distance” approach
assumes that the best cut-off is the point on the ROC curve closest to the (0,1)
point, i.e. high up on the left-hand side of the graph (where sensitivity=1
and specificity=1). The CNI threshold estimated by this approach was 1.78,
and the corresponding sensitivity and specificity values were 0.56 (±0.25)
and specificity 0.72 (±0.13). The Youden index assigns the cut-off value to
the point on the ROC curve for which the sum (sensitivity + specificity)
is maximal [Youden, 1950; Reiser, 2000]. The CNI threshold obtained us-
ing this method was 2.67, and the corresponding sensitivity and specificity
values were 0.38 (±0.23) and specificity 0.94 (±0.14). In order to find the
CNI threshold that maximizes and balances simultaneously the specificity
and the sensitivity, the point on the ROC curve for which the sum (sensi-
tivity + specificity) is maximal and the difference |(sensitivity− specificity)|
is minimal was estimated. The CNI threshold obtained using this method
was 1.55, and the corresponding sensitivity and specificity were 0.62 (±0.25)
and a specificity of 0.63 (±0.13). Table 6.2 summarizes the results form the
proposed method and the CNI index.
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Figure 6.11: Receiver operating characteristic (ROC) curve for standard CNI
approach. The optimal cut-off points estimated using different methods are
displayed.
Threshold Sensitivity Specificity AUC
Minimum distance 1.78 0.56 (±0.25) 0.72 (±0.13)
Youden 2.67 0.38 (±0.23) 0.94 (±0.14) 0.70 (±0.16)
Balanced 1.55 0.62 (±0.25) 0.63 (±0.13)
SVM - 0.80 (±0.19) 0.87 (±0.09) 0.92 (±0.09)
Table 6.2: Performances of the CNI method and the proposed SVM-based
approach.
The proposed method provides higher sensitivity than the standard CNI ap-
proach for all the CNI thresholds analyzed. The specificity is also better
except for the CNI threshold estimated using the Youden index approach.
However, the high specificity for the CNI index in this case (0.94 ±0.14) is
related to a very low sensitivity (0.38 ±0.23). The ROC curves in Figure 6.12
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show that the presented approach also outperforms CNI in terms of accuracy
since it has a significantly higher area under the curve (AUC). In addition,
the proposed method is more robust across patients as demonstrated by the
lower variances for the accuracy, sensitivity and specificity. An example of
a probability map of relapse areas generated by the proposed approach is
shown in Figure 6.13. As it can be seen, relapse regions predicted by the
SVM-based method are in high accordance with the manually contoured re-
gion.
Figure 6.12: Receiver operating characteristic (ROC) curves for the proposed
method (blue) and for the standard CNI approach (red). The corresponding
areas under the curve (AUC) are also displayed.
The bar plot in Figure 6.14 clearly shows that the combined use of MRI and
MRSI improves the performance of the classifier. The results obtained using
the CNI method are also displayed for comparison purposes.
It is worth noting that SVM methods predict only class labels without
probability information. In this study we have used an extension to derive
class probability estimates [Platt, 2000; Wu et al., 2004; Lin and Weng, 2004;
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Figure 6.13: Pre-RT T1-Gd (top), probability maps of GBM relapse gen-
erated by the proposed approach (middle) and reference manual contours
of the relapse for a given patient (bottom). Each slice represents a slice in
the axial view. Dark blue on the probability maps indicate voxels where
metabolic information was not available. The areas at risk of relapse pre-
dicted by the proposed approach (using MR data acquired before RT) are in
clear accordance with the manually contoured relapse regions.
Chang and Lin, 2011]. Alternatively, regression approaches like ridge logistic
regression or elastic net could have been also considered. Logistic regression
and elastic nets perform pretty similar than traditional linear SVMs [Gareth,
2013]. However, logistic regression also allows kernel extensions [Zhu and
Hastie, 2012], and elastic net regularization can be combined within the SVM
method in order to perform feature selection with SVM classification. In ad-
dition, elastic nets can be helpful in classification problems where the number
of features is much higher than the number of obervations, and where fea-
tures are highly correlated. However, compared to these approaches, more
efficient and well documented libraries are available for SVM approaches. It
is relevant to mention here that, recently, it has been shown that any elas-
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Figure 6.14: The combined use of image intensities and spectroscopic infor-
mation improves the accuracy of the classifier.
tic net regression problem can be reduced to SVM classification Zhou et al.
[2015]. Therefore, elastic net problems can be efficiently solved using the
existing optimized SVM algorithms to obtain a highly optimized solver for
the elastic net.
6.6 Conclusion
A learning system based on SVM trained with multi-parametric MR data
has been presented. Reported results imply that this learning scheme can
provide probability maps indicating the areas of relapse of GBM. This study
has shown that, in comparison with single-variable classifiers like the CNI
index, it is possible to increase the cross-patient robustness by using a multi-
parametric set of features through machine learning techniques. The results
suggest the potential of multi-parametric MR data in addressing specific
questions in GBM management. A key finding of this study, from the tumor
biology perspective, is that metabolic features in the pre-treatment scan ap-
pear to provide relevant information to predict the tumor relapse. Future
work includes the assessment of the method with a larger cohort of patients
and the integration of other imaging modalities. Combining dimension re-
duction techniques with SVM classifiers can also be considered in order to
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improve the classification performance. The integration of the RT dose into
the features space would be an interesting approach to be addressed in future
works.
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MRSI unmixing
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7.1 Introduction
As shown in Chapter 5, quantification is the conventional method to ex-
tract information from MRSI data. Quantification results are influenced
by the presence of artifacts in the data and the choice of the quantifica-
tion algorithm. Therefore, alternative approaches to interpret MRSI data
are emerging. This chapter describes a novel spectral unmixing algorithm
for brain tissue classification and visualization of tumor spread using MRSI
data [Laruelo et al., 2016a]. Different experiments with in-vivo MRSI data
are shown to demonstrate the ability of the algorithm to extract physically
meaningful patterns and its robustness against the presence of low quality
spectra.
7.2 Motivation
Conventional magnetic resonance imaging (MRI) is widely used for the di-
agnosis and follow-up of brain tumors due to its ability to provide detailed
information about brain structures. Nevertheless, MRI does not always have
sufficient specificity to identify different pathological areas in heterogeneous
brain tumors. MR spectroscopic imaging (MRSI) helps to overcome this
limitation as it is able to characterize biochemical changes in brain tissues
before they become visible in conventional MRI [Laprie et al., 2008; Deviers
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et al., 2014]. The existence of areas with different metabolic profiles lead-
ing to different treatment response have been reported in previous studies.
1H MRSI has been proved to highlight the metabolically active areas of the
tumor in high-grade gliomas [McKnight et al., 2002; Pirzkall et al., 2004].
This metabolic tool is also able to characterize hypoxic areas associated with
a poorer response to radiotherapy treatments [Deviers et al., 2014]. On the
other hand, many studies have reported metabolic evidence of microscopic
tumor activity/infiltration beyond the borders of the contrast-enhancing le-
sions and lesions appearing as hyperintense on T2-weighted MR images of
both patients with recurrent and newly diagnosed gliomas [Patel et al., 1999;
Burtscher et al., 2000; Graves et al., 2000; Pirzkall et al., 2001]. The results
from these studies demonstrate that, on average, one third to one half of the
non-enhancing regions of malignant glioma contain active tumor that, if left
untreated, may have a negative impact on patient survival [McKnight et al.,
2002]. Therefore, the ability to identify different metabolic tumor areas and
tumor activity in the nonenhancing regions is crucial for the management of
most brain tumors.
Supervised pattern recognition methods relying on known spectral models
have been widely used to discriminate between brain tissue types. How-
ever, the outcome of these methods strongly depends on the prior knowledge
considered and the algorithm used [Mosconi et al., 2014b]. In addition, su-
pervised methods require a large number of expert-labeled spectra which are
not always available. Blind source separation (BSS) techniques appear as
an interesting alternative for the analysis of MRSI data as they allow to es-
timate the sources and their abundances without (or with very little) prior
knowledge. Different BSS methods have been proposed in the context of
neuro-oncology to distinguish normal from abnormal spectra. Most of these
methods are variants of the well-known non-negative matrix factorization
(NMF) algorithm [Lee and Seung, 1999]. Sajda et al. [Sajda et al., 2004]
proposed a constrained non-negative matrix factorization method to extract
physically meaningful tissue patterns from long-echo time (TE) MRSI data.
Ortega-Martorel et al. [Ortega-Martorell et al., 2012] used convex NMF for
brain tumor delineation on pre-clinical data. Li et al. [Li et al., 2013] intro-
duced a hierarchical NMF method able to identify normal, tumor and necro-
sis tissues in glioblastoma (GBM) patients. All these methods are heavily
dependent on the initialization values and/or require the sources to be non-
negative. The use of non-negative sources can be a clear limitation for the
analysis of MRSI data given that MR spectra can take negative values (such
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as the inverted lactate peak for long-TE data.)
Recently, BSS methods exploiting not only the spectral but also the spatial
context of the signals have been proposed [Gillis, 2012]. These algorithms
incorporate spatial priors based on smooth spatial variations or on the spar-
sity of the abundance matrix. In this chapter we describe a method which
jointly incorporates prior knowledge about the spatial and spectral dimen-
sions of MRSI data. The originality of this method lies in the combination
of spectral and spatial priors in a transformed domain into a spectral unmix-
ing procedure, as well as the control of the non-negativity constraint for the
sources. It aims at increasing the signal-to-noise ratio (SNR) of the data and
favoring solutions with few irregularities in the spatial and the spectral di-
mensions. The proposed method is able to extract more than two physically
meaningful tissue patterns and it is not restricted to non-negative sources.
In addition, the convergence to a global optimal solution is guaranteed since
this algorithm relies on the optimization of convex functions. Furthermore,
it is robust to noise and to the presence of low quality spectra.
7.3 Blind Source Separation
BSS methods assume that the measurements (spectra) can be expressed as
linear mixtures of sources plus some noise. This can be expressed in matrix
form as follows:
Y = SA+N , [7.1]
where Y ∈ RM×R is the data matrix in which each column is a measurement
(real or magnitude spectrum) involving M spectral points and R spatial
positions, S ∈ RM×K is the unknown source matrix in which each column
is a source, A ∈ RK×R is the unknown mixing matrix which defines the
contribution (abundance) of each source in each spatial position (voxel) and
N is the unknown noise matrix accounting for instrumental noise and/or
model imperfections. Note that the sources matrix S in equation [7.1] is
equivalent to the matrix B in equation [5.3] of Chapter 5. However, while
B is a known matrix in Chapter 5, in the current problem [7.1] S needs to
be estimated together with the abundances matrix A.
BSS methods aim at estimating both A and S from the measured data
Y . Under the assumption of independent and identically distributed (i.i.d.)
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Gaussian noise, the maximum-likelihood estimator is defined by the standard
problem:
(Ŝ, Â) = arg min
S,A
1
2
‖Y − SA‖22. [7.2]
The problem [7.2] is ill-posed in the sense that it has an infinite number
of solutions. In order to find an optimal solution of [7.2] it is standard to
constrain A and/or S to privilege solutions with desired properties. These
constraints can be seen as prior information injected in the resolution of [7.2].
The following sections describe the priors used in this work.
7.3.1 Spectral prior
In many applications, sources are considered sparse as for the case for MRSI
spectra. In the wide sense, a sparse signal is a signal that can be expressed
with only few non-zero coefficients, or can be well approximated in such a
way. The sparsity of the sources can be enforced by constraining their `1
norm, which leads to the following optimization problem:
(Ŝ, Â) = arg min
S,A
1
2
‖Y − SA‖22 + α1‖S‖1, [7.3]
where α1 ∈ R+ controls the trade-off between data fidelity and prior infor-
mation. In order to better model this kind of signals, one can express them
in a different domain where the sparsity is more noticeable. In this chapter,
we exploit the fact that the sources are sparse in the wavelet domain leading
to the following problem:
(Ŝ, Â) = arg min
S,A
1
2
‖Y − SA‖22 + α1‖TS‖1, [7.4]
where T is a dyadic 1D orthonormal wavelet decomposition operator.
7.3.2 Spatial prior
As shown in Chapters 4 and 5, recent methods to process MRSI data incor-
porate not only the spectral, but also the spatial context of the signals by
incorporating spatial priors [Nguyen et al., 2010; Sava et al., 2011; Kelm et al.,
2012; Laruelo et al., 2013a]. MRSI signals are no longer processed individu-
ally but the intrinsic spatio-spectral nature of the data is exploited by taking
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advantage of the correlations between spatial and spectral neighbors. Follow-
ing this idea, some BSS methods have targeted the integration of contextual
information to guide the sources extraction and/or the abundances estima-
tion steps. Previous BSS methods favor smooth spatial variations or spatial
sparsity by imposing appropriate constraints on the mixing-matrix A [Kim
and Haesun, 2008; Moudden et al., 2009; Gillis and Plemmons, 2012]. We
propose a novel spatial prior which, together with the spectral term, increases
the signal-to-noise ratio (SNR) of the data and exploits the neighbouring in-
formation along the spatial dimension for a given MRSI voxel. The proposed
criterion to be minimized can be written as follows:
arg min
S,A
1
2
‖Y − SA‖22 + α1‖TS‖1 + α2
M∑
m=1
‖F (SA)m‖1, [7.5]
where α2 ∈ R+ is the regularization parameter of the spatial prior informa-
tion, m = 1, ...,M is the spectral frequency, (SA)m is the 2D image which
results from reshaping the mth column of SA and F is a dyadic 2D orthonor-
mal wavelet decomposition operator.
7.3.3 Non-negativity constraints
The entries of both the abundances A and the sources S are often assumed
to be non-negative. This is always true for A since the mixture coefficients
are function of the relative concentrations of the observed physical entities,
which are necessarily non-negative. However the non-negativity assumption
does not always hold for MRSI spectra that may include negative peaks (as
it is the case of the inverted lactate peak for long-TE MRSI data). BSS
methods based on NMF are limited to use absolute or truncated spectra
(negative values set to zero). In order to avoid this limitation, we propose
to relax the non-negativity constraint for the matrix of extracted sources as
follows:
(Ŝ, Â) = arg min
S,A
1
2
‖Y − SA‖22 + α1‖TS‖1 + α2
M∑
m=1
‖F (SA)m‖1
+ i+(A) + α3i
+(S), [7.6]
where i+ is the indicator function of the non-negative half line R+ = [0,+∞),
and α3 ∈ {0, 1} allows the relaxation of the non-negativity constraint of the
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sources. The indicator function of the non-negative half-line R+ is defined
as:
i+(x) =
{
0, if x ≥ 0;
+∞, otherwise.
7.3.4 Optimization procedure
The minimization of the objective function [7.6] can be carried out solving
alternately the convex subproblems with respect to A and S. However the
objective functions of both sub-problems are not differentiable, which pre-
vents the use of standard gradient-based algorithms for minimization. We
therefore propose to perform the minimization by using proximal splitting
methods [Combettes and Pesquet, 2008, 2011; Pustelnik et al., 2011] that,
as it has been shown in previous chapters (Chapter 4 and Chapter 5), have
already been successfully used in a number of recent works in convex opti-
mization [Chaari et al., 2011]. Proximal splitting methods aim at minimizing
convex functions which are not differentiable. The idea of these methods is
to split the cost function into the sum of several convex functions which are
alternately locally minimized. The marginal problem in S is a convex func-
tional that can be split into the sum of a convex smooth and two convex
non-smooth terms:
Ŝ = arg min
S
1
2
‖Y − SA‖22 + α1‖TS‖1 + α3i+(S). [7.7]
The smooth part of the objective function is the data fidelity term:
D(S) =
1
2
‖Y − SA‖22, [7.8]
where D is differentiable and its gradient ∇D(S) = (SA − Y )AT is L-
Lipschitz with L = ‖AAT‖2. On the other hand, the proximity operator of
the sum of the two non-smooth terms has an explicit form:
proxα1‖T.‖1+α3i+(.)(x) =
[
sign(x)[|x| − α1]+
]
+
, [7.9]
where [x]+ = max(x, 0),∀x ∈ R. Therefore, the problem [7.7] can be solved
using a well known proximal splitting algorithm: the forward-backward split-
ting algorithm (FBS) [Combettes and Pesquet, 2008]. However, we propose
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to solve the marginal problem in S by using the generalized forward-backward
(GFB) algorithm [Raguet et al., 2013] that is able to to cope with more than
one non-smooth terms. Using this approach, we can switch on and off any of
the terms (set α3 = 0 to allow sources with negative peaks for example), or
to keep the flexibility of incorporating other regularizations as, for example,
‖TS‖p with p > 1. The use of the GFB algorithm also keeps open the possi-
bility of incorporating more terms in the criterion [7.7], since it is among the
first algorithms able to deal with more than one non-smooth regularization
terms.
In the case of the subproblem in A, the term α2
∑M
m=1 ‖F (SA)m‖1, where
the non-smooth convex function ‖.‖1 ◦ F is evaluated on the product of the
the matrix S by the sought solution A, prevents us to consider in this case
the GFB algorithm used to solve the subproblem in S. We propose to solve
the minimization problem with respect toA using the simultaneous direction
method of multipliers (SDMM) described in [Combettes and Pesquet, 2008]
and already introduced in Chapter 5.
Using these algorithms to solve the subproblems in A and S, we can now
solve the unmixing problem [7.6] by alternating the updates of A and S for
a number of iterations. The steps of the proposed unmixing algorithm are
described in Algorithm 3.
Algorithm 3 BSS Algorithm
Set N,T, F, α1, α2, α3
Set NbSources = V CA(Y )
Set A0 = abs(randn(NbSources,NbSpectra))
for n = 1 to N do
Set A−1 = pinv(An−1)
Set Sn−1 = Y ∗A−1
Calculate Sn = GFB(Y ,An−1,Sn−1, T, α1, α3)
Calculate An = SDMM(Y ,An−1,Sn−1, F, α2)
end for
return S = SN
Normalize columns of AN .
return A = AN
154
7.4 Results
We have tested the proposed method on in-vivo MRSI data from 10 patients
with newly diagnosed GBM included in the prospective clinical trial Spectro-
Glio (see Chapter 2, Section 2.5.2.2). We show the results for different repre-
sentative cases: identification of intratumoral necrotic areas, discrimination
of necrosis and hypoxia and detection of tumor infiltration. The locations of
the tissue patterns were confirmed by experienced research staff involved in
the clinical trial. Data were acquired with a Siemens Avanto 1.5 T using a 3D
CSI sequence with water suppression, echo time (TE) of 135 ms, repetition
time (TR) of 1500 ms, 512 data points and 4 averages.
Preprocessing applied to in vivo MRSI spectra included residual water sup-
pression (using the Hankel singular value decomposition (HSVD)
algorithm [Laudadio et al., 2002]), frequency alignment and standard polyno-
mial baseline correction. The spectra were normalized to the same intensity
scale, with one being the maximum (absolute) peak intensity for every spec-
trum. This was accomplished by dividing all spectrum intensities by the
absolute maximum value.
We have used Vertex Component Analysis (VCA) [Nascimento and Biou-
cas Dias, 2005] to estimate the number of sources. Highly correlated sources
(Pearson’s correlation coefficient [Swinscow and Campbell, 2002] (ρ) higher
than a threshold) were automatically discarded. The threshold used for this
study was 0.8. Figures 7.1 and 7.2 show examples of uncorrelated sources
(Pearson’s coefficient below the selected threshold) and correlated sources
(Pearson’s coefficient above the selected threshold), respectively.
A was initialized as the absolute value of an i.i.d. Gaussian random matrix.
The values of the spatial and the spectral regularization parameters of the
objective function [7.6] were estimated by cross validation and set to α1 =
0.05 and α2 = 0.1. Regarding the wavelet decompositions, a Daubechies
basis with 2 vanishing moments over one resolution level was considered.
Fig. 7.4 shows a comparison of the proposed method (SSR) with two other
state-of-the-art BSS methods, accelerated HALS [Gillis and Glineur, 2012]
and preprocessed NMF (PNMF) [Gillis, 2012]. HALS stands for accelerated
hierarchical alternating least squares algorithm and was initially proposed
in [Cichocki et al., 2007]. This algorithm successively updates each column
of the observed data (Y ) with an optimal and easy to compute closed-form
solution. We have used the accelerated version of this algorithm proposed
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Figure 7.1: Sources with Pearson’s correlation coefficient below 0.8 (left).
Scatterplot of the two sources (right).
Figure 7.2: Sources with Pearson’s correlation coefficient above 0.8 (left).
Scatterplot of two sources (right).
in [Gillis and Glineur, 2012]. Preprocessed NMF, introduced in [Gillis, 2012],
is based on the preprocessing of the input data matrix (Y ) with the aim to
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obtain more well-posed NMF problems whose solutions are sparser. Both
algorithms have been run using the default parameters proposed by their
authors. In order to show the improvement due to the incorporation of the
spatial term, the results obtained when only the sparsity of the sources is
considered (α1 = 0.05 and α2 = 0 in [7.6]) are also displayed and referred
to as SSR-Spectro. While HALS and PNMF are able to extract only two
physically meaningful sources, SSR is able to detect three sources (normal
(j), tumor (k) and necrosis (l) in Fig. 7.4) that are in agreement with the
companion MRI image. Note that the abundance maps correspond to the
voxels within the volume of interest (VOI), i.e., the inner 10× 10 grid inside
the white rectangle. With “physically meaningful sources” we refer to spectral
sources that can be easily associated to a specific tissue type. Examples of
sources reflecting different tissue patterns are shown in Figure 7.3.
Figure 7.3: Spectral sources reflecting different tissue types.
Among the compared methods, SSR is the only one capable of identifying the
necrosis area even when only the spectral prior is considered (SSR-Spectro).
However, by adding the spatial term, the identification of the tumor and
necrosis regions is clearly improved and the sources are less correlated (mean
ρ is 0.65 for SSR and 0.74 for SSR-Spectro) and therefore more easily inter-
pretable than the sources obtained with SSR-Spectro. The identification of
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intratumoral necrotic tissue can be helpful in several situations. Necrosis may
help to distinguish anaplastic glioma from GBM [Fayed and Modrego, 2005],
as this finding is much more frequent in GBM. In fact, necrosis is the hall-
mark of glioblastoma and is caused by tumor hypoxia as a result of increased
cell proliferation and mitotic activity, as well as insufficient tissue perfusion.
On conventional contrast-enhanced T1-weighted images, tumor necrosis can
be easily diagnosed with the fact that necrotic zones are typically less en-
hanced, giving the tumor an appearance of irregular rim enhancing mass
(Figure 4(a)). However, imaging diagnosis of necrosis can be problematic
in early stages or in micronecrosis in which the necrotic region may show
to be enhanced or not enhanced at all. MRSI is able to show characteristic
metabolites accumulated in the necrotic regions, even when necrosis is not
clearly seen on contrast-enhanced T1-weighted images. Differentiating tumor
and therapy-related necrosis remains challenging because both entities share
similar imaging features, such as irregular rim-like contrast enhancement,
mass effect, and vasogenic edema [Hung-Wen et al., 2013]. MRSI has been
shown to differentiate between the two conditions. In the study of Nakajima
et al. [Nakajima et al., 2009], it was shown that the Lac/Cho ratios are sig-
nificantly higher in radiation necrosis than in tumor recurrence.
Another clinical application is the differentiation between ring-enhancing
brain abscesses and tumor necrosis on T1-weighted images as shown in [Lai
et al., 2002]. On the other hand, tumor necrosis is a significant prognos-
tic factor of survival. In [Martens et al., 2013], patients with tumor visible
necrosis had a median survival of 5.4 months whereas patients without tumor
necrosis had a median survival of 7.2 months. A likely explanation might be
the effect of hypoxia on radiosensitivity (hypoxia impacts on outcome by
reducing radiosensitivity).
For the comparison we have used magnitude spectra since HALS and SNMF
(NMF-based methods) are restricted to non-negative sources. This can be
a clear limitation because different tissue patterns may present similar mag-
nitude spectra. For example, the presence of lactate (marker of hypoxia)
and lipids (indicating the presence of necrosis) are of high diagnostic value
because these metabolites are not detectable in healthy brain tissue. How-
ever, in (long-TE) MRSI spectra the inverted peak of lactate occupies the
same resonant frequency as lipid, and both metabolites are difficult to dif-
ferentiate when using magnitude spectra. The regions of lactate most likely
represent areas of hypoxic but viable tumor, whereas the regions of mobile
lipid represent necrotic nonviable tissue. The separate detection of the two
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Figure 7.4: Left: Maps showing the spatial distribution of the different tissue
patterns (sources). Middle: sources related to normal tissue (a, d, g, j), tumor
(b, e, h, k) and necrosis (c, f, i, l). Right: T1-weighted after gadolinium
injection (top), voxels within the volume of interest (bottom).
metabolites is therefore important in studying the relationship between hy-
poxia and necrosis within a brain tumor [Cha, 2006]. Fig. 7.5 shows the
results provided by the proposed method using the real part of the spectra
for an MRSI dataset presenting hypoxic and necrotic tumor regions. The
spatially predominant (c) spectral pattern (g) corresponds to spectra with
normal levels of choline (Cho), creatine (Cr) and N-acetyl-aspartate (NAA)
and presence of lactate (Lac) throughout the FLAIR-enhanced area (b). SSR
is able to differentiate two different tumor patterns, the necrotic core (d)
(spectral pattern (h) showing the presence of lipids) and a hypoxic area (e)
(spectral pattern (i) showing high Cho, low NAA and presence of Lac). Ap-
part from the presence of Lipids, the spectral pattern showing necrosis (h)
presents abnormal metabolite levels (elevated Cho and low NAA). This pre-
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sumably corresponds to a mixture of tumor and necrosis tissues due to the
relatively large size of the MRSI voxels. In addition, the proposed method
is robust against the presence of bad quality spectra, which are grouped in
a separated pattern. This is the case of the fourth source (j) that represents
spectra where the NAA signal is obscured due to a severe lipid contamination.
Figure 7.5: T1-weighted after gadolinium injection (left) and voxels within
the volume of interest (right) (a); FLAIR (left) and voxels within the volume
of interest (right) (b); Maps showing the spatial distribution of normal tissue
(c), necrosis (d), hypoxia (e) and lipid contamination (f); Sources related to
normal tissue (g), necrosis (h), hypoxia (i) and lipid contamination (j).
Tumor infiltration into the normal tissue, beyond the contrast-enhanced or
abnormal MRI areas, is a well-known phenomenon that cannot always be dif-
ferentiated from edema on T2-weighted or FLAIR images. By using MRSI,
it is possible to discriminate both aspects: edema does not modify metabolic
ratios whereas the area of cellular infiltration usually demonstrates abnor-
mal Cho/NAA ratio [Nelson et al., 2002]. Fig. 7.6 shows that the proposed
method is also able to differentiate between tumor infiltration and edema in
peri-enhancing FLAIR/T2 areas. The spectral pattern of edema (j) shows
normal metabolic ratios, while tumor infiltration (f) shows a pattern (i) with
increased Choline and decreased NAA. The pattern of edema (j) shows re-
duced metabolite peaks possibly due to the presence of interstitial water
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that decreases the signal of the metabolites [Di Costanzo et al., 2003]. The
presence of Lac and decreased NAA are also in accordance with cerebral per-
itumoral edema [Riccia et al., 2007]. The map of tumor infiltration (f) is in
accordance with the later relapse of the patient (d).
Figure 7.6: T1-weighted after gadolinium injection and FLAIR images before
treatment (a) and (b); corresponding voxels within the volume of interest
(c); T1-weighted after gadolinium injection at relapse (d); Maps showing the
spatial distribution of normal tissue (e), tumor infiltration (f) and edema (g);
Sources related to normal tissue (h), tumor infiltration (i) and edema (j).
Figure 7.7 below, shows a recently resected patient. In this case, the resection
cavity shows remaining tumor with high levels of lipids indicating necrosis.
The tissue around the cavity does not shows signs of infiltration. The spectral
pattern in this area shows a sloping baseline which may result from the
presence of interstitial water from the edema [Di Costanzo et al., 2003].
In some cases, using a higher number of sources can provide additional infor-
mation about the heterogeneous distribution of the lesion. Figure 7.8 shows
the results for a biopsied patient before RT using 3 sources. The number of
sources was estimated using [Nascimento and Bioucas Dias, 2005] and the
the highly correlated sources were discarded as described above. The peri-
enhancing apparently oedematous area (a,b) shows presumed tumour with a
spectral pattern (f) with high levels of Cho and a highly abnormal Cho/NAA
ratio. Spectra in regions closer to the skull (e) are contaminated by lipids
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Figure 7.7: T1-weighted after gadolinium injection and FLAIR images before
treatment (a) and (b); Maps showing the spatial distribution of tumor tissue
(c), edema (d) and normal (e); Sources related to tumor (f), edema (g) and
normal tissue (h).
and are correctly identified by the proposed method. Figure 7.9 shows the
results for the same patient using 4 sources. Using an additional sources,
the method is able to discriminate between the tumor core (d) and tumor
infiltration (e). The area showing higher infiltration (e) corresponds to the
area of posterior relapse of the patient (c). This suggests that testing with
an additional source may be useful to extract more detailed information for
some cases.
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Figure 7.8: T1-weighted after gadolinium injection and FLAIR images before
treatment (a) and (b); Maps showing the spatial distribution of tumor tissue
(c), normal (d) and lipid contamination (e); Sources related to tumor (f),
normal (g) and lipid contamination (h).
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Figure 7.9: T1-weighted after gadolinium injection and FLAIR images before
treatment (a) and (b); T1-weighted after gadolinium injection at relapse
(c); Maps showing the spatial distribution of tumor tissue (d), infiltration
(e) normal (f) and lipid contamination (g); Sources related to tumor (h),
infiltration (i), normal (j) and lipid contamination (k).
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7.5 Conclusion
We presented a new blind source separation method which combines spatial
and spectral regularizations in the wavelet domain. The method exploits
magnetic resonance spectroscopic imaging data properties such as the spar-
sity of the spectra in the wavelet domain and the spatial regularity between
neighbouring voxels. Experiments on in-vivo data show that the proposed
method is able to extract more than two physically meaningful tissue patterns
easily interpretable. The abundance maps show spatially coherent and well
defined areas, in agreement with expert assesment conducted on companion
anatomical MRI images. Unlike previous existing methods, the proposed
strategy can deal with negative sources and is not sensitive to initialization.
In addition it is robust against noise and the presence of low quality spectra.
Future work includes a consistency analysis of the proposed method for a
larger group of patients.
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Chapter 8
Conclusion
MRSI is a non-invasive imaging modality which has demonstrated the ability
to characterize physiological changes in tissues before they become visible in
conventional MRI. Information provided by MRSI can be used to guide RT
treatments by the definition of biologically tailored target volumes for dose
escalation. Despite the numerous publications on the topic, the interpreta-
tion of MRSI data is still a challenging problem due to different factors such
as the low SNR of the signals, the overlap of spectral lines or the presence
of nuisance components. This PhD thesis has contributed to the develop-
ment of new processing algorithms able to achieve reliable results even under
degraded experimental conditions. This objective is addressed through a
methodological approach based on novel processing methods that incorpo-
rate prior knowledge on the MRSI data using a hybrid regularization in the
wavelet domain. Contrary to previous approaches, the suggested methods
combine two regularization terms to favor solutions with specific properties
in both the spatial and the spectral dimensions. Experiments on synthetic
and in vivo data have shown the benefit of using this type of regularization
in different applications. Chapter 4 described a method that exploits the
proposed regularization scheme to increase the SNR of MRSI data. It sup-
presses noise in MRSI signals in a non-constrained way. Results showed that
the SNR is increased while the spectral and the spatial features of the data
are preserved. This makes this technique suitable to describe the disturbed
lineshapes and the spatial variations exhibited by in vivo scans, especially in
the context of lesions. In Chapter 5, the proposed spatio-spectral regulariza-
tion is used to improve the robustness of the quantification of MRSI data.
Unlike previous quantification algorithms, which are restricted to spatially
smooth variations of the parameters, this method allows the use of other
prior knowledge such as the sparsity of the MRSI spectra in the wavelet
domains. Results demonstrated significant improvements in quantification
accuracy and robustness compared to well-known existing methods. In addi-
tion, the proposed algorithm was able to correctly quantify metabolites that
are missed by other methods due their lower concentrations. This quantifi-
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cation algorithm is then used as a feature extraction technique in Chapter 6,
where a supervised classification method for the identification of regions at
risk of relapse in brain tumor patients is described. Results from this work
showed the potential of integrating MRSI information in the RT treatment
planning. Finally, Chapter 7 presented a novel blind source separation tech-
nique for tissue classification based on the proposed spatio-spectral regular-
ization. This method showed to be robust against noise and the presence of
low quality spectra. Unlike other existing techniques, this algorithm is able
to extract many physically meaningful tissue patterns and can deal with neg-
ative sources.
In all the presented methods, regularization is used to inject prior knowledge
about the solutions in the wavelet domain. The dependency on only two
hyperparameters (weights of both regularization terms), and the use of fast
proximal algorithms that allows parallel computations facilitate the automa-
tion of these approaches, which is crucial for the acceptance of the MRSI
technique into the clinical routine. The proximal optimization algorithms
have been carefully chosen and adapted depending on the specificities of
each of the proposed methods.
This PhD opens the way for future developments and applications to be ad-
dressed in future works:
1) 3D regularization: extension of the proposed methods to incorporate 3D
spatial information available from 3D MRSI data.
2) Validation with high-spatial resolution data: validation of the presented
algorithms with high-spatial resolution MRSI data where the low signal-to-
noise ratio is a major limitation.
3)Integration of an automatic hyperparameter estimation method: develop-
ment of a fully auto-calibrated approach to automatically estimate the reg-
ularization parameters directly from the data.
4) Multi-parametric regularization: the proposed methods can be extended
to incorporate more sophisticated priors, such as tissue distributions, anatom-
ical configurations or functional information extracted from companion (MRI)
imaging modalities.
5) Spectral unmixing to improve spatial coverage: any classification method
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based on quantification estimates is limited by the fact that there are many
MRSI voxels where the quality of the spectra does not allow reliable quantifi-
cation. Spectral unmixing algorithms tend to be more robust against noise
and nuisance components than conventional quantification methods. They
can therefore be used as an alternative approach to obtain information from
those voxels where quantification is not possible. Combining information
from both techniques to build the feature space could be an interesting ap-
proach to improve the performance (more information from each voxel), and
the spatial coverage (more voxels with available information) of the classifi-
cation method.
6) Other MRI applications: all the experiments presented in this work have
been focused on brain data. It would be very interesting to process MRSI
data from other organs, like prostate or breast, with the proposed algorithms.
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Title:  
Integration of magnetic resonance spectroscopic imaging into the radiotherapy treatment planning 
 
Summary: 
The aim of this thesis is to propose new algorithms to overcome the current limitations and to 
address the open challenges in the processing of magnetic resonance spectroscopic imaging (MRSI) 
data. MRSI is a non‐invasive modality able to provide the spatial distribution of relevant biochemical 
compounds (metabolites) commonly used as biomarkers of disease. Information provided by MRSI 
can be used as a valuable insight for the diagnosis, treatment and follow‐up of several diseases such 
as cancer or neurological disorders. Obtaining accurate and reliable information from in vivo MRSI 
signals is a crucial requirement for the clinical utility of this technique. Despite the numerous 
publications on the topic, the interpretation of MRSI data is still a challenging problem due to 
different factors such as the low signal‐to‐noise ratio (SNR) of the signals, the overlap of spectral 
lines or the presence of nuisance components. This thesis addresses the problem of interpreting 
MRSI data and characterizing recurrence in tumor brain patients. These objectives are addressed 
through a methodological approach based on novel processing methods that incorporate prior 
knowledge on the MRSI data using a spatio‐spectral regularization. 
As an application, the thesis addresses the integration of MRSI into the radiotherapy treatment 
workflow within the context of the European project SUMMER (Software for the Use of Multi‐
Modality images in External Radiotherapy) founded by the European Commission (FP7–PEOPLE–ITN 
framework). 
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RESUME en français 
L'objectif de cette thèse est de proposer de nouveaux algorithmes pour surmonter les limitations 
actuelles et de relever les défis ouverts dans le traitement de l’imagerie spectroscopique par 
résonance magnétique (ISRM). L’ISRM est une modalité non invasive capable de fournir la distribution 
spatiale des composés biochimiques (métabolites) utilisés comme biomarqueurs de la maladie. Les 
informations fournies par l’ISRM peuvent être utilisées pour le diagnostic, le traitement et le suivi de 
plusieurs maladies telles que le cancer ou des troubles neurologiques. Cette modalité se montre utile 
en routine clinique notamment lorsqu’il est possible d’en extraire des informations précises et fiables. 
Malgré les nombreuses publications sur le sujet, l'interprétation des données d’ISRM est toujours un 
problème difficile en raison de différents facteurs tels que le faible rapport signal sur bruit des 
signaux, le chevauchement des raies spectrales ou la présence de signaux de nuisance. Cette thèse 
aborde le problème de l'interprétation des données d’ISRM et la caractérisation de la rechute des 
patients souffrant de tumeurs cérébrales. Ces objectifs sont abordés à travers une approche 
méthodologique intégrant des connaissances a priori sur les données d’ISRM avec une régularisation 
spatio‐spectrale.  
Concernant le cadre applicatif, cette thèse contribue à l'intégration de l’ISRM dans le workflow de 
traitement en radiothérapie dans le cadre du projet européen SUMMER (Software for the Use of 
Multi‐Modality images in External Radiotherapy) financé par la Commission européenne (FP7‐
PEOPLE‐ITN). 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